CancerPPD 2.0 - Browse by Length

Browsing by Length

Browse Results:

Filter by Year
From
Upto

ID	PMID	YEAR	Sequence	Name	Length	Linear/Cyclic	Chirality	Chem-MOD	C-ter MOD	N-ter MOD	Nature	Origin	Cell Line	Cancer Type	Assay	Activity	Testing Time	Tissue Affected	Patents
7675	38464729	2024	NCSIHGDIPAY	U7	11	Linear	L	None	Free	Free	Anticancer	Phoenix dactylifera	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 523 µM	48-h	Liver	None
7673	38464729	2024	NCSIHGDIPAY	U7	11	Linear	L	None	Free	Free	Anticancer	Phoenix dactylifera	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 554 µM	48-h	Breast	None
7674	38464729	2024	NCSIHGDIPAY	U7	11	Linear	L	None	Free	Free	Anticancer	Phoenix dactylifera	T-47D	Breast Cancer	MTT assay	IC₅₀ = 584 ± 29.99 µM	48-h	Breast	None
7666	38464729	2024	NGSIPATWASL	U3	11	Linear	L	None	Free	Free	Anticancer	Phoenix dactylifera	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 561 µM	48-h	Liver	None
7665	38464729	2024	NGSIPATWASL	U3	11	Linear	L	None	Free	Free	Anticancer	Phoenix dactylifera	T-47D	Breast Cancer	MTT assay	IC₅₀ = 517.6 ± 34.86 µM	48-h	Breast	None
7664	38464729	2024	NGSIPATWASL	U3	11	Linear	L	None	Free	Free	Anticancer	Phoenix dactylifera	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 555 µM	48-h	Breast	None
7652	37298595	2023	rRP-Hyp-G-Thi-S-(D)Pip-Thi-R	BK-7	10	Linear	Mix	Hyp = hydroxyproline; Thi = thienylalanine; (D)Pip—(D)-piperidine-2-carboxylic acid	Free	Free	Anticancer	Synthetic analogue of Bradykinin	HCT-116	Colorectal Cancer	MTS assay	Not Available	24-h	Colon	None
7653	37298595	2023	Aaa-rRP-Hyp-G-Thi-S-(D)Pip-Thi-R	BK-8	10	Linear	Mix	Hyp = hydroxyproline; Thi = thienylalanine; (D)Pip—(D)-piperidine-2-carboxylic acid	Free	Aaa = [(3S,5S,7S)-adamantan-1-yl]acetic acid	Anticancer	Synthetic analogue of Bradykinin	HCT-116	Colorectal Cancer	MTS assay	Not Available	24-h	Colon	None
7650	37298595	2023	rRP-Hyp-G-Thi-S-f-(L)Pip-R	BK-5	10	Linear	Mix	Hyp = hydroxyproline; Thi = thienylalanine; (L)Pip—(L)-piperidine-2-carboxylic acid	Free	Free	Anticancer	Synthetic analogue of Bradykinin	HCT-116	Colorectal Cancer	MTS assay	Not Available	24-h	Colon	None
7651	37298595	2023	Aaa-rRP-Hyp-G-Thi-S-(D)Pip-(L)Pip-R	BK-6	10	Linear	Mix	Hyp = hydroxyproline; Thi = thienylalanine; (L)Pip—(L)-piperidine-2-carboxylic acid;(D)Pip—(D)-piperidine-2-carboxylic acid	Free	Aaa = [(3S,5S,7S)-adamantan-1-yl]acetic acid	Anticancer	Synthetic analogue of Bradykinin	HCT-116	Colorectal Cancer	MTS assay	Not Available	24-h	Colon	None
7648	37298595	2023	Aaa-rRP-Hyp-G-Thi-S-Acc-Thi-R	BK-3	10	Linear	Mix	Hyp = hydroxyproline; Thi = thienylalanine; Acc = 1-aminocyclohexane-1-carboxylic acid	Free	Aaa = [(3S,5S,7S)-adamantan-1-yl]acetic acid	Anticancer	Synthetic analogue of Bradykinin	HCT-116	Colorectal Cancer	MTS assay	Not Available	24-h	Colon	None
7649	37298595	2023	Aaa-rRP-Hyp-G-Thi-S-f-Acc-R	BK-4	10	Linear	Mix	Hyp = hydroxyproline; Thi = thienylalanine; Acc = 1-aminocyclohexane-1-carboxylic acid	Free	Aaa = [(3S,5S,7S)-adamantan-1-yl]acetic acid	Anticancer	Synthetic analogue of Bradykinin	HCT-116	Colorectal Cancer	MTS assay	Not Available	24-h	Colon	None
7646	37298595	2023	rRP-Hyp-G-Thi-S-Apc-Thi-R	BK-1	10	Linear	Mix	Hyp = hydroxyproline; Thi = thienylalanine; Apc =1-aminocyclopentyl-1-carboxylic acid	Free	Free	Anticancer	Synthetic analogue of Bradykinin	HCT-116	Colorectal Cancer	MTS assay	Not Available	24-h	Colon	None
7647	37298595	2023	rRP-Hyp-G-Thi-S-f-Apc-R	BK-2	10	Linear	Mix	Hyp = hydroxyproline; Thi = thienylalanine; Apc =1-aminocyclopentyl-1-carboxylic acid	Free	Free	Anticancer	Synthetic analogue of Bradykinin	HCT-116	Colorectal Cancer	MTS assay	Not Available	24-h	Colon	None
7622	37001908	2023	EYVQTVKSSKG	A11	11	Linear	L	None	Free	Free	Anticancer	Annexin A1	A-375	Skin Cancer	Biotin Pull Down assay	Not Available	24-h	Skin	None
7620	37001908	2023	EYVQTVKSSKG	A11	11	Linear	L	None	Free	Free	Anticancer	Annexin A1	MDA-MB-231	Breast Cancer	Biotin Pull Down assay	Not Available	24-h	Breast	None
7621	37001908	2023	EYVQTVKSSKG	A11	11	Linear	L	None	Free	Free	Anticancer	Annexin A1	H-460	Lung Cancer	Biotin Pull Down assay	Not Available	24-h	Lung	None
7618	36934526	2023	RLLRLLRLRRLLRL	WP2	14	Linear	L	None	Hydroxamic acid	Acetylation	Anticancer	Derived from RLL peptide	HepG-2	Liver Cancer	Cell Viability assay	IC₅₀ = 34.05 ± 0.53 μM	48-h	Liver	None
7619	36934526	2023	RLLRLLRLRRLLRL	WP2	14	Linear	L	None	Hydroxamic acid	Acetylation	Anticancer	Derived from RLL peptide	HT-29	Colon Cancer	Cell Viability assay	IC₅₀ = 42.6 ± 4.0 μM	48-h	Colon	None
7616	36934526	2023	RLLRLLRLRRLLRL	WP2	14	Linear	L	None	Hydroxamic acid	Acetylation	Anticancer	Derived from RLL peptide	HeLa	Cervical Cancer	HDAC inhibition assay	IC₅₀ = 0.446±0.095 µM	Not Available	Cervix	None
7617	36934526	2023	RLLRLLRLRRLLRL	WP2	14	Linear	L	None	Hydroxamic acid	Acetylation	Anticancer	Derived from RLL peptide	Huh-7	Liver Cancer	Cell Viability assay	IC₅₀ = 28.12 ± 1.5 μM	48-h	Liver	None
7613	36934526	2023	RLLRLMRLRMLLRM	WP1	14	Cyclic(M6-M10)	L	None	Hydroxamic acid	Acetylation	Anticancer	Derived from RLL peptide	Huh-7	Liver Cancer	Cell Viability assay	IC₅₀ = 43.74 ± 5.4 μM	48-h	Liver	None
7614	36934526	2023	RLLRLMRLRMLLRM	WP1	14	Cyclic(M6-M10)	L	None	Hydroxamic acid	Acetylation	Anticancer	Derived from RLL peptide	HepG-2	Liver Cancer	Cell Viability assay	IC₅₀ = 52.23 ± 0.9 μM	48-h	Liver	None
7615	36934526	2023	RLLRLMRLRMLLRM	WP1	14	Cyclic(M6-M10)	L	None	Hydroxamic acid	Acetylation	Anticancer	Derived from RLL peptide	HT-29	Colon Cancer	Cell Viability assay	IC₅₀ = 54.6 ± 2.1 μM	48-h	Colon	None
7612	36934526	2023	RLLRLMRLRMLLRM	WP1	14	Cyclic(M6-M10)	L	None	Hydroxamic acid	Acetylation	Anticancer	Derived from RLL peptide	HeLa	Cervical Cancer	HDAC inhibition assay	IC₅₀ = 0.310±0.064 µM	Not Available	Cervix	None
7602	37764521	2023	GAGIVVASIDTGVRVSHE	GE18	18	Linear	L	None	Free	Free	Antimicrobial	Aphanomyces invadans	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 35.34 µM	24-h	Breast	None
7599	36626098	2023	DLIWKLLSKAQEKFGKNKSR	LFampin265–284	20	Linear	L	None	Amidation	Free	Antimicrobial	Lectoferrin Peptide	Jurkat	Blood Cancer	MTT assay	cell viability ~ 47% at 10 µM	6-h	Blood	None
7598	36626098	2023	DLIWKLLSKAQEKFGKNKSR	LFampin265–284	20	Linear	L	None	Amidation	Free	Antimicrobial	Lectoferrin Peptide	HepG-2	Liver Cancer	MTT assay	cell viability ~ 50% at 1 µM	12-h	Liver	None
7597	36626098	2023	FKCRRWQWRMKKLG	LFcin17–30	14	Linear	L	None	Amidation	Free	Antimicrobial	Lectoferrin Peptide	Jurkat	Blood Cancer	MTT assay	cell viability ~ 70% at 20 µM	6-h	Blood	None
7596	36626098	2023	FKCRRWQWRMKKLG	LFcin17–30	14	Linear	L	None	Amidation	Free	Antimicrobial	Lectoferrin Peptide	HepG-2	Liver Cancer	MTT assay	cell viability ~ 50% at 1 µM	12-h	Liver	None
7593	36509220	2023	KLLKINLK(Aib)LAALAKKIL	KM8-Aib	18	Linear	L	Aib = 2-Aminoisobutyric acid	Amidation	Free	Antimicrobial	Synthetic derivative of KM8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
7592	36509220	2023	KLLKINLKALAALAKKIL	KM8	18	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic derivative of Mastoparan	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
7591	36509220	2023	INLKALAALAKKIL	Mastoparan	14	Linear	L	None	Amidation	Free	Antimicrobial	Wasp venom	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
7588	36567478	2023	DGDWDAWTRETS	mtp1	12	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	MTS assay	17.4% decrease in cell viability at 10 μM	24-h	Lung	None
7586	36567478	2023	DGDWDAWTRETS	mtp1	12	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTS assay	33.6% decrease in cell viability at 10 μM	24-h	Breast	None
7587	36567478	2023	DGDWDAWTRETS	mtp1	12	Linear	L	None	Free	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTS assay	30.2 % decrease in cell viability at 10 μM	24-h	Cervix	None
7575	37514049	2023	FAVWGCADYRGY	Salamandrin - I	12	Linear	L	None	Amidation	Free	Antioxidant	Salamandra salamandra	HL-60	Leukemia Cancer	LDH leakage assay	Absorbance ~ 2 at 490 nm at 27 27 µM	48-h	Blood	None
7574	37514049	2023	FAVWGCADYRGY	Salamandrin - I	12	Linear	L	None	Amidation	Free	Antioxidant	Salamandra salamandra	HL-60	Leukemia Cancer	MTT assay	IC₅₀ = 27 µM	48-h	Blood	None
7570	36730301	2023	VNWKKILGKIIKVVK	Lasioglossin - III	15	Linear	L	None	Amidation	Free	Antimicrobial	Lasioglossum laticeps	HepG-2	Liver Cancer	Not Available	IC₅₀ = 7.75 μM	Not Available	Liver	None
7569	36730301	2023	VNWKKILGKIIKVVK	Lasioglossin - III	15	Linear	L	None	Amidation	Free	Antimicrobial	Lasioglossum laticeps	A-549	Lung Cancer	Not Available	IC₅₀ = 26.36 μM	Not Available	Lung	None
7564	36910465	2023	KLWCKSSQVPQSR	ALA-A2	13	Linear	L	None	Free	Free	Anticancer	Alpha-Lactalbumin	HT-29	Colon Cancer	MTT assay	~50% cell viability	24-h	Colon	None
7563	36910465	2023	KLWCKSSQVPQSR	ALA-A2	13	Linear	L	None	Free	Free	Anticancer	Alpha-Lactalbumin	A-549	Lung Cancer	MTT assay	~50% cell viability	24-h	Lung	None
7560	37183466	2023	WKLFKKILKVL	CM11	11	Linear	L	None	Amidation	Free	Antimicrobial	Cecropin-Melittin Hybrid Peptide	Raji	Blood Cancer	MTT assay	Survival rate = 51% at 32 μg/ml	24-h	Blood	None
7559	37183466	2023	WKLFKKILKVL	CM11	11	Linear	L	None	Amidation	Free	Antimicrobial	Cecropin-Melittin Hybrid Peptide	Jurkat	Blood Cancer	MTT assay	Survival rate = 47% at 32 μg/ml	24-h	Blood	None
7544	36982610	2023	UKLUGGLUGI	K2-NH₂	10	Linear	L	U = 2-Aminoisobutyric acid	Amidation	Oct = 1-octanoyl	Antimicrobial and Antifungal	Trichogin GA	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 9 µM	24-h	Breast	None
7542	36982610	2023	UGLUKKLUGI	K56-Lol	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	Antimicrobial and Antifungal	Trichogin GA	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ =12 µM	24-h	Breast	None
7543	36982610	2023	UGLUGKLUGI	K6-NH₂	10	Linear	L	U = 2-Aminoisobutyric acid	Amidation	Oct = 1-octanoyl	Antimicrobial and Antifungal	Trichogin GA	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ =8 µM	24-h	Breast	None
7540	36982610	2023	UKLUKGLUKI	K259-Lol	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	Antimicrobial and Antifungal	Trichogin GA	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ =10 µM	24-h	Breast	None
7541	36982610	2023	UKLUKGLUGI	K25-Lol	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	Antimicrobial and Antifungal	Trichogin GA	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ =9 µM	24-h	Breast	None
7539	36982610	2023	UKLUKGLUKI	K259-NH₂	10	Linear	L	U = 2-Aminoisobutyric acid	Amidation	Oct = 1-octanoyl	Antimicrobial and Antifungal	Trichogin GA	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ =13 µM	24-h	Breast	None
7537	36982610	2023	UGLLGGLUGI	Leu4-NH₂	10	Linear	L	U = 2-Aminoisobutyric acid	Amidation	Oct = 1-octanoyl	Antimicrobial and Antifungal	Trichogin GA	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ > 20 µM	24-h	Breast	None
7538	36982610	2023	UKLUKKLUKI	K2569-Lol	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	Antimicrobial and Antifungal	Trichogin GA	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 12 µM	24-h	Breast	None
7536	36982610	2023	UGLUGGLZGI	Api8-NH₂	10	Linear	L	Z =4-aminopiperidine-4-carboxylic acid , U = 2-Aminoisobutyric acid	Amidation	Oct = 1-octanoyl	Antimicrobial and Antifungal	Trichogin GA	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ > 20 µM	24-h	Breast	None
7527	36678914	2023	P-Cha-Aib-Aib-IV-Aib-Aib-AMAE	trichoderin A analogue 4	10	Linear	L	AHMOD replaced by Cha(L-cyclohexylalanine); MDA = 2-methyl decanoic acid; Aib = a-aminoisobutyric acid;AMAE = 2-[(20-aminopropyl) methylamino] ethanol	Free	Free	Antitubercular	Trichoderin A	PANC-1	Pancreatic Cancer	CyQUANT Direct assay	IC₅₀ = 0.5 μM	24-h	Pancreas	None
7526	36678914	2023	MDA-P-Cha-Aib-Aib-IV-Aib-Aib-AMAE	trichoderin A	10	Linear	L	MDA = 2-methyl decanoic acid; AHMOD = 2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid; Aib = a-aminoisobutyric acid;AMAE = 2-[(20-aminopropyl) methylamino] ethanol	Free	Free	Antitubercular	Trichoderma sp. fungus, strain 05FI48	PANC-1	Pancreatic Cancer	CyQUANT Direct assay	IC₅₀ = 0.3 μM	24-h	Pancreas	None
7516	36678914	2023	MDA-P-Cha-Aib-Aib-IV-Aib-Aib-AMAE	trichoderin A	10	Linear	L	MDA = 2-methyl decanoic acid; AHMOD = 2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid; Aib = a-aminoisobutyric acid;AMAE = 2-[(20-aminopropyl) methylamino] ethanol	Free	Free	Antitubercular	Trichoderma sp. fungus, strain 05FI48	BxPC-3	Pancreatic Cancer	PrestoBlue assay	IC₅₀ = 0.4 μM	24-h	Pancreas	None
7517	36678914	2023	P-Cha-Aib-Aib-IV-Aib-Aib-AMAE	trichoderin A analogue 4	10	Linear	L	AHMOD replaced by Cha(L-cyclohexylalanine); MDA = 2-methyl decanoic acid; Aib = a-aminoisobutyric acid;AMAE = 2-[(20-aminopropyl) methylamino] ethanol	Free	Free	Antitubercular	Trichoderin A	BxPC-3	Pancreatic Cancer	PrestoBlue assay	IC₅₀ = 0.4 μM	24-h	Pancreas	None
7471	36687035	2023	RRWQWRWQWR	RR-1-R	10	Linear	L	None	Amidation	Free	Antibacterial and Anticancer	Synthetic analogue of LfcinB(21-25)Pal	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 68 µM	24-h	Breast	None
7472	36687035	2023	RRWQWRWQWR	RR-1-R	10	Linear	L	None	Amidation	Free	Antibacterial and Anticancer	Synthetic analogue of LfcinB(21-25)Pal	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 73 µM	24-h	Breast	None
7470	36687035	2023	RWQWRWQWRR	R-1-RR	10	Linear	L	None	Amidation	Free	Antibacterial and Anticancer	Synthetic analogue of LfcinB(21-25)Pal	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 95 µM	24-h	Breast	None
7468	36687035	2023	RRWQWRWQWRR	RR-1-RR	11	Linear	L	None	Amidation	Free	Antibacterial and Anticancer	Synthetic analogue of LfcinB(21-25)Pal	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 67 µM	24-h	Breast	None
7469	36687035	2023	RWQWRWQWRR	R-1-RR	10	Linear	L	None	Amidation	Free	Antibacterial and Anticancer	Synthetic analogue of LfcinB(21-25)Pal	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 122 µM	24-h	Breast	None
7467	36687035	2023	RRWQWRWQWRR	RR-1-RR	11	Linear	L	None	Amidation	Free	Antibacterial and Anticancer	Synthetic analogue of LfcinB(21-25)Pal	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 58 µM	24-h	Breast	None
7463	37818062	2023	FAAATGATPIAGR	P10	13	Linear	L	None	Free	Free	Anticancer	40S ribosomal protein fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 1.01 at 50 μg/ml	48-h	Bone	None
7461	37818062	2023	AAGTLYTYPENWR	P09	13	Linear	L	None	Free	Free	Anticancer	Eukaryotic Translation Elongation Factor 1 Gamma (Eef1G) fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 1.07 at 50 μg/ml	48-h	Bone	None
7462	37818062	2023	FAAATGATPIAGR	P10	13	Linear	L	None	Free	Free	Anticancer	40S ribosomal protein fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 1.08 at 50 μg/ml	48-h	Bone	None
7460	37818062	2023	AAGTLYTYPENWR	P09	13	Linear	L	None	Free	Free	Anticancer	Eukaryotic Translation Elongation Factor 1 Gamma (Eef1G) fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 0.85 at 50 μg/ml	48-h	Bone	None
7458	37818062	2023	NSNLVGAAHEELQQSR	P08	16	Linear	L	None	Free	Free	Anticancer	Lamin A/C (LMNA) fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 0.92 at 50 μg/ml	48-h	Bone	None
7459	37818062	2023	NSNLVGAAHEELQQSR	P08	16	Linear	L	None	Free	Free	Anticancer	Lamin A/C (LMNA) fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 1.06 at 50 μg/ml	48-h	Bone	None
7456	37818062	2023	VEPGLGADNSVVR	P07	13	Linear	L	None	Free	Free	Anticancer	FLNA (Filamin A) fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 0.96 at 50 μg/ml	48-h	Bone	None
7457	37818062	2023	VEPGLGADNSVVR	P07	13	Linear	L	None	Free	Free	Anticancer	FLNA (Filamin A) fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 0.96 at 50 μg/ml	48-h	Bone	None
7454	37818062	2023	GAGTGGLGLAVEGPSEAK	P06	18	Linear	L	None	Free	Free	Anticancer	FLNA (Filamin A) fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 0.92 at 50 μg/ml	48-h	Bone	None
7455	37818062	2023	GAGTGGLGLAVEGPSEAK	P06	18	Linear	L	None	Free	Free	Anticancer	FLNA (Filamin A) fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 1.17 at 50 μg/ml	48-h	Bone	None
7453	37818062	2023	HVFGESDELIGQK	P03	13	Linear	L	None	Free	Free	Anticancer	Triosephosphate Isomerase (TPI) fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 0.98 at 50 μg/ml	48-h	Bone	None
7451	37818062	2023	SETAPAAPAAPAPAEK	P01	16	Linear	L	None	Free	Free	Anticancer	Histone H1.4 (H1-4) Fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 1.13 at 50 μg/ml	48-h	Bone	None
7452	37818062	2023	HVFGESDELIGQK	P03	13	Linear	L	None	Free	Free	Anticancer	Triosephosphate Isomerase (TPI) fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 1.04 at 50 μg/ml	48-h	Bone	None
7449	37818062	2023	IGEHTPSALAIMENANVLAR	P04	20	Linear	L	None	Free	Free	Anticancer	Aldolase A fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 0.83 at 50 μg/ml	48-h	Bone	None
7450	37818062	2023	SETAPAAPAAPAPAEK	P01	16	Linear	L	None	Free	Free	Anticancer	Histone H1.4 (H1-4) Fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 0.84 at 50 μg/ml	48-h	Bone	None
7448	37818062	2023	IGEHTPSALAIMENANVLAR	P04	20	Linear	L	None	Free	Free	Anticancer	Aldolase A fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 0.86 at 50 μg/ml	48-h	Bone	None
7446	37818062	2023	AEEYEFLTPMEEAPK	P02	15	Linear	L	None	Free	Free	Anticancer	Rho GDP Dissociation Inhibitor Alpha fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 0.88 at 50 μg/ml	48-h	Bone	None
7447	37818062	2023	AEEYEFLTPMEEAPK	P02	15	Linear	L	None	Free	Free	Anticancer	Rho GDP Dissociation Inhibitor Alpha fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 0.93 at 50 μg/ml	48-h	Bone	None
7445	37818062	2023	ADDGRPFPQVIK	P05	12	Linear	L	None	Free	Free	Anticancer	Aldolase A fragment	U-2 OS	Bone Cancer	MTT assay	Relative viability = 0.98 at 50 μg/ml	48-h	Bone	None
7444	37818062	2023	ADDGRPFPQVIK	P05	12	Linear	L	None	Free	Free	Anticancer	Aldolase A fragment	MG-63	Bone Cancer	MTT assay	Relative viability = 0.85 at 50 μg/ml	48-h	Bone	None
7440	37646048	2023	RRRRRGLFDIIKKIIKSF	Aurein 1.2_mutant_R5 (R5-Aurm)	18	Linear	L	None	Free	Acetylation	Antimicrobial	Synthetic	HT-29	Colon Cancer	MTT assay	54.22% cell viability	24-h	Colon	None
7439	37646048	2023	RRRRRGLFDIIKKIIKSF	Aurein 1.2_mutant_R5 (R5-Aurm)	18	Linear	L	None	Free	Acetylation	Antimicrobial	Synthetic	SW-480	Colon Cancer	MTT assay	40.62% cell viability	24-h	Colon	None
7438	37646048	2023	RRRRRGLFDIIKKIAESF	Aurein 1.2_R5 (R5-Aur)	18	Linear	L	None	Free	Acetylation	Antimicrobial	Synthetic	HT-29	Colon Cancer	MTT assay	61.56% cell viability	24-h	Colon	None
7436	37646048	2023	GLFDIIKKIIKSF	Aurein 1.2_mutant (Aurm)	13	Linear	L	None	Free	Acetylation	Antimicrobial	Synthetic	HT-29	Colon Cancer	MTT assay	66.10% cell viability	24-h	Colon	None
7437	37646048	2023	RRRRRGLFDIIKKIAESF	Aurein 1.2_R5 (R5-Aur)	18	Linear	L	None	Free	Acetylation	Antimicrobial	Synthetic	SW-480	Colon Cancer	MTT assay	43.89% cell viability	24-h	Colon	None
7435	37646048	2023	GLFDIIKKIIKSF	Aurein 1.2_mutant (Aurm)	13	Linear	L	None	Free	Acetylation	Antimicrobial	Synthetic	SW-480	Colon Cancer	MTT assay	51.63% cell viability	24-h	Colon	None
7430	37867694	2023	CH₃-CO-Ahx-RWQWRWQWR	CH₃CO-Ahx-[Pal]	10	Linear	L	Ahx = Amino Hexanoic Acid	Amidation	Acetylation	Anticancer	Synthetic	CaCo-2	Colorectal Cancer	MTT assay	IC₅₀ = 31 μM	24-h	Colon	None
7425	37867694	2023	Ahx-RWQWRWQWR	Ahx-[Pal]	10	Linear	L	Ahx = Amino Hexanoic Acid	Amidation	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT assay	IC₅₀ = 119 μM	24-h	Colon	None
7426	37867694	2023	Ahx-RWQWRWQWR	Ahx-[Pal]	10	Linear	L	Ahx = Amino Hexanoic Acid	Amidation	Free	Anticancer	Synthetic	CaCo-2	Colorectal Cancer	MTT assay	IC₅₀ = 40 μM	24-h	Colon	None
7418	36410436	2023	RRRRRRRRGGILTVVELRVP	6F (I113-P122)	20	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-D	48-h	Liver	None
7416	36410436	2023	RRRRRRRRGGGLTIYFY	2D5(G45-Y51)	17	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	IC₅₀ = 19.4 μM	48-h	Liver	None
7415	36410436	2023	RRRRRRRRGGGLTIYFYN	2D3(G45-N52)	18	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-C	48-h	Liver	None
7414	36410436	2023	RRRRRRRRGGQGLTIYFY	2D2(Q44-Y51)	18	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-C	48-h	Liver	None
7405	37833918	2023	RLRRILRKIVRRL	Crabrolin-PR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 12.29 μM	24-h	Breast	None
7404	37833918	2023	RLRRILRKIVRRL	Crabrolin-PR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 16.29 μM	24-h	Colon	None
7403	37833918	2023	RLRRILRKIVRRL	Crabrolin-PR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 17.70 μM	24-h	Brain	None
7402	37833918	2023	RLRRILRKIVRRL	Crabrolin-PR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 22.37 μM	24-h	Prostate	None
7401	37833918	2023	RLRRILRKIVRRL	Crabrolin-PR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	H-838	Lung Cancer	MTT assay	IC₅₀ = 32.32 μM	24-h	Lung	None
7399	37833918	2023	RLPRILRKIVRRL	Crabrolin-AR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 29.90 μM	24-h	Colon	None
7400	37833918	2023	RLPRILRKIVRRL	Crabrolin-AR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 32.51 μM	24-h	Breast	None
7398	37833918	2023	RLPRILRKIVRRL	Crabrolin-AR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 52.01 μM	24-h	Brain	None
7397	37833918	2023	RLPRILRKIVRRL	Crabrolin-AR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 28.78 μM	24-h	Prostate	None
7396	37833918	2023	RLPRILRKIVRRL	Crabrolin-AR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	H-838	Lung Cancer	MTT assay	IC₅₀ = 41.31 μM	24-h	Lung	None
7395	37833918	2023	RLPRILRKIVRAL	Crabrolin-FR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 33.85 μM	24-h	Breast	None
7394	37833918	2023	RLPRILRKIVRAL	Crabrolin-FR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 30.29 μM	24-h	Colon	None
7392	37833918	2023	RLPRILRKIVRAL	Crabrolin-FR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 15.87 μM	24-h	Prostate	None
7393	37833918	2023	RLPRILRKIVRAL	Crabrolin-FR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 62.17 μM	24-h	Brain	None
7391	37833918	2023	RLPRILRKIVRAL	Crabrolin-FR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	H-838	Lung Cancer	MTT assay	IC₅₀ = 31.51 μM	24-h	Lung	None
7390	37833918	2023	FLPRILRKIVRAL	Crabrolin-TR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 3.459 μM	24-h	Breast	None
7389	37833918	2023	FLPRILRKIVRAL	Crabrolin-TR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 2.810 μM	24-h	Colon	None
7388	37833918	2023	FLPRILRKIVRAL	Crabrolin-TR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 12.40 μM	24-h	Brain	None
7387	37833918	2023	FLPRILRKIVRAL	Crabrolin-TR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 3.944 μM	24-h	Prostate	None
7385	37833918	2023	FLPKILRKIVTAL	Crabrolin-4K	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 23.18 μM	24-h	Breast	None
7386	37833918	2023	FLPRILRKIVRAL	Crabrolin-TR	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	H-838	Lung Cancer	MTT assay	IC₅₀ = 4.637 μM	24-h	Lung	None
7384	37833918	2023	FLPKILRKIVTAL	Crabrolin-4K	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 42.88 μM	24-h	Colon	None
7383	37833918	2023	FLPKILRKIVTAL	Crabrolin-4K	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 23.51 μM	24-h	Brain	None
7382	37833918	2023	FLPKILRKIVTAL	Crabrolin-4K	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 20.58 μM	24-h	Prostate	None
7380	37833918	2023	FLPRILRKIVTAL	Crabrolin-4R	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 20.26 μM	24-h	Breast	None
7381	37833918	2023	FLPKILRKIVTAL	Crabrolin-4K	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	H-838	Lung Cancer	MTT assay	IC₅₀ = 22.55 μM	24-h	Lung	None
7379	37833918	2023	FLPRILRKIVTAL	Crabrolin-4R	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 47.02 μM	24-h	Colon	None
7378	37833918	2023	FLPRILRKIVTAL	Crabrolin-4R	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 25.09 μM	24-h	Brain	None
7377	37833918	2023	FLPRILRKIVTAL	Crabrolin-4R	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 17.98 μM	24-h	Prostate	None
7375	37833918	2023	FLPLILRKIVTAL	Crabrolin	13	Linear	L	None	Amidation	Free	Antimicrobial	European hornet (Vespa crabro)	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 26.49 μM	24-h	Breast	None
7376	37833918	2023	FLPRILRKIVTAL	Crabrolin-4R	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic Analog of Crabrolin	H-838	Lung Cancer	MTT assay	IC₅₀ = 11.40 μM	24-h	Lung	None
7374	37833918	2023	FLPLILRKIVTAL	Crabrolin	13	Linear	L	None	Amidation	Free	Antimicrobial	European hornet (Vespa crabro)	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 8.539 μM	24-h	Colon	None
7373	37833918	2023	FLPLILRKIVTAL	Crabrolin	13	Linear	L	None	Amidation	Free	Antimicrobial	European hornet (Vespa crabro)	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 20.13 μM	24-h	Brain	None
7371	37833918	2023	FLPLILRKIVTAL	Crabrolin	13	Linear	L	None	Amidation	Free	Antimicrobial	European hornet (Vespa crabro)	H-838	Lung Cancer	MTT assay	IC₅₀ = 27.71 μM	24-h	Lung	None
7372	37833918	2023	FLPLILRKIVTAL	Crabrolin	13	Linear	L	None	Amidation	Free	Antimicrobial	European hornet (Vespa crabro)	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 32.13 μM	24-h	Prostate	None
7365	33630204	2022	DVNFLLHKIYGNIRY	LvHemB1	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	hemocyanin of Litopenaeus vannamei	EJ	Bladder Cancer	MTS assay	89.6% apoptotic cells at 50 μg/mL	24-h	Bladder	None
7367	None	2022	MDNHVCIPLCPP	MP12	12	Linear	L	None	Free	Free	Antiproliferative	Aphanomyces invadans	Hep-2	Larynx Cancer	MTT assay	IC₅₀ = 24.7 ± 0.34 μM	Not Available	Larynx	None
7363	33630204	2022	DVNFLLHKIYGNIRY	LvHemB1	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	hemocyanin of Litopenaeus vannamei	EC-109	Esophageal Cancer	MTS assay	57.1% apoptotic cells at 50 μg/mL	24-h	Esophagus	None
7364	33630204	2022	DVNFLLHKIYGNIRY	LvHemB1	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	hemocyanin of Litopenaeus vannamei	HepG-2	Liver Cancer	MTS assay	44.2% apoptotic cells at 50 μg/mL	24-h	Liver	None
7362	33630204	2022	DVNFLLHKIYGNIRY	LvHemB1	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	hemocyanin of Litopenaeus vannamei	HeLa	Cervical cancer	MTS assay	65.1% apoptotic cells at 50 μg/mL	24-h	Cervix	None
7360	35200639	2022	WYIRKIRRFFKWLKKKLKKK	P6	20	Linear	L	None	Free	Free	Antitumor	Arca inflata	SW-620	Colon Cancer	MTT assay	IC₅₀ >27 μg/mL	48-h	Colon	None
7361	35200639	2022	WYIRKIRRFFKWLKKKLKKK	P6	20	Linear	L	None	Free	Free	Antitumor	Arca inflata	L02	Colorectal Cancer	MTT assay	IC₅₀ >150 μg/mL	48-h	Colon	None
7359	35200639	2022	WYIRKIRRFFKWLKKKLKKK	P6	20	Linear	L	None	Free	Free	Antitumor	Arca inflata	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 10.88 ± 0.72 μg/mL	48-h	Colon	None
7358	35200639	2022	WYIRKIRRFFKWLKKKLKKK	P6	20	Linear	L	None	Free	Free	Antitumor	Arca inflata	DLD-1	Colorectal Cancer	MTT assay	IC₅₀ = 2.14 ± 0.28 μg/mL	48-h	Colon	None
7357	35200639	2022	WYIRKIRRFFKWLKKKLKKK	P6	20	Linear	L	None	Free	Free	Antitumor	Arca inflata	HT-29	Colorectal Cancer	MTT assay	IC₅₀ = 4.43 ± 0.15 μg/mL	48-h	Colon	None
7347	36212827	2022	LIKKLKEYLKKLI	Lt-MAP2	13	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Synthetic; Derivative of Lataracin-3a	C1498	Blood Cancer	Cytotoxicity assay	EC₅₀ = 43.9 ± 0.5 µg/mL	24-h	Blood	None
7348	36212827	2022	LIKKLKEYLKKLI	Lt-MAP2	13	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Synthetic; Derivative of Lataracin-3a	K-562	Blood Cancer	Cytotoxicity assay	EC₅₀ = 44 ± 3 µg/mL	24-h	Blood	None
7346	36426386	2022	GIFKVLKNLAKGVITSLKS	[D4K,A18K]OCN-3N	19	Linear	L	None	Amidation	Free	Host Defense	Synthetic; Derivative of ocellatin-3N	HT-29	Colorectal Cancer	CellTiter-Glo assay	LC₅₀ = 46 ± 12 μM	24-h	Colon	None
7344	36426386	2022	GIFKVLKNLAKGVITSLKS	[D4K,A18K]OCN-3N	19	Linear	L	None	Amidation	Free	Host Defense	Synthetic; Derivative of ocellatin-3N	A-549	Lung Cancer	CellTiter-Glo assay	LC₅₀ = 25 ± 1 μM	24-h	Lung	None
7345	36426386	2022	GIFKVLKNLAKGVITSLKS	[D4K,A18K]OCN-3N	19	Linear	L	None	Amidation	Free	Host Defense	Synthetic; Derivative of ocellatin-3N	MDA-MB-231	Breast Cancer	CellTiter-Glo assay	LC₅₀ = 31 ± 1 μM	24-h	Breast	None
7343	36426386	2022	GIFKVLKNLAKGVITSLKS	[D4K]OCN-3N	19	Linear	L	None	Amidation	Free	Host Defense	Synthetic; Derivative of ocellatin-3N	HT-29	Colorectal Cancer	CellTiter-Glo assay	LC₅₀ = 20 ± 1 μM	24-h	Colon	None
7341	36426386	2022	GIFKVLKNLAKGVITSLKS	[D4K]OCN-3N	19	Linear	L	None	Amidation	Free	Host Defense	Synthetic; Derivative of ocellatin-3N	A-549	Lung Cancer	CellTiter-Glo assay	LC₅₀ = 12 ± 1 μM	24-h	Lung	None
7342	36426386	2022	GIFKVLKNLAKGVITSLKS	[D4K]OCN-3N	19	Linear	L	None	Amidation	Free	Host Defense	Synthetic; Derivative of ocellatin-3N	MDA-MB-231	Breast Cancer	CellTiter-Glo assay	LC₅₀ = 15 ± 1 μM	24-h	Breast	None
7340	36426386	2022	GIFDVLKNLAKGVITSLAS	Ocellatin-3N	19	Linear	L	None	Amidation	Free	Host Defense	Leptodactylus nesiotus	HT-29	Colorectal Cancer	CellTiter-Glo assay	LC₅₀ = 69 ± 10 μM	24-h	Colon	None
7338	36426386	2022	GIFDVLKNLAKGVITSLAS	Ocellatin-3N	19	Linear	L	None	Amidation	Free	Host Defense	Leptodactylus nesiotus	A-549	Lung Cancer	CellTiter-Glo assay	LC₅₀ = 35 ± 1 μM	24-h	Lung	None
7339	36426386	2022	GIFDVLKNLAKGVITSLAS	Ocellatin-3N	19	Linear	L	None	Amidation	Free	Host Defense	Leptodactylus nesiotus	MDA-MB-231	Breast Cancer	CellTiter-Glo assay	LC₅₀ = 51 ± 16 μM	24-h	Breast	None
7336	36426386	2022	GIFDVLKNLAKGVITSLKS	[A18K]OCN-3N	19	Linear	L	None	Amidation	Free	Host Defense	Synthetic; Derivative of ocellatin-3N	MDA-MB-231	Breast Cancer	CellTiter-Glo assay	LC₅₀ = 69 ± 18 μM	24-h	Breast	None
7337	36426386	2022	GIFDVLKNLAKGVITSLKS	[A18K]OCN-3N	19	Linear	L	None	Amidation	Free	Host Defense	Synthetic; Derivative of ocellatin-3N	HT-29	Colorectal Cancer	CellTiter-Glo assay	LC₅₀ = 59 ± 4 μM	24-h	Colon	None
7335	36426386	2022	GIFDVLKNLAKGVITSLKS	[A18K]OCN-3N	19	Linear	L	None	Amidation	Free	Host Defense	Synthetic; Derivative of ocellatin-3N	A-549	Lung Cancer	CellTiter-Glo assay	LC₅₀ = 30 ± 1 μM	24-h	Lung	None
7334	35209215	2022	NGVQPKYRWWRWWRRWW	RT2	17	Linear	L	None	Amidation	Free	Antimicrobial	Crocodylus siamensis	CaCo-2	Colon Cancer	MTT assay	IC₅₀ = 29.74 μM	24-h	Colon	None
7327	34999227	2022	SKVWRHWRRFWHRAHRLH	LA-C1b	18	Linear	L	Lauric acid conjugated to the 17th Lys-residue	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	Not Available	Not Available	Not Available	Cervix	None
7328	34999227	2022	SKVWRHWRRFWHRAHRLH	LA-C1b	18	Linear	L	Lauric acid conjugated to the 17th Lys-residue	Amidation	Free	Anticancer	Synthetic	A-375	Skin Cancer	Not Available	Not Available	Not Available	Skin	None
7324	34999227	2022	SKVWRHWRRFWHRAHRLH	OA-C1b	18	Linear	L	Octanoic acid acid conjugated to the 17th Lys-residue	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	Not Available	Not Available	Not Available	Cervix	None
7325	34999227	2022	SKVWRHWRRFWHRAHRLH	OA-C1b	18	Linear	L	Octanoic acid acid conjugated to the 17th Lys-residue	Amidation	Free	Anticancer	Synthetic	A-375	Skin Cancer	Not Available	Not Available	Not Available	Skin	None
7326	34999227	2022	SKVWRHWRRFWHRAHRLH	LA-C1b	18	Linear	L	Lauric acid conjugated to the 17th Lys-residue	Amidation	Free	Anticancer	Synthetic	MCF-7	Breast Cancer	Not Available	Not Available	Not Available	Breast	None
7322	34999227	2022	SKVWRHWRRFWHRAHRLH	PA-C1b	18	Linear	L	Palmitic acid conjugated to the 17th Lys-residue	Amidation	Free	Anticancer	Synthetic	A-375	Skin Cancer	Not Available	Not Available	Not Available	Skin	None
7323	34999227	2022	SKVWRHWRRFWHRAHRLH	OA-C1b	18	Linear	L	Octanoic acid acid conjugated to the 17th Lys-residue	Amidation	Free	Anticancer	Synthetic	MCF-7	Breast Cancer	Not Available	Not Available	Not Available	Breast	None
7320	34999227	2022	SKVWRHWRRFWHRAHRLH	PA-C1b	18	Linear	L	Palmitic acid conjugated to the 17th Lys-residue	Amidation	Free	Anticancer	Synthetic	MCF-7	Breast Cancer	Not Available	Not Available	Not Available	Breast	None
7321	34999227	2022	SKVWRHWRRFWHRAHRLH	PA-C1b	18	Linear	L	Palmitic acid conjugated to the 17th Lys-residue	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	Not Available	Not Available	Not Available	Cervix	None
7319	34999227	2022	SKVWRHWRRFWHRAHRLH	Chensinin-1b	18	Linear	L	None	Amidation	Free	Antmicrobial and Anticancer	Synthetic	A-375	Skin Cancer	Not Available	Not Available	Not Available	Skin	None
7318	34999227	2022	SKVWRHWRRFWHRAHRLH	Chensinin-1b	18	Linear	L	None	Amidation	Free	Antmicrobial and Anticancer	Synthetic	HeLa	Cervical Cancer	Not Available	Not Available	Not Available	Cervix	None
7317	34999227	2022	SKVWRHWRRFWHRAHRLH	Chensinin-1b	18	Linear	L	None	Amidation	Free	Antmicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	Not Available	Not Available	Not Available	Breast	None
7316	36555235	2022	FAKKLAKLKKKLAKLALAL	AC-P19	19	Linear	L	None	Free	Free	Anticancer	Synthetic	H-460	Lung Cancer	WST-8 assay	IC₅₀ = 49.08 µM	24-h	Lung	None
7314	36483599	2022	EQQQQQQPQNRRFRE	Q7	15	Linear	L	None	Free	Free	Anticancer	Pisum sativum	HEC-1-A	Endometrial Cancer	MTT assay	IC₅₀ = 129.82 ± 7.53 μM	48-h	Endometrium	None
7315	36555235	2022	FAKKLAKLKKKLAKLALAL	AC-P19	19	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	WST-8 assay	IC₅₀ = 52.14 µM	24-h	Lung	None
7313	None	2022	RRGKGGRRVTMSF	RF13	13	Linear	L	None	Free	Free	Anticancer	VSP26B of C. striatus	HEp-2	Larynx Cancer	MTT assay	IC₅₀ = 49.65 µM	24-h	Larynx	None
7310	36555235	2022	FAKKLAKLKKKLAKLAKKR	AC-P19M	19	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Synthetic analogue of AC-P19	H-460	Lung Cancer	WST-8 assay	IC₅₀ = 6.29 µM	24-h	Lung	None
7309	36555235	2022	FAKKLAKLKKKLAKLAKKR	AC-P19M	19	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Synthetic analogue of AC-P19	A-549	Lung Cancer	WST-8 assay	IC₅₀ = 9.84 µM	24-h	Lung	None
7308	36183673	2022	EARPALLTSRLRFIPK	GV1001	16	Linear	L	None	Free	Free	Anticancer	Human telomerase reverse transcriptase (hTERT)	A-549	Lung Cancer	Cell Viability assay	Graph Fig 2A	24-h	Lung	None
7269	35631675	2022	FAKLLAKLARRLL	HB43-mut3	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	AlamarBlue assay	75% cell viability at 20 μM	Not Available	Breast	None
7268	35631675	2022	FAKLLAKLARRLL	HB43-mut3	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HT-29	Colon Cancer	AlamarBlue assay	IC₅₀ = 9 ± 1 μM	24-h	Colon	None
7266	35631675	2022	FAKLLAKLARRLL	HB43-mut3	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SW-480	Colon Cancer	AlamarBlue assay	IC₅₀ = 8 ± 1 μM	24-h	Colon	None
7267	35631675	2022	FAKLLAKLARRLL	HB43-mut3	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SW-620	Colon Cancer	AlamarBlue assay	IC₅₀ = 9 ± 1 μM	24-h	Colon	None
7265	35631675	2022	FAKLLAKLAKLLK	HB43-mut2	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	AlamarBlue assay	80% cell viability at 20 μM	Not Available	Breast	None
7263	35631675	2022	FAKLLAKLAKLLK	HB43-mut2	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SW-620	Colon Cancer	AlamarBlue assay	IC₅₀ = 40 ± 3 μM	24-h	Colon	None
7264	35631675	2022	FAKLLAKLAKLLK	HB43-mut2	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HT-29	Colon Cancer	AlamarBlue assay	IC₅₀ = 50 ± 3 μM	24-h	Colon	None
7262	35631675	2022	FAKLLAKLAKLLK	HB43-mut2	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SW-480	Colon Cancer	AlamarBlue assay	IC₅₀ = 34 ± 2 μM	24-h	Colon	None
7261	35631675	2022	FAKLLAKLAKKLL	HB43	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	AlamarBlue assay	50% cell viability at 20 μM	Not Available	Breast	None
7259	35631675	2022	FAKLLAKLAKKLL	HB43	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SW-620	Colon Cancer	AlamarBlue assay	IC₅₀ = 10 ± 1 μM	24-h	Colon	None
7260	35631675	2022	FAKLLAKLAKKLL	HB43	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HT-29	Colon Cancer	AlamarBlue assay	IC₅₀ = 11 ± 1 μM	24-h	Colon	None
7258	35631675	2022	FAKLLAKLAKKLL	HB43	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SW-480	Colon Cancer	AlamarBlue assay	IC₅₀ = 12 ± 4 μM	24-h	Colon	None
7252	35094208	2022	HARIKpTFRRlKWKYKGKFW	CIGB-552	20	Linear	Mix	None	Free	Acetylation	Antitumor	Synthetic	A-549	Lung Cancer	Sulforhodamine B assay	IC₅₀ = 44.6 μM	48-h	Lung	None
7251	35094208	2022	HARIKpTFRRlKWKYKGKFW	CIGB-552	20	Linear	Mix	None	Free	Acetylation	Antitumor	Synthetic	NCI-H-460	Lung Cancer	Sulforhodamine B assay	IC₅₀ = 287.9 μM	48-h	Lung	None
7246	36174494	2022	KIIIKIKKKIKIIIK	At12	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 14.0 µM	NA	Lung	None
7247	36174494	2022	KIIIKIKKKIKIIIK	At12	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 13.4 µM	NA	Liver	None
7245	36174494	2022	IIIKKIKKKIKKIII	At11	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 7.6 µM	NA	Liver	None
7244	36174494	2022	IIIKKIKKKIKKIII	At11	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 7.9 µM	NA	Lung	None
7243	36174494	2022	IKKIIKIIKKIIKKI	At10	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 3.2 µM	NA	Liver	None
7242	36174494	2022	IKKIIKIIKKIIKKI	At10	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 4.4 µM	NA	Lung	None
7241	36174494	2022	KVVKKVKKKVKKVVK	At9	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 51.7 µM	NA	Liver	None
7240	36174494	2022	KVVKKVKKKVKKVVK	At9	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 100 µM	NA	Lung	None
7239	36174494	2022	KLLKKLKKKLKKLLK	At8	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 8.9 µM	NA	Liver	None
7238	36174494	2022	KLLKKLKKKLKKLLK	At8	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 13.4 µM	NA	Lung	None
7237	36174494	2022	KIIKKIKKKIKKIIK	At7	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 8.8 µM	NA	Liver	None
7236	36174494	2022	KIIKKIKKKIKKIIK	At7	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 10.3 µM	NA	Lung	None
7235	36174494	2022	KVVKKVVKVVKKVVK	At6	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 70.8 µM	NA	Liver	None
7234	36174494	2022	KVVKKVVKVVKKVVK	At6	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ > 100 µM	NA	Lung	None
7232	36174494	2022	KIIKKIIKIIKKIIK	At5	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 3.6 µM	NA	Lung	None
7233	36174494	2022	KIIKKIIKIIKKIIK	At5	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 1.5 µM	NA	Liver	None
7231	36174494	2022	KLLKKLLKLLKKLLK	At4	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.5 µM	NA	Liver	None
7230	36174494	2022	KLLKKLLKLLKKLLK	At4	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 7.2 µM	NA	Lung	None
7228	36174494	2022	KLLKKVVKLFKKLLK	Ponericin-W1 (11-25) [P4K; S5K; G8K; K13L; Q15K], At3	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 4.3 µM	NA	Lung	None
7229	36174494	2022	KLLKKVVKLFKKLLK	Ponericin-W1 (11-25) [P4K; S5K; G8K; K13L; Q15K], At3	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.2 µM	NA	Liver	None
7227	36174494	2022	KLLKKVVKLFKKKKK	Ponericin-W1 (11-25) [P4K; S5K; G8K; Q15K], At2	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ >100 µM	NA	Liver	None
7226	36174494	2022	KLLKKVVKLFKKKKK	Ponericin-W1 (11-25) [P4K; S5K; G8K; Q15K], At2	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ >100 µM	NA	Lung	None
7224	36174494	2022	KLLPSVVGLFKKKKQ	Ponericin-W1 (11-25), At1	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ > 100 µM	NA	Lung	None
7225	36174494	2022	KLLPSVVGLFKKKKQ	Ponericin-W1 (11-25), At1	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ >100 µM	NA	Liver	None
7208	34679257	2022	WRRRYRRWRRRRRWRRRPRR	vCPP2319	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	SK-BR-3	Breast Cancer	MTT assay	IC₅₀ = 14.0 ± 1.0 μM	24-h	Breast	None
7207	34679257	2022	WRRRYRRWRRRRRWRRRPRR	vCPP2319	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	BT-474	Breast Cancer	MTT assay	IC₅₀ = 15.7 ± 1.5 μM	24-h	Breast	None
7206	34679257	2022	WRRRYRRWRRRRRWRRRPRR	vCPP2319	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	BT-20	Breast Cancer	MTT assay	IC₅₀ = 4.2 ± 2.2 μM	24-h	Breast	None
7205	34679257	2022	WRRRYRRWRRRRRWRRRPRR	vCPP2319	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 4.5 ± 0.1 μM	24-h	Breast	None
7204	34679257	2022	RRLTLRQLLGLGSRRRRRSR	vCPP0769	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	SK-BR-3	Breast Cancer	MTT assay	IC₅₀ = 21.1 ± 2.0 μM	24-h	Breast	None
7203	34679257	2022	RRLTLRQLLGLGSRRRRRSR	vCPP0769	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	BT-474	Breast Cancer	MTT assay	IC₅₀ = 37.5 ± 1.7 μM	24-h	Breast	None
7202	34679257	2022	RRLTLRQLLGLGSRRRRRSR	vCPP0769	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	BT-20	Breast Cancer	MTT assay	IC₅₀ = 3.5 ± 1.5 μM	24-h	Breast	None
7201	34679257	2022	RRLTLRQLLGLGSRRRRRSR	vCPP0769	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 9.0 ± 0.1 μM	24-h	Breast	None
7200	34679257	2022	RPRRRATTRRRITTGTRRRR	vCPP0667	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	SK-BR-3	Breast Cancer	MTT assay	IC₅₀ = 71.2 ± 1.1 μM	24-h	Breast	None
7199	34679257	2022	RPRRRATTRRRITTGTRRRR	vCPP0667	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	BT-474	Breast Cancer	MTT assay	IC₅₀ = 92.8 ± 1.1 μM	24-h	Breast	None
7198	34679257	2022	RPRRRATTRRRITTGTRRRR	vCPP0667	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	BT-20	Breast Cancer	MTT assay	IC₅₀ = 88.8 ± 1.0 μM	24-h	Breast	None
7197	34679257	2022	KKRYKKKYKAYKPYKKKKKF	vCPP0275	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	SK-BR-3	Breast Cancer	MTT assay	IC₅₀ = 34.0 ± 1.0 μM	24-h	Breast	None
7196	34679257	2022	KKRYKKKYKAYKPYKKKKKF	vCPP0275	20	Linear	L	None	Amidation	Free	Anticancer and Cell Penetrating	Capsid protein of the Torque teno douroucouli virus	BT-20	Breast Cancer	MTT assay	IC₅₀ = 44.8 ± 1.1 μM	24-h	Breast	None
7181	34509120	2022	LC-Propargyl-GIIKKIIKKIIKKII	GI-15	17	Linear	L	None	Amidation	LC-Propargylglycine	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 16.6 ± 0.8 µM	72-h	Cervix	None
7180	34509120	2022	LC-Propargyl-GIIKKIIKKIIKKII	GI-15	17	Linear	L	None	Amidation	LC-Propargylglycine	Anticancer	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 13.6 ± 0.2 µM	72-h	Colon	None
7178	34509120	2022	CIIKKIIKKIIKKII	CI-15	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 7.7 ± 0.2 µM	72-h	Colon	None
7179	34509120	2022	CIIKKIIKKIIKKII	CI-15	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 2.7 ± 0.5 µM	72-h	Cervix	None
7177	34509120	2022	CLLRRLLRRLLRR	LR13	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 26.7 ± 1.3 µM	72-h	Cervix	None
7176	34509120	2022	CLLRRLLRRLLRR	LR13	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 15.6 ± 1.0 µM	72-h	Colon	None
7174	34509120	2022	CIIRRIIRRIIRR	IR13	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ > 100 µM	72-h	Colon	None
7175	34509120	2022	CIIRRIIRRIIRR	IR13	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ > 100 µM	72-h	Cervix	None
7173	34509120	2022	CLLKKLLKKLLKK	LK13	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 83 ± 9 µM	72-h	Cervix	None
7171	34509120	2022	CIIKKIIKKIIKK	IK13	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 47±5 µM	72-h	Cervix	None
7172	34509120	2022	CLLKKLLKKLLKK	LK13	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 23 ± 2 µM	72-h	Colon	None
7170	34509120	2022	CIIKKIIKKIIKK	IK13	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 29 ± 6 µM	72-h	Colon	None
7123	35740884	2022	FLPLiiGALSSLLPKiF	Temporin-PKE-3i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 72.06 μM	24-h	Colon	None
7124	35740884	2022	FLPLiiGALSSLLPKiF	Temporin-PKE-3i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 71.18 μM	24-h	Lung	None
7122	35740884	2022	FLPLiiGALSSLLPKiF	Temporin-PKE-3i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	H-838	Lung Cancer	MTT assay	IC₅₀ = 193.4 μM	24-h	Lung	None
7121	35740884	2022	FLPLiiGALSSLLPKiF	Temporin-PKE-3i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 167 μM	24-h	Prostate	None
7120	35740884	2022	FLPLiiGALSSLLPKiF	Temporin-PKE-3i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 120.6 μM	24-h	Brain	None
7119	35740884	2022	FLPLIIGALSSLLPKiF	Temporin-PKE-i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 2.94 μM	24-h	Lung	None
7117	35740884	2022	FLPLIIGALSSLLPKiF	Temporin-PKE-i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	H-838	Lung Cancer	MTT assay	IC₅₀ = 5.28 μM	24-h	Lung	None
7118	35740884	2022	FLPLIIGALSSLLPKiF	Temporin-PKE-i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 3.07 μM	24-h	Colon	None
7116	35740884	2022	FLPLIIGALSSLLPKiF	Temporin-PKE-i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 3.35 μM	24-h	Prostate	None
7115	35740884	2022	FLPLIIGALSSLLPKiF	Temporin-PKE-i	17	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 4.46 μM	24-h	Brain	None
7114	35740884	2022	FLPKIIGKLSSKLPKIF	Temporin-PKE-4K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 27.76 μM	24-h	Lung	None
7113	35740884	2022	FLPKIIGKLSSKLPKIF	Temporin-PKE-4K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 99.36 μM	24-h	Colon	None
7111	35740884	2022	FLPKIIGKLSSKLPKIF	Temporin-PKE-4K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 49.50 μM	24-h	Prostate	None
7112	35740884	2022	FLPKIIGKLSSKLPKIF	Temporin-PKE-4K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-838	Lung Cancer	MTT assay	IC₅₀ = 35.28 μM	24-h	Lung	None
7110	35740884	2022	FLPKIIGKLSSKLPKIF	Temporin-PKE-4K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 85.52 μM	24-h	Brain	None
7109	35740884	2022	FLPKIIGKLSSLLPKIF	Temporin-PKE-3K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 3.29 μM	24-h	Lung	None
7108	35740884	2022	FLPKIIGKLSSLLPKIF	Temporin-PKE-3K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 0.38 μM	24-h	Colon	None
7106	35740884	2022	FLPKIIGKLSSLLPKIF	Temporin-PKE-3K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 3.01 μM	24-h	Prostate	None
7107	35740884	2022	FLPKIIGKLSSLLPKIF	Temporin-PKE-3K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-838	Lung Cancer	MTT assay	IC₅₀ = 0.51 μM	24-h	Lung	None
7105	35740884	2022	FLPKIIGKLSSLLPKIF	Temporin-PKE-3K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 2.83 μM	24-h	Brain	None
7103	35740884	2022	FLPLIIGALSSKLPKIF	Temporin-PKE-K12	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 22.09 μM	24-h	Colon	None
7104	35740884	2022	FLPLIIGALSSKLPKIF	Temporin-PKE-K12	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 24.03 μM	24-h	Lung	None
7102	35740884	2022	FLPLIIGALSSKLPKIF	Temporin-PKE-K12	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-838	Lung Cancer	MTT assay	IC₅₀ = 22.67 μM	24-h	Lung	None
7101	35740884	2022	FLPLIIGALSSKLPKIF	Temporin-PKE-K12	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 27.32 μM	24-h	Prostate	None
7100	35740884	2022	FLPLIIGALSSKLPKIF	Temporin-PKE-K12	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 25.75 μM	24-h	Brain	None
7099	35740884	2022	FLPLIIGKLSSLLPKIF	Temporin-PKE-2K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 2.78 μM	24-h	Lung	None
7098	35740884	2022	FLPLIIGKLSSLLPKIF	Temporin-PKE-2K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 2.84 μM	24-h	Colon	None
7097	35740884	2022	FLPLIIGKLSSLLPKIF	Temporin-PKE-2K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-838	Lung Cancer	MTT assay	IC₅₀ = 3.07 μM	24-h	Lung	None
7096	35740884	2022	FLPLIIGKLSSLLPKIF	Temporin-PKE-2K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 2.64 μM	24-h	Prostate	None
7095	35740884	2022	FLPLIIGKLSSLLPKIF	Temporin-PKE-2K	17	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 2.49 μM	24-h	Brain	None
7094	35740884	2022	FLPLIIGALSSLLPKIF	Temporin-PKE	17	Linear	L	None	Amidation	Free	Antimicrobial	skin secretion of Pelophylax kl. esculentus	H-157	Lung Cancer	MTT assay	IC₅₀ = 17.40 μM	24-h	Lung	None
7093	35740884	2022	FLPLIIGALSSLLPKIF	Temporin-PKE	17	Linear	L	None	Amidation	Free	Antimicrobial	skin secretion of Pelophylax kl. esculentus	HCT-116	Colorectal Cancer	MTT assay	IC₅₀ = 21.31 μM	24-h	Colon	None
7092	35740884	2022	FLPLIIGALSSLLPKIF	Temporin-PKE	17	Linear	L	None	Amidation	Free	Antimicrobial	skin secretion of Pelophylax kl. esculentus	H-838	Lung Cancer	MTT assay	IC₅₀ = 16.38 μM	24-h	Lung	None
7091	35740884	2022	FLPLIIGALSSLLPKIF	Temporin-PKE	17	Linear	L	None	Amidation	Free	Antimicrobial	skin secretion of Pelophylax kl. esculentus	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 7.29 μM	24-h	Prostate	None
7090	35740884	2022	FLPLIIGALSSLLPKIF	Temporin-PKE	17	Linear	L	None	Amidation	Free	Antimicrobial	skin secretion of Pelophylax kl. esculentus	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 23.24 μM	24-h	Brain	None
7069	35740895	2022	FLSGIVGMLaKLF	[G10a]-SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	MNT-1	Skin Cancer	Resazurin dye assay	IC₅₀ = 15.25 ± 0.80 µM	48-h	Skin	US_10550155_B2
7068	35740895	2022	FLSGIVGMLaKLF	[G10a]-SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	PC-3	Prostate Cancer	Resazurin dye assay	IC₅₀ = 13.04 ± 1.99 µM	48-h	Prostate	US_10550155_B2
7067	35740895	2022	FLSGIVGMLaKLF	[G10a]-SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	MiaPaCa.2	Pancreatic Cancer	Resazurin dye assay	IC₅₀ = 22.36 ± 6.07 µM	48-h	Pancreas	US_10550155_B2
7066	35740895	2022	FLSGIVGMLaKLF	[G10a]-SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	A-2780	Ovarian Cancer	Resazurin dye assay	IC₅₀ = 14.75 ± 7.35 µM	48-h	Ovary	US_10550155_B2
7065	35740895	2022	FLSGIVGMLaKLF	[G10a]-SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	A-549	Lung Cancer	Resazurin dye assay	IC₅₀ = 14.52 ± 1.44 µM	48-h	Lung	US_10550155_B2
7064	35740895	2022	FLSGIVGMLaKLF	[G10a]-SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	HepG-2	Liver Cancer	Resazurin dye assay	IC₅₀ = 31.63 ± 1.56 µM	48-h	Liver	US_10550155_B2
7063	35740895	2022	FLSGIVGMLaKLF	[G10a]-SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	MCF-7	Breast Cancer	Resazurin dye assay	IC₅₀ = 15.05 ± 8.51 µM	48-h	Breast	US_10550155_B2
7061	35631515	2022	KKKKFFFFFFKKKK	K4F6K4	14	Linear	L	None	Free	Free	Antimicrobial	Synthetic	A-549	Lung Cancer	AnnexinV-FITC/PI double staining assay	apoptotic cells (early and late) increased from 9.59 ± 1.00% to 43.03 ± 2.13%	12-h	Lung	None
7060	35631515	2022	KKKKFFFFFFFFKKKK	K4F8K4	16	Linear	L	None	Free	Free	Antimicrobial	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 571.87 ± 66.23 μg/mL	48-h	Lung	None
7059	35631515	2022	KKKKFFFFFFKKKK	K4F6K4	14	Linear	L	None	Free	Free	Antimicrobial	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 62.64 ± 9.55 μg/mL	48-h	Lung	None
7057	35631515	2022	KKFFFFFFKK	K2F6K2	10	Linear	L	None	Free	Free	Antimicrobial	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 1146.23 ± 346.83 μg/mL	48-h	Lung	None
7058	35631515	2022	KKKFFFFFFKKK	K3F6K3	12	Linear	L	None	Free	Free	Antimicrobial	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 123.10 ± 35.19 μg/mL	48-h	Lung	None
7056	36364156	2022	PTECQVGTTCKVES	PS14	14	Linear	L	None	Free	Free	Anticancer and Anti-inflammatory	Aphanomyces invadans	Hep-2	Larynx Cancer	LDH leakage assay	45.56 ± 2% LDH release at 20 µM	24-h	Larynx	None
7055	36364155	2022	PTECQVGTTCKVES	PS14	14	Linear	L	None	Free	Free	Anticancer and Anti-inflammatory	Aphanomyces invadans	Hep-2	Larynx Cancer	MTT assay	IC₅₀ = 21 µM	24-h	Larynx	None
7054	35246961	2022	GllellelllkaaGw	d-EEK	15	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 4.78 ± 0.02 µM	72-h	Bone	None
7053	35246961	2022	GllellelllkaaGw	d-EEK	15	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 0.29 ± 0.01 µM	72-h	Breast	None
7052	35246961	2022	GllellelllkaaGw	d-EEK	15	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 0.29 ± 0.01 µM	72-h	Breast	None
7051	35246961	2022	GlldllelllkaaGw	d-DEK	15	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 5.84 ± 0.04 µM	72-h	Bone	None
7050	35246961	2022	GlldllelllkaaGw	d-DEK	15	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 0.36 ± 0 µM	72-h	Breast	None
7049	35246961	2022	GlldllelllkaaGw	d-DEK	15	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 0.44 ± 0.10 µM	72-h	Breast	None
7048	35246961	2022	GlldllhlllkaaGw	d-DHK	15	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 1.24 ± 0.03 µM	72-h	Bone	None
7046	35246961	2022	GlldllhlllkaaGw	d-DHK	15	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 0.32 ± 0.07 µM	72-h	Breast	None
7047	35246961	2022	GlldllhlllkaaGw	d-DHK	15	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 0.23 ± 0.04 µM	72-h	Breast	None
7045	35246961	2022	GLLKLLKLLLKAAGW	KKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 9.65 ± 1.20 µM	72-h	Bone	None
7044	35246961	2022	GLLKLLKLLLKAAGW	KKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.35 ± 0.40 µM	72-h	Breast	None
7042	35246961	2022	GLLHLLKLLLKAAGW	HKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 12.23 ± 0.11 µM	72-h	Bone	None
7043	35246961	2022	GLLKLLKLLLKAAGW	KKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 1.57 ± 0.24 µM	72-h	Breast	None
7041	35246961	2022	GLLHLLKLLLKAAGW	HKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 2.60 ± 0.42 µM	72-h	Breast	None
7039	35246961	2022	GLLELLKLLLKAAGW	EKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 12.20 ± 1.84 µM	72-h	Bone	None
7040	35246961	2022	GLLHLLKLLLKAAGW	HKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.40 ± 0.71 µM	72-h	Breast	None
7038	35246961	2022	GLLELLKLLLKAAGW	EKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.19 ± 0.40 µM	72-h	Breast	None
7037	35246961	2022	GLLELLKLLLKAAGW	EKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 1.72 ± 0.21 µM	72-h	Breast	None
7035	35246961	2022	GLLDLLKLLLKAAGW	DKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.20 ± 0.14 µM	72-h	Breast	None
7036	35246961	2022	GLLDLLKLLLKAAGW	DKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 10.40 ± 1.70 µM	72-h	Bone	None
7034	35246961	2022	GLLDLLKLLLKAAGW	DKK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 1.95 ± 0.35 µM	72-h	Breast	None
7033	35246961	2022	GLLKLLHLLLKAAGW	KHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 12.88 ± 1.24 µM	72-h	Bone	None
7031	35246961	2022	GLLKLLHLLLKAAGW	KHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 2.59 ± 0.92 µM	72-h	Breast	None
7032	35246961	2022	GLLKLLHLLLKAAGW	KHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.40 ± 0.14 µM	72-h	Breast	None
7030	35246961	2022	GLLHLLHLLLKAAGW	HHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 12.65 ± 1.91 µM	72-h	Bone	None
7028	35246961	2022	GLLHLLHLLLKAAGW	HHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.15 ± 0.07 µM	72-h	Breast	None
7029	35246961	2022	GLLHLLHLLLKAAGW	HHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.75 ± 0.21 µM	72-h	Breast	None
7027	35246961	2022	GLLELLHLLLKAAGW	EHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 25.00 ± 0 µM	72-h	Bone	None
7025	35246961	2022	GLLELLHLLLKAAGW	EHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 1.35 ± 0.35 µM	72-h	Breast	None
7026	35246961	2022	GLLELLHLLLKAAGW	EHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 0.71 ± 0.13 µM	72-h	Breast	None
7024	35246961	2022	GLLDLLHLLLKAAGW	DHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 20.45 ± 2.05 µM	72-h	Bone	None
7022	35246961	2022	GLLDLLHLLLKAAGW	DHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 1.75 ±0.49 µM	72-h	Breast	None
7023	35246961	2022	GLLDLLHLLLKAAGW	DHK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.02 ± 0.12 µM	72-h	Breast	None
7021	35246961	2022	GLLKLLELLLKAAGW	KEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 8.15 ± 0.49 µM	72-h	Bone	None
7019	35246961	2022	GLLKLLELLLKAAGW	KEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 1.60 ± 0.14 µM	72-h	Breast	None
7020	35246961	2022	GLLKLLELLLKAAGW	KEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.35 ± 0.07 µM	72-h	Breast	None
7018	35246961	2022	GLLHLLELLLKAAGW	HEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 143.20 ± 80.33 µM	72-h	Bone	None
7017	35246961	2022	GLLHLLELLLKAAGW	HEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 3.45 ± 2.19 µM	72-h	Breast	None
7016	35246961	2022	GLLHLLELLLKAAGW	HEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 2.35 ± 1.06 µM	72-h	Breast	None
7015	35246961	2022	GLLELLELLLKAAGW	EEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 32.88 ± 4.07 µM	72-h	Bone	None
7014	35246961	2022	GLLELLELLLKAAGW	EEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.08 ± 0.18 µM	72-h	Breast	None
7013	35246961	2022	GLLELLELLLKAAGW	EEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 1.10 ± 0.14 µM	72-h	Breast	None
7012	35246961	2022	GLLDLLELLLKAAGW	DEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 19.88 ± 2.65 µM	72-h	Bone	None
7011	35246961	2022	GLLDLLELLLKAAGW	DEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 0.70 ± 0.07 µM	72-h	Breast	None
7010	35246961	2022	GLLDLLELLLKAAGW	DEK	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 1.14 ± 0.52 µM	72-h	Breast	None
7009	35246961	2022	GLLKLLKLLLHAAGW	KKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 13.30 ± 0.99 µM	72-h	Bone	None
7008	35246961	2022	GLLKLLKLLLHAAGW	KKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 2.20 ± 0.42 µM	72-h	Breast	None
7007	35246961	2022	GLLKLLKLLLHAAGW	KKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 2.40 ± 0.85 µM	72-h	Breast	None
7006	35246961	2022	GLLHLLKLLLHAAGW	HKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 18.88 ± 1.24 µM	72-h	Bone	None
7005	35246961	2022	GLLHLLKLLLHAAGW	HKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 3.10 ± 0.57 µM	72-h	Breast	None
7004	35246961	2022	GLLHLLKLLLHAAGW	HKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.45 ± 0.21 µM	72-h	Breast	None
7003	35246961	2022	GLLELLKLLLHAAGW	EKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 23.83 ± 0.81 µM	72-h	Bone	None
7002	35246961	2022	GLLELLKLLLHAAGW	EKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 2.18 ± 0.31 µM	72-h	Breast	None
7001	35246961	2022	GLLELLKLLLHAAGW	EKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 2.75 ± 0.07 µM	72-h	Breast	None
7000	35246961	2022	GLLDLLKLLLHAAGW	DKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 21.13 ± 3.01 µM	72-h	Bone	None
6999	35246961	2022	GLLDLLKLLLHAAGW	DKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 2.80 ± 0.28 µM	72-h	Breast	None
6998	35246961	2022	GLLDLLKLLLHAAGW	DKH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.45 ± 0.07 µM	72-h	Breast	None
6997	35246961	2022	GLLKLLHLLLHAAGW	KHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 39.75 ± 5.30 µM	72-h	Bone	None
6996	35246961	2022	GLLKLLHLLLHAAGW	KHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 4.45 ± 0.49 µM	72-h	Breast	None
6995	35246961	2022	GLLKLLHLLLHAAGW	KHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 5.20 ± 0.71 µM	72-h	Breast	None
6994	35246961	2022	GLLHLLHLLLHAAGW	HHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 185 ± 7 µM	72-h	Bone	None
6993	35246961	2022	GLLHLLHLLLHAAGW	HHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 9.50 ± 0.99 µM	72-h	Breast	None
6991	35246961	2022	GLLELLHLLLHAAGW	EHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 117 ± 7 µM	72-h	Bone	None
6992	35246961	2022	GLLHLLHLLLHAAGW	HHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 21.10 ± 6.93 µM	72-h	Breast	None
6990	35246961	2022	GLLELLHLLLHAAGW	EHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 16.05 ± 3.18 µM	72-h	Breast	None
6989	35246961	2022	GLLELLHLLLHAAGW	EHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 25.35 ± 2.76 µM	72-h	Breast	None
6987	35246961	2022	GLLDLLHLLLHAAGW	DHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 11.90 ± 0.14 µM	72-h	Breast	None
6988	35246961	2022	GLLDLLHLLLHAAGW	DHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 55.85 ± 18.88 µM	72-h	Bone	None
6986	35246961	2022	GLLDLLHLLLHAAGW	DHH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 21.45 ± 2.47 µM	72-h	Breast	None
6985	35246961	2022	GLLKLLELLLHAAGW	KEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 49.25 ± 5.30 µM	72-h	Bone	None
6984	35246961	2022	GLLKLLELLLHAAGW	KEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 2.35 ± 0.07 µM	72-h	Breast	None
6983	35246961	2022	GLLKLLELLLHAAGW	KEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.30 ± 0.42 µM	72-h	Breast	None
6982	35246961	2022	GLLHLLELLLHAAGW	HEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 106 ± 14 µM	72-h	Bone	None
6981	35246961	2022	GLLHLLELLLHAAGW	HEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 10.95 ± 1.06 µM	72-h	Breast	None
6979	35246961	2022	GLLELLELLLHAAGW	EEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 19.60 ± 3.96 µM	72-h	Bone	None
6980	35246961	2022	GLLHLLELLLHAAGW	HEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 28.60 ± 10.75 µM	72-h	Breast	None
6977	35246961	2022	GLLELLELLLHAAGW	EEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.30 ± 0.14 µM	72-h	Breast	None
6978	35246961	2022	GLLELLELLLHAAGW	EEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 3.60 ± 0.85 µM	72-h	Breast	None
6976	35246961	2022	GLLDLLELLLHAAGW	DEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 36.48 ± 3.92 µM	72-h	Bone	None
6975	35246961	2022	GLLDLLELLLHAAGW	DEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 3.60 ± 0.42 µM	72-h	Breast	None
6974	35246961	2022	GLLDLLELLLHAAGW	DEH	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 5.35 ± 1.91 µM	72-h	Breast	None
6973	35246961	2022	GLLKLLKLLLEAAGW	KKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 12.75 ± 1.20 µM	72-h	Bone	None
6972	35246961	2022	GLLKLLKLLLEAAGW	KKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.70 ± 0 µM	72-h	Breast	None
6971	35246961	2022	GLLKLLKLLLEAAGW	KKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 2.05 ± 0.64 µM	72-h	Breast	None
6970	35246961	2022	GLLHLLKLLLEAAGW	HKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 15.95 ± 0.78 µM	72-h	Bone	None
6969	35246961	2022	GLLHLLKLLLEAAGW	HKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.90 ± 0.42 µM	72-h	Breast	None
6968	35246961	2022	GLLHLLKLLLEAAGW	HKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 2.70 ± 0.28 µM	72-h	Breast	None
6967	35246961	2022	GLLELLKLLLEAAGW	EKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 8.00 ± 0.71 µM	72-h	Bone	None
6966	35246961	2022	GLLELLKLLLEAAGW	EKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.30 ± 0.14 µM	72-h	Breast	None
6965	35246961	2022	GLLELLKLLLEAAGW	EKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 1.80 ± 0.28 µM	72-h	Breast	None
6964	35246961	2022	GLLDLLKLLLEAAGW	DKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 9.93 ± 0.25 µM	72-h	Bone	None
6963	35246961	2022	GLLDLLKLLLEAAGW	DKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 1.57 ± 0.33 µM	72-h	Breast	None
6962	35246961	2022	GLLDLLKLLLEAAGW	DKE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 2.10 ± 0 µM	72-h	Breast	None
6961	35246961	2022	GLLKLLHLLLEAAGW	KHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 53 ± 2.83 µM	72-h	Bone	None
6960	35246961	2022	GLLKLLHLLLEAAGW	KHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 2.92 ± 0.17 µM	72-h	Breast	None
6959	35246961	2022	GLLKLLHLLLEAAGW	KHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.70 ± 0.14 µM	72-h	Breast	None
6958	35246961	2022	GLLHLLHLLLEAAGW	HHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 53.25 ± 5.30 µM	72-h	Bone	None
6957	35246961	2022	GLLHLLHLLLEAAGW	HHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 10.75 ± 0.78 µM	72-h	Breast	None
6956	35246961	2022	GLLHLLHLLLEAAGW	HHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 16.70 ± 2.26 µM	72-h	Breast	None
6955	35246961	2022	GLLELLHLLLEAAGW	EHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 18.25 ± 1.06 µM	72-h	Bone	None
6954	35246961	2022	GLLELLHLLLEAAGW	EHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 2.55 ± 0.07 µM	72-h	Breast	None
6953	35246961	2022	GLLELLHLLLEAAGW	EHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.90 ± 0.28 µM	72-h	Breast	None
6952	35246961	2022	GLLDLLHLLLEAAGW	DHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 17.25 ± 1.06 µM	72-h	Bone	None
6951	35246961	2022	GLLDLLHLLLEAAGW	DHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 2.80 ± 0.14 µM	72-h	Breast	None
6950	35246961	2022	GLLDLLHLLLEAAGW	DHE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.75 ± 0.92 µM	72-h	Breast	None
6949	35246961	2022	GLLKLLELLLEAAGW	KEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 49.38 ± 13.26 µM	72-h	Bone	None
6948	35246961	2022	GLLKLLELLLEAAGW	KEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 2.05 ± 0.21 µM	72-h	Breast	None
6947	35246961	2022	GLLKLLELLLEAAGW	KEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 3.75 ± 0.78 µM	72-h	Breast	None
6946	35246961	2022	GLLHLLELLLEAAGW	HEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 47.50 ± 11 µM	72-h	Bone	None
6945	35246961	2022	GLLHLLELLLEAAGW	HEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 4.95 ± 0.49 µM	72-h	Breast	None
6944	35246961	2022	GLLHLLELLLEAAGW	HEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 6.50 ± 0.71 µM	72-h	Breast	None
6943	35246961	2022	GLLELLELLLEAAGW	EEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 78.75 ± 5.30 µM	72-h	Bone	None
6942	35246961	2022	GLLELLELLLEAAGW	EEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 10.55 ± 3.46 µM	72-h	Breast	None
6941	35246961	2022	GLLELLELLLEAAGW	EEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 6.25 ± 1.77 µM	72-h	Breast	None
6940	35246961	2022	GLLDLLELLLEAAGW	DEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	MTT assay	IC₅₀ = 61.00 ± 1.41 µM	72-h	Bone	None
6939	35246961	2022	GLLDLLELLLEAAGW	DEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER-shEcad	Breast Cancer	MTT assay	IC₅₀ = 6.05 ± 2.76 µM	72-h	Breast	None
6938	35246961	2022	GLLDLLELLLEAAGW	DEE	15	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HMLER	Breast Cancer	MTT assay	IC₅₀ = 5.55 ± 0.35 µM	72-h	Breast	None
6863	33603033	2021	RYGFTEVAGNFQQHNFGRG	L. squarrosulus purifed fraction	19	Linear	L	None	Free	Free	Anticancer	Lentinus squarrosulus (Mont.)	H-460	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
6859	34531430	2021	KKRKKKAFALKFVVDLI	PCC-1	17	Linear	L	None	Amidation	Free	Antimicrobial	Poecilocoris lewisi	G361	Skin Cancer	MTS assay	IC₅₀ = 57.8 µM	48-h	Skin	None
6858	34531430	2021	KKRKKKAFALKFVVDLI	PCC-1	17	Linear	L	None	Amidation	Free	Antimicrobial	Poecilocoris lewisi	SK-Mel-28	Skin Cancer	MTS assay	IC₅₀ = 50.8 µM	48-h	Skin	None
6856	33981363	2021	GBKRLVQRLKDBLRNLV	17BIPHE2	17	Linear	L	None	Free	Free	Antimicrobial	Derivative of LL-37	NCI-H-1975	Lung Cancer	MTT assay	IC₅₀ = 71.42 µmol/L	24-h	Lung	None
6855	33981363	2021	GBKRLVQRLKDBLRNLV	17BIPHE2	17	Linear	L	None	Free	Free	Antimicrobial	Derivative of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 34.33 µmol	24-h	Lung	None
6841	33567789	2021	(KLAKLAK)₂	Si1	14	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 746.5 ± 7.6 µM	72-h	Breast	None
6840	33567789	2021	(KLAKLAK)₂	Si1	14	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 124.1 ± 8.12 µM	72-h	Breast	None
6839	33428507	2021	LHHLLHLLHHLLHL	L8H6	14	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 16.4 µM	24-h	Cervix	None
6838	33428507	2021	LHLLLHLLHHLLHL	L9H5-1	14	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 5.4 µM	24-h	Cervix	None
6837	None	2021	FPLPCAYKGTYC	SKACP003	12	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-453	Breast Cancer	MTT assay	IC₅₀ = 156 ± 0.5 µM	24-h	Breast	None
6836	None	2021	FPLPCAYKGTYC	SKACP003	12	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 212 ± 0.5 µM	24-h	Breast	None
6835	None	2021	FPLPCAYKGTYC	SKACP003	12	Linear	L	None	Free	Free	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 193 ± 0.5 µM	24-h	Breast	None
6830	34440185	2021	SFIPRAKSTWLNNIKLL	HMP-S7	17	Linear	L	None	Free	Free	Anticancer	Human Milk	Sup-B15	Blood Cancer	Trypan blue assay	IC₅₀ = 90 ± 14 µM	24-h	Blood	None
6828	34440185	2021	SFIPRAKSTWLNNIKLL	HMP-S7	17	Linear	L	None	Free	Free	Anticancer	Human Milk	RS4;11	Blood Cancer	Trypan blue assay	IC₅₀ = 184 ± 23 µM	24-h	Blood	None
6829	34440185	2021	SFIPRAKSTWLNNIKLL	HMP-S7	17	Linear	L	None	Free	Free	Anticancer	Human Milk	Raji	Lymphoma Cancer	Trypan blue assay	IC₅₀ = 89 ± 24 µM	24-h	Blood	None
6827	34440185	2021	SFIPRAKSTWLNNIKLL	HMP-S7	17	Linear	L	None	Free	Free	Anticancer	Human Milk	Jurkat	Blood Cancer	Trypan blue assay	IC₅₀ = 186 ± 37 µM	24-h	Blood	None
6826	33442881	2021	FLGALWNVAKRVF	[Arg]¹¹-VmCT1	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 25.8 ± 5.2 μmol/L	24-h	Breast	None
6825	33442881	2021	FLGALWRVAKSVF	[Arg]⁷-VmCT1	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 18.0 ± 2.7 μmol/L	24-h	Breast	None
6824	33442881	2021	FLRALWNVAKSVF	[Arg]³-VmCT1	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 20.6 ± 3.1 μmol/L	24-h	Breast	None
6823	33442881	2021	FLGALWNVAKSVF	VmCT1	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Vaejovis mexicanus smithi	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 8.3 ± 1.4 μmol/L	24-h	Breast	None
6821	34941705	2021	ASIGALIQKAIALIKAKAA	LVTX-9-C18	19	Linear	L	None	Amidation	CH₃-(CH₂)₁₆-CO	Anticancer	Synthetic	HepG-2	Liver Cancer	CCK-8 assay	IC₅₀ = 7.0 ± 1.0 µM	24-h	Liver	None
6822	34941705	2021	ASIGALIQKAIALIKAKAA	LVTX-9-C18	19	Linear	L	None	Amidation	CH₃-(CH₂)₁₆-CO	Anticancer	Synthetic	HeLa	Cervical Cancer	CCK-8 assay	IC₅₀ = 4.7 ± 1.4 µM	24-h	Cervix	None
6819	34941705	2021	ASIGALIQKAIALIKAKAA	LVTX-9-C18	19	Linear	L	None	Amidation	CH₃-(CH₂)₁₆-CO	Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 6.2 ± 1.4 µM	24-h	Lung	None
6820	34941705	2021	ASIGALIQKAIALIKAKAA	LVTX-9-C18	19	Linear	L	None	Amidation	CH₃-(CH₂)₁₆-CO	Anticancer	Synthetic	4T1	Breast Cancer	CCK-8 assay	IC₅₀ = 7.6 ± 1.3 µM	24-h	Breast	None
6818	34941705	2021	ASIGALIQKAIALIKAKAA	LVTX-9	19	Linear	L	None	Amidation	Free	Anticancer	Lycosa vittata	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 51.7 ± 4.3 µM	24-h	Lung	None
6817	33244888	2021	IFGTILGFLKGL	Protonectin-F	12	Linear	L	None	Amidation	Free	Antimicrobial	Protonoectin	HCT-116	Colon Cancer	Resazurin dye assay	CC₅₀ = 9.8 ± 1.2 µM	24-h	Colon	None
6816	33244888	2021	IFGTILGFLKGL	Protonectin-F	12	Linear	L	None	Amidation	Free	Antimicrobial	Protonoectin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 16.0 ± 1.2 µM	24-h	Skin	None
6815	33244888	2021	ILGTILGLLKGL	Protonectin	12	Linear	L	None	Amidation	Free	Antimicrobial	Parachartergus fraternus	HCT-116	Colon Cancer	Resazurin dye assay	CC₅₀ = 8.0 ± 0.5 µM	24-h	Colon	None
6814	33244888	2021	ILGTILGLLKGL	Protonectin	12	Linear	L	None	Amidation	Free	Antimicrobial	Parachartergus fraternus	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 14.8 ± 0.9 µM	24-h	Skin	None
6806	34309373	2021	RDVFTKGYGFGL	N-Ter	12	Linear	L	None	Free	Free	Anticancer	Analogue of N-terminal fragment of the VDAC1 protein	A-375	Skin Cancer	MTT assay	IC₅₀(A-375)> 50.0 μM	24-h	Skin	None
6803	34117917	2021	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	N-terminal region of Helicobacter pylori ribosomal protein L1	HT-29	Colon Cancer	MTT assay	IC₅₀ ~ 0.5 µg/mL	24-h	Colon	None
6802	34117917	2021	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	N-terminal region of Helicobacter pylori ribosomal protein L1	CT-26	Colorectal Cancer	MTT assay	IC₅₀ between 0.5 and 1 µg/mL	24-h	Colon	None
6797	33517264	2021	ICIFCCGCCHRSKCGMCCKT	Hepcidin	20	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Homo sapiens	U-266	Lymphoma Cancer	MTT assay	NA	NA	Blood	None
6796	34796903	2021	FLGWLFKVASK	A4W-GGN5	11	Linear	L	None	Amidation	Free	Anticancer	Gaegurin 5	SW-620	Colorectal Cancer	Sulforhodamine B assay	EC₅₀ = 22.07 ± 1.63 µM	48-h	Colon	None
6795	34796903	2021	FLGWLFKVASK	A4W-GGN5	11	Linear	L	None	Amidation	Free	Anticancer	Gaegurin 5	SW-480	Colorectal Cancer	Sulforhodamine B assay	EC₅₀ = 98.63 ± 1.17 µM	48-h	Colon	None
6793	34796903	2021	TYFNAVKPPITA	Loop2-PS2Aa	12	Linear	L	None	Amidation	Free	Anticancer	Parasporin-2Aa1	SW-620	Colorectal Cancer	Sulforhodamine B assay	EC₅₀ = 15.95 ± 0.69 µM	48-h	Colon	None
6794	34796903	2021	FKPQSGGGKCF	Loop1-HCoV-229E	11	Linear	L	None	Amidation	Free	Anticancer	Alphacoronavirus (HCoV-229E)	SW-480	Colorectal Cancer	Sulforhodamine B assay	EC₅₀ = 125.0 ± 1.32 µM	48-h	Colon	None
6792	34796903	2021	TYFNAVKPPITA	Loop2-PS2Aa	12	Linear	L	None	Amidation	Free	Anticancer	Parasporin-2Aa1	SW-480	Colorectal Cancer	Sulforhodamine B assay	EC₅₀ = 92.99 ± 0.98 µM	48-h	Colon	None
6791	34796903	2021	NNETYFNAVKP	Loop1-PS2Aa	11	Linear	L	None	Amidation	Free	Anticancer	Parasporin-2Aa1	SW-620	Colorectal Cancer	Sulforhodamine B assay	EC₅₀ = 106.2 ± 1.67 µM	48-h	Colon	None
6790	34796903	2021	NNETYFNAVKP	Loop1-PS2Aa	11	Linear	L	None	Amidation	Free	Anticancer	Parasporin-2Aa1	SW-480	Colorectal Cancer	Sulforhodamine B assay	EC₅₀ = 23.76 ± 1.25 µM	48-h	Colon	None
6789	34796903	2021	PARDVLNTTSG	P264-G274	11	Linear	L	None	Amidation	Free	Anticancer	Parasporin-2Aa1	SW-620	Colorectal Cancer	Sulforhodamine B assay	EC₅₀ = 11.28 ± 0.52 µM	48-h	Colon	None
6788	34796903	2021	PARDVLNTTSG	P264-G274	11	Linear	L	None	Amidation	Free	Anticancer	Parasporin-2Aa1	SW-480	Colorectal Cancer	Sulforhodamine B assay	EC₅₀ = 90.98 ± 0.75 µM	48-h	Colon	None
6787	33245189	2021	KWCFRVCYRGICYIRRCR	Tachyplesin	17	Linear	L	None	Amidation	Free	Antibacterial	Horseshoe crab	H-460	Lung Cancer	MTT assay	IC₅₀ = 25 µg/ml	24-h	Lung	None
6786	33245189	2021	KWCFRVCYRGICYIRRCR	Tachyplesin	17	Linear	L	None	Amidation	Free	Antibacterial	Horseshoe crab	A-549	Lung Cancer	MTT assay	IC₅₀ = 35 µg/ml	24-h	Lung	None
6749	33919639	2021	RMMRIFWVIKLAR	Pugnin B	13	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic; Using Skin Transcriptome of Treefrog ( Boana pugnax)	PC-3	Prostate Cancer	MTT assay	90% Cytotoxicity at 100 µM	24-h	Prostate	None
6748	33919639	2021	RMMRIFWVIKLAR	Pugnin B	13	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic; Using Skin Transcriptome of Treefrog ( Boana pugnax)	MCF-7	Breast Cancer	MTT assay	5% Cytotoxicity at 100 µM	24-h	Breast	None
6747	33919639	2021	RLMRIFRILKLAR	Pugnin A	13	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic; Using Skin Transcriptome of Treefrog ( Boana pugnax)	PC-3	Prostate Cancer	MTT assay	74% Cytotoxicity at 100 µM	24-h	Prostate	None
6746	33919639	2021	RLMRIFRILKLAR	Pugnin A	13	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic; Using Skin Transcriptome of Treefrog ( Boana pugnax)	MCF-7	Breast Cancer	MTT assay	12% Cytotoxicity at 100 µM	24-h	Breast	None
6681	34867962	2021	FLPLLISALTSLFPKLGK	SSTP1	18	Linear	L	None	Free	Free	Host Defense Peptide	Indosylvirana aurantiaca	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ = 10.22 μM	48-h	Tongue	None
6680	34867962	2021	FLPLLISALTSLFPKLGK	SSTP1	18	Linear	L	None	Free	Free	Host Defense Peptide	Indosylvirana aurantiaca	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 4.5 μM	48-h	Breast	None
6659	None	2021	ILGKIWKGIVSDF	DN4	13	Linear	L	None	Free	Free	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	191.67 ± 12.02 μM	24-h	Liver	None
6658	None	2021	ILGKIVKKLVSDF	DN1	13	Linear	L	None	Free	Free	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	152.17 ± 7.73 μM	24-h	Liver	None
6653	33029595	2020	[LLKKLLKK]₂kC	2-arm branched peptide	18	Linear	L	Branched amide bond in the branching point was formed by the primary amine of lysine.	Free	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	Cell Viability (%) ~ 73.5 ± 2.2 at 30 µg/mL	48-h	Prostate	None
6651	33029595	2020	[LLKKLLKK]₂kC	2-arm branched peptide	18	Linear	L	Branched amide bond in the branching point was formed by the primary amine of lysine.	Free	Free	Antimicrobial	Synthetic	HCT-116	Colon Cancer	MTT assay	Cell Viability (%) ~ 78.6 ± 10.5 at 30 µg/mL	48-h	Colon	None
6652	33029595	2020	[LLKKLLKK]₂kC	2-arm branched peptide	18	Linear	L	Branched amide bond in the branching point was formed by the primary amine of lysine.	Free	Free	Antimicrobial	Synthetic	Bcap-37	Breast Cancer	MTT assay	Cell Viability (%) ~ 81.8 ± 8.8 at 30 µg/mL	48-h	Breast	None
6650	33029595	2020	[LLKKLLKK]₂kC	2-arm branched peptide	18	Linear	L	Branched amide bond in the branching point was formed by the primary amine of lysine.	Free	Free	Antimicrobial	Synthetic	SK-HEP-1	Liver Cancer	MTT assay	Cell Viability (%) ~ 85.7 ± 4.3 at 30 µg/mL	48-h	Liver	None
6649	33029595	2020	LLKKLLKKLLKKLLKK	(LLKK)4 linear peptide	16	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	Cell Viability (%) ~ 17.1 ± 5.0 at 30 µg/mL	48-h	Prostate	None
6648	33029595	2020	LLKKLLKKLLKKLLKK	(LLKK)4 linear peptide	16	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Bcap-37	Breast Cancer	MTT assay	Cell Viability (%) ~ 15.07 ± 0.5 at 30 µg/mL	48-h	Breast	None
6647	33029595	2020	LLKKLLKKLLKKLLKK	(LLKK)4 linear peptide	16	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HCT-116	Colon Cancer	MTT assay	Cell Viability (%) ~ 10.73 ± 2.4 at 30 µg/mL	48-h	Colon	None
6646	33029595	2020	LLKKLLKKLLKKLLKK	(LLKK)4 linear peptide	16	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	SK-HEP-1	Liver Cancer	MTT assay	Cell Viability (%) ~ 14.1 ± 0.8 at 30 µg/mL	48-h	Liver	None
6645	32716104	2020	YFYPKDFTPGCT	YT12	12	Linear	L	None	Free	Free	Anticancer	Arthrospira platensis	HT-29	Colon Cancer	MTT assay	IC₅₀ = 12.5 μM	NA	Colon	None
6642	32971958	2020	VGAlAvVvWlWlWlW	Gramicidin A	15	Linear	Mix	None	NCH2CH2OH	Formylation	Antimicrobial	Aneurinibacillus migulanus	HT-29	Colon Cancer	MTT assay	IC₅₀ = 9.78 μM	48-h	Colon	None
6577	32567085	2020	FKRILQRIKDFLR	LL-37 Analogue 18	13	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 29.2 µg/mL	48-h	Lung	None
6576	32567085	2020	FKRILQRIKDFLR	LL-37 Analogue 17	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 19.2 µg/mL	48-h	Lung	None
6575	32567085	2020	FKRIVQLLKKLLR	LL-37 Analogue 16	13	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 9.8 µg/mL	48-h	Lung	None
6574	32567085	2020	FKRIVQLLKKLLR	LL-37 Analogue 15	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 12.8 µg/mL	48-h	Lung	None
6573	32567085	2020	FKRIVQIIKKFLR	LL-37 Analogue 14	13	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 12.9 µg/mL	48-h	Lung	None
6572	32567085	2020	FKRIVQIIKKFLR	LL-37 Analogue 13	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 20.0 µg/mL	48-h	Lung	None
6570	32567085	2020	FKRIVQRIKDLLR	LL-37 Analogue 11	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 75 µg/mL	48-h	Lung	None
6571	32567085	2020	FKRIVQRIKDLLR	LL-37 Analogue 12	13	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 45.5 µg/mL	48-h	Lung	None
6569	32567085	2020	FKRIVQLIKDFLR	LL-37 Analogue 10	13	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 13.9 µg/mL	48-h	Lung	None
6568	32567085	2020	FKRIVQLIKDFLR	LL-37 Analogue 9	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 18.9 µg/mL	48-h	Lung	None
6567	32567085	2020	FKRIVQKIKDFLR	LL-37 Analogue 8	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 145 µg/mL	48-h	Lung	None
6566	32567085	2020	FKRIVQRIRDFLR	LL-37 Analogue 7	13	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 12.5 µg/mL	48-h	Lung	None
6565	32567085	2020	FKRIVQRIRDFLR	LL-37 Analogue 6	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 56 µg/mL	48-h	Lung	None
6564	32567085	2020	FKSARIVQRILDFLR	LL-37 Analogue 5	15	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 10.7 µg/mL	48-h	Lung	None
6563	32567085	2020	FΚRIVQRILDFLR	LL-37 Analogue 4	13	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 3.9 µg/mL	48-h	Lung	None
6562	32567085	2020	AKRIVQRIKDFLR	LL-37 Analogue 3	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 29.8 µg/mL	48-h	Lung	None
6561	32567085	2020	LKRIVQRIKDFLR	LL-37 Analogue 2	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 33.7 µg/mL	48-h	Lung	None
6560	32567085	2020	FKRIVQRIKDFLR	LL-37 Analogue 1	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic Analog of LL-37	A-549	Lung Cancer	MTT assay	IC₅₀ = 20.1 µg/mL	48-h	Lung	None
6559	33276536	2020	NFFKRIRRAWKRIWKWIYSA	ΔM4	20	Linear	L	None	Free	Free	Anticancer	Synthetic	A-375	Skin Cancer	Not Available	IC₅₀ = 9.31 μM	NA	Skin	None
6558	37300579	2020	IDWKKLLDAAKLIL	MP1-Q12K	14	Linear	L	None	Amidation	Free	Antimicrobial	Analog of Polybia MP1	A-549	Lung Cancer	MTT assay	IC₅₀ = 12.5 μM	24-h	Lung	None
6557	37300579	2020	IDWKKLLDAAKQIL	Polybia-MP1	14	Linear	L	None	Amidation	Free	Antimicrobial	Polybia paulista	A-549	Lung Cancer	MTT assay	IC₅₀ = 12.5 μM	24-h	Lung	None
6554	32967114	2020	FIGTLIPLALGALTKLFK	Figainin 1	18	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Boana raniceps	B16-F10	Skin Cancer	MTT assay	IC₅₀ = 10.5 µM	NA	Skin	None
6553	32967114	2020	FIGTLIPLALGALTKLFK	Figainin 1	18	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Boana raniceps	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 11.1 µM	NA	Cervix	None
6552	32967114	2020	FIGTLIPLALGALTKLFK	Figainin 1	18	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Boana raniceps	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 13.7 µM	NA	Breast	None
6543	34508563	2020	FFPLIFGALSSILPKIL	Temporin-HLa	17	Linear	L	None	Amidation	Free	Antimicrobial	Hylarana latouchii	H-460	Lung Cancer	MTT assay	IC₅₀ = 1.64 ± 0.41 μM	24-h	Lung	None
6542	34508563	2020	FFPLIFGALSSILPKIL	Temporin-HLa	17	Linear	L	None	Amidation	Free	Antimicrobial	Hylarana latouchii	H-157	Lung Cancer	MTT assay	IC₅₀ = 15.18 ± 2.98 μM	24-h	Lung	None
6541	34508563	2020	FFPLIFGALSSILPKIL	Temporin-HLa	17	Linear	L	None	Amidation	Free	Antimicrobial	Hylarana latouchii	NCI-H23	Lung Cancer	MTT assay	IC₅₀ = 4.96 ± 0.94 μM	24-h	Lung	None
6540	32903706	2020	FFRKVLKLIRKIWR	HX-12C	14	Linear	L	None	Free	Free	Antimicrobial	Synthetic derivative of Temporin-Pta	KB-C2	Cervical Cancer	MTT assay	IC₅₀ = 6.06 μM	72-h	Cervix	None
6539	32903706	2020	FFRKVLKLIRKIF	HX-12B	13	Linear	L	None	Free	Free	Antimicrobial	Synthetic derivative of Temporin-Pta	KB-C2	Cervical Cancer	MTT assay	IC₅₀ = 7.61 μM	72-h	Cervix	None
6538	32903706	2020	FFRKVLKLIRKI	HX-12A	12	Linear	L	None	Free	Free	Antimicrobial	Synthetic derivative of Temporin-Pta	KB-C2	Cervical Cancer	MTT assay	IC₅₀ = 6.45 μM	72-h	Cervix	None
6537	32959810	2020	RWrGGGGGLFDIIKKIAESF	RA-3	20	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 44.14 μM	48-h	Breast	None
6536	32959810	2020	RWrGGGGGLFDIIKKIAESF	RA-3	20	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 28.4 μM	48-h	Breast	None
6535	32959810	2020	RWrGGGGGLFDIIKKIAESF	RA-3	20	Linear	Mix	None	Amidation	Free	Anticancer	Synthetic	U87-MG	Brain Tumor	MTT assay	IC₅₀ = 32.27 μM	48-h	Brain	None
6530	32151609	2020	RRWFWRRRRWFWRR	DIM-LF11-339	14	Linear	L	None	Amidation	Free	Anticancer	Synthetic	WM164	Skin Cancer	MTS assay	LC₅₀ = 3.8 ± 0.3 μM	24-h	Skin	EP_2943215_B1
6529	32151609	2020	RRWFWRRRRWFWRR	DIM-LF11-339	14	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 4.7 ± 0.3 μM	24-h	Skin	EP_2943215_B1
6528	32151609	2020	RRWFWRRRRWFWRR	DIM-LF11-339	14	Linear	L	None	Amidation	Free	Anticancer	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 4.8 ± 0.4 μM	24-h	Skin	EP_2943215_B1
6524	32151609	2020	PWRIRIRRPRRIRIWP	R-DIM-P-LF11-334	16	Linear	L	None	Amidation	Free	Anticancer	Synthetic	WM164	Skin Cancer	MTS assay	LC₅₀ = 5.0 ± 0.1 μM	24-h	Skin	EP_2943215_B1
6523	32151609	2020	PWRIRIRRPRRIRIWP	R-DIM-P-LF11-334	16	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 3.4 ± 0.4 μM	24-h	Skin	EP_2943215_B1
6522	32151609	2020	PWRIRIRRPRRIRIWP	R-DIM-P-LF11-334	16	Linear	L	None	Amidation	Free	Anticancer	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 6.6 ± 0.3 μM	24-h	Skin	EP_2943215_B1
6521	32151609	2020	FWRIRIRRPRRIRIRWF	R-DIM-P-LF11-215	17	Linear	L	None	Amidation	Free	Anticancer	Synthetic	WM164	Skin Cancer	MTS assay	LC₅₀ = 4.6 ± 0.1 μM	24-h	Skin	EP_2943215_B1
6520	32151609	2020	FWRIRIRRPRRIRIRWF	R-DIM-P-LF11-215	17	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ < 1 ± 0.0 μM	24-h	Skin	EP_2943215_B1
6519	32151609	2020	FWRIRIRRPRRIRIRWF	R-DIM-P-LF11-215	17	Linear	L	None	Amidation	Free	Anticancer	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 2.7 ± 0.9 μM	24-h	Skin	EP_2943215_B1
6518	32151609	2020	PFWRIRIRRPFWRIRIRR	DIM-LF11-322	18	Linear	L	None	Free	Free	Anticancer	Synthetic	WM164	Skin Cancer	MTS assay	LC₅₀ = 4.6 ± 0.1 μM	24-h	Skin	EP_2943215_B1
6517	32151609	2020	PFWRIRIRRPFWRIRIRR	DIM-LF11-322	18	Linear	L	None	Free	Free	Anticancer	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ < 1 ± 0.0 μM	24-h	Skin	EP_2943215_B1
6516	32151609	2020	PFWRIRIRRPFWRIRIRR	DIM-LF11-322	18	Linear	L	None	Free	Free	Anticancer	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 6.3 ± 0.3 μM	24-h	Skin	EP_2943215_B1
6515	32151609	2020	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Anticancer	Synthetic	WM164	Skin Cancer	MTS assay	LC₅₀ = 4.7 ± 0.2 μM	24-h	Skin	EP_2943215_B1
6514	32151609	2020	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 2.5 ± 0.1 μM	24-h	Skin	EP_2943215_B1
6513	32151609	2020	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Anticancer	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 4.2 ± 0.2 μM	24-h	Skin	EP_2943215_B1
6502	32462055	2020	LRKLRKRLLRLVGRQLEEFL	HM-10/10	20	Linear	L	None	Amidation	Acetylation	Anti-inflammatory and Anticancer	Synthetic	CT-26	Colorectal Cancer	MTS assay	~60% cell viability at 10 μg/mL	24-h	Colon	None
6495	32126228	2020	ILPWKWPWWPWKK	Indolicidin-Lys	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 9.5 μM	24-h	Blood	None
6494	32126228	2020	ILPWKWPWWPWRR	Indolicidin-Arg	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 13.7 μM	24-h	Blood	None
6493	32126228	2020	FPVTWRWWRWWRG	PuroA-Lys	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 12.0 μM	24-h	Blood	None
6492	32126228	2020	FPVTWKWWKWWKG	PuroA-Arg	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 10.0 μM	24-h	Blood	None
6489	32126228	2020	CVRRFPWWYPFLRRC	Tritrp DiSu	15	Cyclic(C1-15)	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 12.3 μM	24-h	Blood	None
6487	32126228	2020	VRRFPWYYPFLRR	Tritrp-W78Y	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 25.6 μM	24-h	Blood	None
6488	32126228	2020	VRRFPYYYPFLRR	Tritrp-W678Y	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ ≥ 65 μM	24-h	Blood	None
6486	32126228	2020	VRRFPYWYPFLRR	Tritrp-W68Y	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 35.4 μM	24-h	Blood	None
6485	32126228	2020	VRRFPYYWPFLRR	Tritrp-W67Y	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 32.2 μM	24-h	Blood	None
6484	32126228	2020	VRRFPWWYPFLRR	Tritrp-W8Y	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 12.0 μM	24-h	Blood	None
6483	32126228	2020	VRRFPWYWPFLRR	Tritrp-W7Y	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 11.4 μM	24-h	Blood	None
6482	32126228	2020	VRRFPYWWPFLRR	Tritrp-W6Y	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 19.3 μM	24-h	Blood	None
6481	32126228	2020	VRRFPAAAPFLRR	Tritrp-W678A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ ≥ 65 μM	24-h	Blood	None
6480	32126228	2020	VRRFPWAAPFLRR	Tritrp-W78A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ ≥ 65 μM	24-h	Blood	None
6479	32126228	2020	VRRFPAWAPFLRR	Tritrp-W68A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ ≥ 65 μM	24-h	Blood	None
6478	32126228	2020	VRRFPAAWPFLRR	Tritrp-W67A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ ≥ 65 μM	24-h	Blood	None
6477	32126228	2020	VRRFPWWAPFLRR	Tritrp-W8A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 22.8 μM	24-h	Blood	None
6476	32126228	2020	VRRFPWAWPFLRR	Tritrp-W7A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 48.2 μM	24-h	Blood	None
6475	32126228	2020	VRRFPAWWPFLRR	Tritrp-W6A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 36.5 μM	24-h	Blood	None
6474	32126228	2020	VRRFP(hW)(hW)(hW)PFLRR	Tritrp-W789hW	13	Linear	L	5-hydroxytryptophan	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 44.8 μM	24-h	Blood	None
6472	32126228	2020	VRRFPW(hW)WPFLRR	Tritrp-W7hW	13	Linear	L	5-hydroxytryptophan	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 15.1 μM	24-h	Blood	None
6473	32126228	2020	VRRFPWW(hW)PFLRR	Tritrp-W8hW	13	Linear	L	5-hydroxytryptophan	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 10.7 μM	24-h	Blood	None
6469	32126228	2020	VRRFPFFFPFLRR	Tritrp-W678F	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 24.6 μM	24-h	Blood	None
6470	32126228	2020	VRRFP(bTA)(bTA)(bTA)PFLRR	Tritrp-W678bTA	13	Linear	L	β-3-benzothienyl-1-Ala	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 9.6 μM	24-h	Blood	None
6471	32126228	2020	VRRFP(hW)WWPFLRR	Tritrp-W6hW	13	Linear	L	5-hydroxytryptophan	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 16.1 μM	24-h	Blood	None
6468	32126228	2020	VKKFPWWWAFLKK	Tritrp-P9A-Lys	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 15.1 μM	24-h	Blood	None
6467	32126228	2020	VRRFPWWWAFLRR	Tritrp-P9A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 6.8 μM	24-h	Blood	None
6466	32126228	2020	VKKFAWWWPFLKK	Tritrp-P5A-Lys	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 27.6 μM	24-h	Blood	None
6465	32126228	2020	VRRFAWWWPFLRR	Tritrp-P5A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 16.2 μM	24-h	Blood	None
6464	32126228	2020	VKKFAWWWAFLKK	Tritrp-P59A-Lys	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 27.6 μM	24-h	Blood	None
6463	32126228	2020	VRRFAWWWAFLRR	Tritrp-P59A	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 12.5 μM	24-h	Blood	None
6462	32126228	2020	V(Orn)(Orn)FPWWWPFL(Orn)(Orn)	Tritrp-Orn	13	Linear	L	Orn = Ornithine	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ ≤ 6.5 μM	24-h	Blood	None
6461	32126228	2020	V(Dab)(Dab)FPWWWPFL(Dab)(Dab)	Tritrp-Dab	13	Linear	L	Dab = 2,4-diaminobutyric acid	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ ≤ 6.5 μM	24-h	Blood	None
6459	32126228	2020	VKKFPWWWPFLKK	Tritrp-Lys	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 11.5 μM	24-h	Blood	None
6460	32126228	2020	V(Dap)(Dap)FPWWWPFL(Dap)(Dap)	Tritrp-Dap	13	Linear	L	Dap = 2,3-diaminopropionic acid	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ ≥ 65 μM	24-h	Blood	None
6457	32126228	2020	V(Agb)(Agb)FPWWWPFL(Agb)(Agb)	Tritrp-Agb	13	Linear	L	Agb = (S)-2-amino-4 guanidinobutyric acid	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 9.6 μM	24-h	Blood	None
6458	32126228	2020	V(hArg)(hArg)FPWWWPFL(hArg)(hArg)	Tritrp-hArg	13	Linear	L	Homo-arginine	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 13.3 μM	24-h	Blood	None
6456	32126228	2020	VRRFPWWWPFLRR	Tritrp-Arg	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 9.4 μM	24-h	Blood	None
6455	32126228	2020	VRRFPWWWPFLRR	Tritrpticin	13	Linear	L	None	Free	Free	Antimicrobial		Jurkat	Blood Cancer	MTT assay	IC₅₀ = 18.3 μM	24-h	Blood	None
6446	33363118	2020	GLFAVIKKVASVIKGL	A4K14 - Citropin 1.1	16	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CCK-8 assay	IC₅₀ = 14.16 µM	24-h	Breast	None
6445	33363118	2020	GLFAVIKKVASVIKGL	A4K14 - Citropin 1.1	16	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	U-87	Brain Tumor	CCK-8 assay	IC₅₀ = 14.8 µM	24-h	Brain	None
6443	33363118	2020	GLFAVIKKVASVIKGL	A4K14 - Citropin 1.1	16	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	C4-2B	Prostate Cancer	CCK-8 assay	IC₅₀ = 29.05 µM	24-h	Prostate	None
6444	33363118	2020	GLFAVIKKVASVIKGL	A4K14 - Citropin 1.1	16	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 14.97 µM	24-h	Lung	None
6442	33363118	2020	GS₅FAVS₅KKVASVIKGL	A4K14 - Citropin 1.1 - Sp 1	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CCK-8 assay	IC₅₀ = 11.26 µM	24-h	Breast	None
6440	33363118	2020	GS₅FAVS₅KKVASVIKGL	A4K14 - Citropin 1.1 - Sp 1	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 12.48 µM	24-h	Lung	None
6441	33363118	2020	GS₅FAVS₅KKVASVIKGL	A4K14 - Citropin 1.1 - Sp 1	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	U-87	Brain Tumor	CCK-8 assay	IC₅₀ = 11.88 µM	24-h	Brain	None
6439	33363118	2020	GS₅FAVS₅KKVASVIKGL	A4K14 - Citropin 1.1 - Sp 1	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	C4-2B	Prostate Cancer	CCK-8 assay	IC₅₀ = 8.94 µM	24-h	Prostate	None
6436	33363118	2020	GLFAS₅IKKS₅ASVIKGL	A4K14 - Citropin 1.1 - Sp 2	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 12.55 µM	24-h	Lung	None
6437	33363118	2020	GLFAS₅IKKS₅ASVIKGL	A4K14 - Citropin 1.1 - Sp 2	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	U-87	Brain Tumor	CCK-8 assay	IC₅₀ = 14.76 µM	24-h	Brain	None
6438	33363118	2020	GLFAS₅IKKS₅ASVIKGL	A4K14 - Citropin 1.1 - Sp 2	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CCK-8 assay	IC₅₀ = 12.65 µM	24-h	Breast	None
6435	33363118	2020	GLFAS₅IKKS₅ASVIKGL	A4K14 - Citropin 1.1 - Sp 2	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	C4-2B	Prostate Cancer	CCK-8 assay	IC₅₀ = 10.14 µM	24-h	Prostate	None
6434	33363118	2020	GLFAVS₅KKVS₅SVIKGL	A4K14 - Citropin 1.1 - Sp 3	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CCK-8 assay	IC₅₀ = 11.92 µM	24-h	Breast	None
6432	33363118	2020	GLFAVS₅KKVS₅SVIKGL	A4K14 - Citropin 1.1 - Sp 3	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 12.11 µM	24-h	Lung	None
6433	33363118	2020	GLFAVS₅KKVS₅SVIKGL	A4K14 - Citropin 1.1 - Sp 3	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	U-87	Brain Tumor	CCK-8 assay	IC₅₀ = 11.93 µM	24-h	Brain	None
6431	33363118	2020	GLFAVS₅KKVS₅SVIKGL	A4K14 - Citropin 1.1 - Sp 3	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	C4-2B	Prostate Cancer	CCK-8 assay	IC₅₀ = 17.89 µM	24-h	Prostate	None
6430	33363118	2020	GLFAVIKKS₅ASVS₅KGL	A4K14 - Citropin 1.1 - Sp 4	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CCK-8 assay	IC₅₀ = 10.49 µM	24-h	Breast	None
6428	33363118	2020	GLFAVIKKS₅ASVS₅KGL	A4K14 - Citropin 1.1 - Sp 4	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 10.51 µM	24-h	Lung	None
6429	33363118	2020	GLFAVIKKS₅ASVS₅KGL	A4K14 - Citropin 1.1 - Sp 4	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	U-87	Brain Tumor	CCK-8 assay	IC₅₀ = 7.277 µM	24-h	Brain	None
6427	33363118	2020	GLFAVIKKS₅ASVS₅KGL	A4K14 - Citropin 1.1 - Sp 4	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	C4-2B	Prostate Cancer	CCK-8 assay	IC₅₀ = 8.9 µM	24-h	Prostate	None
6426	33363118	2020	GLFAVIKKVAS₅VIKS₅L	A4K14 - Citropin 1.1 - Sp 5	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CCK-8 assay	IC₅₀ = 12.42 µM	24-h	Breast	None
6424	33363118	2020	GLFAVIKKVAS₅VIKS₅L	A4K14 - Citropin 1.1 - Sp 5	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 9.899 µM	24-h	Lung	None
6425	33363118	2020	GLFAVIKKVAS₅VIKS₅L	A4K14 - Citropin 1.1 - Sp 5	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	U-87	Brain Tumor	CCK-8 assay	IC₅₀ = 8.229 µM	24-h	Brain	None
6423	33363118	2020	GLFAVIKKVAS₅VIKS₅L	A4K14 - Citropin 1.1 - Sp 5	16	Cyclic	L	S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	C4-2B	Prostate Cancer	CCK-8 assay	IC₅₀ = 11.9 µM	24-h	Prostate	None
6422	33363118	2020	GR₈FAVIKKS₅ASVIKGL	A4K14 - Citropin 1.1 - Sp 6	16	Cyclic	L	R₈=(R)-2-(7-octenyl)alanine; S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CCK-8 assay	IC₅₀ = 23.78 µM	24-h	Breast	None
6420	33363118	2020	GR₈FAVIKKS₅ASVIKGL	A4K14 - Citropin 1.1 - Sp 6	16	Cyclic	L	R₈=(R)-2-(7-octenyl)alanine; S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 30.19 µM	24-h	Lung	None
6421	33363118	2020	GR₈FAVIKKS₅ASVIKGL	A4K14 - Citropin 1.1 - Sp 6	16	Cyclic	L	R₈=(R)-2-(7-octenyl)alanine; S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	U-87	Brain Tumor	CCK-8 assay	IC₅₀ = 34.49 µM	24-h	Brain	None
6419	33363118	2020	GR₈FAVIKKS₅ASVIKGL	A4K14 - Citropin 1.1 - Sp 6	16	Cyclic	L	R₈=(R)-2-(7-octenyl)alanine; S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	C4-2B	Prostate Cancer	CCK-8 assay	IC₅₀ = 35.84 µM	24-h	Prostate	None
6418	33363118	2020	GLFAVR₈KKVASVS₅KGL	A4K14 - Citropin 1.1 - Sp 7	16	Cyclic	L	R₈=(R)-2-(7-octenyl)alanine; S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CCK-8 assay	IC₅₀ = 12.1 µM	24-h	Breast	None
6417	33363118	2020	GLFAVR₈KKVASVS₅KGL	A4K14 - Citropin 1.1 - Sp 7	16	Cyclic	L	R₈=(R)-2-(7-octenyl)alanine; S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	U-87	Brain Tumor	CCK-8 assay	IC₅₀ = 14.72 µM	24-h	Brain	None
6416	33363118	2020	GLFAVR₈KKVASVS₅KGL	A4K14 - Citropin 1.1 - Sp 7	16	Cyclic	L	R₈=(R)-2-(7-octenyl)alanine; S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 16.37 µM	24-h	Lung	None
6415	33363118	2020	GLFAVR₈KKVASVS₅KGL	A4K14 - Citropin 1.1 - Sp 7	16	Cyclic	L	R₈=(R)-2-(7-octenyl)alanine; S₅= (S)-2-(4-pentenyl)alanine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	C4-2B	Prostate Cancer	CCK-8 assay	IC₅₀ = 10.23 µM	24-h	Prostate	None
6414	32630734	2020	FIQHLIPLIPHAIQGIKDIF	Kassiniatuerin-3	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Kassina senegalensis	NCI-H23	Lung Cancer	MTT assay	IC₅₀ = 4.52 µM	24-h	Lung	None
6413	32630734	2020	FIQHLIPLIPHAIQGIKDIF	Kassiniatuerin-3	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Kassina senegalensis	H-157	Lung Cancer	MTT assay	IC₅₀ = 21.54 µM	24-h	Lung	None
6412	32630734	2020	FIQHLIPLIPHAIQGIKDIF	Kassiniatuerin-3	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Kassina senegalensis	H-460	Lung Cancer	MTT assay	IC₅₀ = 1.67 µM	24-h	Lung	None
6411	32630734	2020	FIQHLIPLIPHAIQGIKDIF	Kassiniatuerin-3	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Kassina senegalensis	H-838	Lung Cancer	MTT assay	IC₅₀ = 10.03 µM	24-h	Lung	None
6410	32630734	2020	FIQHLIPLIPHAIQGIKDIF	Kassiniatuerin-3	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Kassina senegalensis	LNCaP	Prostate Cancer	MTT assay	IC₅₀ = 3.79 µM	24-h	Prostate	None
6409	32630734	2020	FIQHLIPLIPHAIQGIKDIF	Kassiniatuerin-3	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Kassina senegalensis	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 13.20 µM	24-h	Brain	None
6228	30862544	2019	GGTCVIRGCVPKKLM	GM15	15	Linear	L	None	Free	Free	Antioxidant	Arthrospira platensis	KB	Oral Cancer	MTT assay	~ 35% cell viability at 25 μM	24-h	Not Available	None
6208	None	2019	CHYRVKPKIKRFEKYKGRMW	LPSBD-2	20	Linear	L	None	Free	Free	Anticancer	Synthetic	THP-1	Leukemia Cancer	Not Available	Not Available	24-h	Blood	None
6178	31909181	2019	FLFKLIKKKIKKLIKKFK	AP1-Z9	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	MCF-7	Breast Cancer	MTT assay	Graph Figure 2A	24-h	Breast	None
6179	31909181	2019	FLFKLIKKKIKKLIKKFK	AP1-Z9	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	A-375	Skin Cancer	MTT assay	Graph Figure 2B	24-h	Skin	None
6180	31909181	2019	FLFKLIKKKIKKLIKKFK	AP1-Z9	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	U-87	Brain Tumor	MTT assay	Graph Figure 2C	24-h	Brain	None
6176	31909181	2019	FLFKLIKKAIKKLIKAFK	AP1-Z7	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	A-375	Skin Cancer	MTT assay	Graph Figure 2B	24-h	Skin	None
6177	31909181	2019	FLFKLIKKAIKKLIKAFK	AP1-Z7	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	U-87	Brain Tumor	MTT assay	Graph Figure 2C	24-h	Brain	None
6173	31909181	2019	FLFSLIKHAISKLISAFK	AP1-Z3b	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	A-375	Skin Cancer	MTT assay	Graph Figure 2B	24-h	Skin	None
6174	31909181	2019	FLFSLIKHAISKLISAFK	AP1-Z3b	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	U-87	Brain Tumor	MTT assay	Graph Figure 2C	24-h	Brain	None
6175	31909181	2019	FLFKLIKKAIKKLIKAFK	AP1-Z7	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	MCF-7	Breast Cancer	MTT assay	Graph Figure 2A	24-h	Breast	None
6170	31909181	2019	FLFSLIKHAIKGLISAFK	AP1-Z3a	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	A-375	Skin Cancer	MTT assay	Graph Figure 2B	24-h	Skin	None
6171	31909181	2019	FLFSLIKHAIKGLISAFK	AP1-Z3a	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	U-87	Brain Tumor	MTT assay	Graph Figure 2C	24-h	Brain	None
6172	31909181	2019	FLFSLIKHAISKLISAFK	AP1-Z3b	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	MCF-7	Breast Cancer	MTT assay	Graph Figure 2A	24-h	Breast	None
6168	31909181	2019	FLFKLIKHAIKGLIKAFK	AP1-Z5b	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	U-87	Brain Tumor	MTT assay	IC₅₀ = 3.115 μM	24-h	Brain	None
6169	31909181	2019	FLFSLIKHAIKGLISAFK	AP1-Z3a	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	MCF-7	Breast Cancer	MTT assay	Graph Figure 2A	24-h	Breast	None
6165	31909181	2019	FLFKLIPKAIKGLIKAFK	AP1-Z5a	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	U-87	Brain Tumor	MTT assay	Graph Figure 2C	24-h	Brain	None
6166	31909181	2019	FLFKLIKHAIKGLIKAFK	AP1-Z5b	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 1.037 μM	24-h	Breast	None
6167	31909181	2019	FLFKLIKHAIKGLIKAFK	AP1-Z5b	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	A-375	Skin Cancer	MTT assay	IC₅₀ = 2.607 μM	24-h	Skin	None
6163	31909181	2019	FLFKLIPKAIKGLIKAFK	AP1-Z5a	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	MCF-7	Breast Cancer	MTT assay	Graph Figure 2A	24-h	Breast	None
6164	31909181	2019	FLFKLIPKAIKGLIKAFK	AP1-Z5a	18	Linear	L	None	Amidation	Amidation	Antimicrobial	Mutant of APR-Z1	A-375	Skin Cancer	MTT assay	Graph Figure 2B	24-h	Skin	None
6161	31909181	2019	FLFSLIPHAISGLISAFK	AP1-Z1	18	Linear	L	None	Amidation	Amidation	Antimicrobial	AcrAP1 from the venom of the Arabian scorpion	A-375	Skin Cancer	MTT assay	IC₅₀ = 9.478 μM	24-h	Skin	None
6162	31909181	2019	FLFSLIPHAISGLISAFK	AP1-Z1	18	Linear	L	None	Amidation	Amidation	Antimicrobial	AcrAP1 from the venom of the Arabian scorpion	U-87	Brain Tumor	MTT assay	IC₅₀ = 10.21 μM	24-h	Brain	None
6160	31909181	2019	FLFSLIPHAISGLISAFK	AP1-Z1	18	Linear	L	None	Amidation	Amidation	Antimicrobial	AcrAP1 from the venom of the Arabian scorpion	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 7.222 μM	24-h	Breast	None
6155	31714739	2019	KWCFRVCYRGFCYRRCRK	[I11F-G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 5.1 ± 0.3 µM	24-h	Cervix	None
6154	31714739	2019	KWCFRVCYRGFCYRRCRK	[I11F-G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 1.9 ± 0.1 µM	24-h	Blood	None
6153	31714739	2019	KWCFRVCYRGFCYRRCRK	[I11F-G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.9 ± 0.2 µM	24-h	Skin	None
6152	31714739	2019	KWCFRVCYRGFCYRRCRK	[I11F-G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HT-144	Skin Cancer	Resazurin dye assay	CC₅₀ = 3.2 ± 0.1 µM	24-h	Skin	None
6151	31714739	2019	KWCFRVCYRGFCYRRCRK	[I11F-G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.3 ± 0.1 µM	24-h	Skin	None
6150	31714739	2019	KWCFRVCYRGICYRRCRK	[G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 6.7 ± 1.1 µM	24-h	Cervix	None
6149	31714739	2019	KWCFRVCYRGICYRRCRK	[G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 1.7 ± 0.1 µM	24-h	Blood	None
6148	31714739	2019	KWCFRVCYRGICYRRCRK	[G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.7 ± 0.2 µM	24-h	Skin	None
6147	31714739	2019	KWCFRVCYRGICYRRCRK	[G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HT-144	Skin Cancer	Resazurin dye assay	CC₅₀ = 3.2 ± 0.1 µM	24-h	Skin	None
6146	31714739	2019	KWCFRVCYRGICYRRCRK	[G18K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.0 ± 0.1 µM	24-h	Skin	None
6145	31714739	2019	KWCFRVCYSGICYSRCSG	[R9S-R14S-R17S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 4.8 ± 0.3 µM	24-h	Blood	None
6144	31714739	2019	KWCFRVCYSGICYSRCSG	[R9S-R14S-R17S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 11.1 ± 0.9 µM	24-h	Skin	None
6143	31714739	2019	KWCFRVCYSGICYSRCSG	[R9S-R14S-R17S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HT-144	Skin Cancer	Resazurin dye assay	CC₅₀ = 11.8 ± 0.9 µM	24-h	Skin	None
6142	31714739	2019	KWCFRVCYRGICYRRCSG	[R17S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 12.2 ± 0.4 µM	24-h	Cervix	None
6141	31714739	2019	KWCFRVCYRGICYRRCSG	[R17S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MDA-MB-435S	Skin Cancer	Resazurin dye assay	CC₅₀ = 4.5 ± 0.3 µM	24-h	Skin	None
6140	31714739	2019	KWCFRVCYRGICYRRCSG	[R17S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.8 ± 0.1 µM	24-h	Skin	None
6139	31714739	2019	KWCFRVCYRGICYRRCSG	[R17S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HT-144	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.2 ± 0.1 µM	24-h	Skin	None
6138	31714739	2019	KWCFRVCYRGICYRRCSG	[R17S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.8 ± 0.1 µM	24-h	Skin	None
6137	31714739	2019	KWCFRVCYRGICYSRCRG	[R14S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 7.5 ± 0.3 µM	24-h	Cervix	None
6136	31714739	2019	KWCFRVCYRGICYSRCRG	[R14S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MDA-MB-435S	Skin Cancer	Resazurin dye assay	CC₅₀ = 3.5 ± 0.3 µM	24-h	Skin	None
6135	31714739	2019	KWCFRVCYRGICYSRCRG	[R14S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.7 ± 0.1 µM	24-h	Skin	None
6134	31714739	2019	KWCFRVCYRGICYSRCRG	[R14S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HT-144	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.3 ± 0.2 µM	24-h	Skin	None
6133	31714739	2019	KWCFRVCYRGICYSRCRG	[R14S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.7 ± 0.1 µM	24-h	Skin	None
6132	31714739	2019	KWCFRVCYSGICYRRCRG	[R9S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MDA-MB-435S	Skin Cancer	Resazurin dye assay	CC₅₀ = 5.3 ± 0.6 µM	24-h	Skin	None
6131	31714739	2019	KWCFRVCSRGSCYRRCRG	[Y8S-I11S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 13.2 ± 0.9 µM	24-h	Blood	None
6130	31714739	2019	KWCFRVCSRGSCYRRCRG	[Y8S-I11S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 28.2 ± 2.0 µM	24-h	Skin	None
6129	31714739	2019	KWCFRVCSRGSCYRRCRG	[Y8S-I11S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HT-144	Skin Cancer	Resazurin dye assay	CC₅₀ = 27.8 ± 2.2 µM	24-h	Skin	None
6128	31714739	2019	KWCFRVCSRGSCYRRCRG	[Y8S-I11S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 17.3 ± 1.0 µM	24-h	Skin	None
6127	31714739	2019	KSCFRVCYRGICYRRCRG	[W2S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 22.5 ± 2.1 µM	24-h	Cervix	None
6126	31714739	2019	KSCFRVCYRGICYRRCRG	[W2S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 2.7 ± 0.2 µM	24-h	Blood	None
6125	31714739	2019	KSCFRVCYRGICYRRCRG	[W2S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MDA-MB-435S	Skin Cancer	Resazurin dye assay	CC₅₀ = 18.9 ± 0.9 µM	24-h	Skin	None
6124	31714739	2019	KSCFRVCYRGICYRRCRG	[W2S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 3.9 ± 0.2 µM	24-h	Skin	None
6123	31714739	2019	KSCFRVCYRGICYRRCRG	[W2S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HT-144	Skin Cancer	Resazurin dye assay	CC₅₀ = 3.0 ± 0.2 µM	24-h	Skin	None
6122	31714739	2019	KSCFRVCYRGICYRRCRG	[W2S]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.0 ± 0.1 µM	24-h	Skin	None
6121	31714739	2019	KWCFKVCYKGICYKKCKG	[R/K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 13.4 ± 1.9 µM	24-h	Cervix	None
6120	31714739	2019	KWCFKVCYKGICYKKCKG	[R/K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 2.5 ± 0.1 µM	24-h	Blood	None
6119	31714739	2019	KWCFKVCYKGICYKKCKG	[R/K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MDA-MB-435S	Skin Cancer	Resazurin dye assay	CC₅₀ = 3.5 ± 0.4 µM	24-h	Skin	None
6118	31714739	2019	KWCFKVCYKGICYKKCKG	[R/K]cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 4.3 ± 0.3 µM	24-h	Skin	None
6117	31714739	2019	KWCFRVCYRGICYRRCRG	cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 6.7 ± 0.6 µM	24-h	Cervix	None
6116	31714739	2019	KWCFRVCYRGICYRRCRG	cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MCF-7	Breast Cancer	Resazurin dye assay	CC₅₀ = 6.4 ± 0.6 µM	24-h	Breast	None
6115	31714739	2019	KWCFRVCYRGICYRRCRG	cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 2.0 ± 0.1 µM	24-h	Blood	None
6114	31714739	2019	KWCFRVCYRGICYRRCRG	cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MDA-MB-435S	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.7 ± 0.3 µM	24-h	Skin	None
6113	31714739	2019	KWCFRVCYRGICYRRCRG	cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.7 ± 0.1 µM	24-h	Skin	None
6112	31714739	2019	KWCFRVCYRGICYRRCRG	cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	HT-144	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.4 ± 0.1 µM	24-h	Skin	None
6111	31714739	2019	KWCFRVCYRGICYRRCRG	cT1	18	Cyclic	L	None	Cyclized	Cyclized	Host Defense Peptide	Synthetic	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.3 ± 0.1 µM	24-h	Skin	None
6110	31714739	2019	KWCFRVCYRGICYRRCR	T1	17	Linear	L	None	Amidation	Free	Host Defense Peptide	Horseshoe Crab	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 13.1 ± 1.2 µM	24-h	Cervix	None
6109	31714739	2019	KWCFRVCYRGICYRRCR	T1	17	Linear	L	None	Amidation	Free	Host Defense Peptide	Horseshoe Crab	MCF-7	Breast Cancer	Resazurin dye assay	CC₅₀ = 16.0 ± 2.0 µM	24-h	Breast	None
6108	31714739	2019	KWCFRVCYRGICYRRCR	T1	17	Linear	L	None	Amidation	Free	Host Defense Peptide	Horseshoe Crab	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 1.7 ± 0.1 µM	24-h	Blood	None
6107	31714739	2019	KWCFRVCYRGICYRRCR	T1	17	Linear	L	None	Amidation	Free	Host Defense Peptide	Horseshoe Crab	MDA-MB-435S	Skin Cancer	Resazurin dye assay	CC₅₀ = 8.0 ± 0.6 µM	24-h	Skin	None
6106	31714739	2019	KWCFRVCYRGICYRRCR	T1	17	Linear	L	None	Amidation	Free	Host Defense Peptide	Horseshoe Crab	WM164	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.5 ± 0.1 µM	24-h	Skin	None
6105	31714739	2019	KWCFRVCYRGICYRRCR	T1	17	Linear	L	None	Amidation	Free	Host Defense Peptide	Horseshoe Crab	HT-144	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.7 ± 0.2 µM	24-h	Skin	None
6104	31714739	2019	KWCFRVCYRGICYRRCR	T1	17	Linear	L	None	Amidation	Free	Host Defense Peptide	Horseshoe Crab	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.5 ± 0.1 µM	24-h	Skin	None
6037	30612735	2019	FLSLIPHIVSGVAALANHL	Phylloseptin-PBa3	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	H-838	Lung Cancer	MTT assay	Cell viability ~ 65% at 10^-5 M	72-h	Lung	None
6036	30612735	2019	FLSLIPHIVSGVAALANHL	Phylloseptin-PBa3	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	MDA-MB-435S	Breast Cancer	MTT assay	IC₅₀ = 208 µM	72-h	Breast	None
6035	30612735	2019	FLSLIPHIASGIASLVKNF	Phylloseptin-PBa1	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	H-838	Lung Cancer	MTT assay	Cell viability ~ 65% at 10^-5 M	72-h	Lung	None
6034	30612735	2019	FLSLIPHIASGIASLVKNF	Phylloseptin-PBa1	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	H-460	Lung Cancer	MTT assay	Cell viability < 50% at 10^-5 M	72-h	Lung	None
6033	30612735	2019	FLSLIPHIASGIASLVKNF	Phylloseptin-PBa1	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	DU-145	Prostate Cancer	MTT assay	Cell viability ~ 50% at 10^-5 M	72-h	Prostate	None
6032	30612735	2019	FLSLIPHIASGIASLVKNF	Phylloseptin-PBa1	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	U251-MG	Brain Tumor	MTT assay	Cell viability ~ 40% at 10^-5 M	72-h	Brain	None
6031	30612735	2019	FLSLIPHIASGIASLVKNF	Phylloseptin-PBa1	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	MDA-MB-435S	Breast Cancer	MTT assay	IC₅₀ = 0.50 µM	72-h	Breast	None
6030	30612735	2019	FLSLLPHIASGIASLVSKF	Phylloseptin-PBa3	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	H-838	Lung Cancer	MTT assay	Cell viability ~ 65% at 10^-5 M	72-h	Lung	None
6029	30612735	2019	FLSLLPHIASGIASLVSKF	Phylloseptin-PBa3	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	H-460	Lung Cancer	MTT assay	Cell viability ~ 60% at 10^-5 M	72-h	Lung	None
6028	30612735	2019	FLSLLPHIASGIASLVSKF	Phylloseptin-PBa2	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	U251-MG	Brain Tumor	MTT assay	Cell viability ~ 60% at 10^-5 M	72-h	Brain	None
6027	30612735	2019	FLSLLPHIASGIASLVSKF	Phylloseptin-PBa2	19	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa burmeisteri	MDA-MB-435S	Breast Cancer	MTT assay	IC₅₀ = 0.29 µM	72-h	Breast	None
6017	30563041	2018	RIRDAIAHGYIVDKV	B11	15	Linear	L	None	Free	Free	Antimicrobial	Litopenaeus vannamei hemocyanin-derived peptide	EC-109	Esophageal Cancer	MTS assay	Decreased cell viability by 13% at 50 μg/mL	24-h	Esophagus	None
6016	30563041	2018	RIRDAIAHGYIVDKV	B11	15	Linear	L	None	Free	Free	Antimicrobial	Litopenaeus vannamei hemocyanin-derived peptide	HepG-2	Liver Cancer	MTS assay	Decreased cell viability by 23% at 50 μg/mL	24-h	Liver	None
6015	30563041	2018	RIRDAIAHGYIVDKV	B11	15	Linear	L	None	Free	Free	Antimicrobial	Litopenaeus vannamei hemocyanin-derived peptide	HeLa	Cervical Cancer	MTS assay	Decreased cell viability by 20% at 50 μg/mL	24-h	Cervix	None
5986	30031283	2018	NGVQPKYRWWRWWRRWW	RT2	17	Linear	L	None	Amidation	Free	Antimicrobial	Crocodylus siamensis	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 90.25 μg/mL	24-h	Colon	None
5985	30031283	2018	NGVQPKYKWWKWWKKWW	KT2	17	Linear	L	None	Amidation	Free	Antimicrobial	Crocodylus siamensis	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 90.25 μg/mL	24-h	Colon	None
5982	28254375	2018	ASVVNKLTGGVAGLLK	TP	16	Linear	L	None	Free	Free	Antimicrobial	Tibetan swine	NB-4	Leukemia Cancer	MTT assay	IC₅₀ = 11.479 μM	48-h	Blood	None
5981	28254375	2018	ASVVNKLTGGVAGLLK	TP	16	Linear	L	None	Free	Free	Antimicrobial	Tibetan swine	MKN-45	Gastric Cancer	MTT assay	IC₅₀ = 4.686 μM	48-h	Stomach	None
5969	30123940	2018	Ahx-(KAVPIAQKE)RRRRRRRR	SmacN7-Arg8 fused peptide P5	18	Cyclic	L	Ahx = aminohexanoic acid; Lactam Bridge between K2 and E10	Amidation	Free	Anticancer	Synthetic	U-266	Skin Cancer	Cell Titer Blue Cell Viability assay	Cell viability < 50% at 50 μM	48-h	Skin	None
5968	30123940	2018	Ahx-AVPIAQK(KRRRRRRRRRE)	SmacN7-Arg8 fused peptide P4	18	Cyclic	L	Ahx = aminohexanoic acid; Lactam Bridge between K6 and E18	Amidation	Free	Anticancer	Synthetic	U-266	Skin Cancer	Cell Titer Blue Cell Viability assay	Cell viability < 50% at 50 μM	48-h	Skin	None
5948	29993185	2018	WCYKLPDRVSIKEKGRCN	Peptide13 Gonearrestide	18	Linear	L	None	Amidation	Free	Anticancer	Androctonus mauritanicus	U-251	Brain tumor	MTT assay	Not Available	24-h	Brain	None
5947	29993185	2018	WCYKLPDRVSIKEKGRCN	Peptide13 Gonearrestide	18	Linear	L	None	Amidation	Free	Anticancer	Androctonus mauritanicus	Dks8	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5945	29993185	2018	WCYKLPDRVSIKEKGRCN	Peptide13 Gonearrestide	18	Linear	L	None	Amidation	Free	Anticancer	Androctonus mauritanicus	DLD-1	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5946	29993185	2018	WCYKLPDRVSIKEKGRCN	Peptide13 Gonearrestide	18	Linear	L	None	Amidation	Free	Anticancer	Androctonus mauritanicus	HKe-3	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5944	29993185	2018	WCYKLPDRVSIKEKGRCN	Peptide13 Gonearrestide	18	Linear	L	None	Amidation	Free	Anticancer	Androctonus mauritanicus	HCT-116	Colon Cancer	MTT assay	IC₅₀ ~ 100 μM/L	24-h	Colon	None
5938	29993185	2018	KLSAIISKIRDE	Peptide6 Gonearrestide	12	Linear	L	None	Free	Free	Anticancer	Androctonus australis	U-251	Brain tumor	MTT assay	Not Available	24-h	Brain	None
5937	29993185	2018	KLSAIISKIRDE	Peptide6 Gonearrestide	12	Linear	L	None	Free	Free	Anticancer	Androctonus australis	Dks8	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5936	29993185	2018	KLSAIISKIRDE	Peptide6 Gonearrestide	12	Linear	L	None	Free	Free	Anticancer	Androctonus australis	HKe-3	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5935	29993185	2018	KLSAIISKIRDE	Peptide6 Gonearrestide	12	Linear	L	None	Free	Free	Anticancer	Androctonus australis	DLD-1	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5934	29993185	2018	KLSAIISKIRDE	Peptide6 Gonearrestide	12	Linear	L	None	Free	Free	Anticancer	Androctonus australis	HCT-116	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5933	29993185	2018	ADAPGNYPLDARGKSYYC	Peptide4 Gonearrestide	18	Linear	L	None	Free	Free	Anticancer	Androctonus australis	U-251	Brain tumor	MTT assay	Not Available	24-h	Brain	None
5932	29993185	2018	ADAPGNYPLDARGKSYYC	Peptide4 Gonearrestide	18	Linear	L	None	Free	Free	Anticancer	Androctonus australis	Dks8	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5931	29993185	2018	ADAPGNYPLDARGKSYYC	Peptide4 Gonearrestide	18	Linear	L	None	Free	Free	Anticancer	Androctonus australis	HKe-3	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5930	29993185	2018	ADAPGNYPLDARGKSYYC	Peptide4 Gonearrestide	18	Linear	L	None	Free	Free	Anticancer	Androctonus australis	DLD-1	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5929	29993185	2018	ADAPGNYPLDARGKSYYC	Peptide4 Gonearrestide	18	Linear	L	None	Free	Free	Anticancer	Androctonus australis	HCT-116	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5928	30409511	2018	FLSTIWNGIKSLL	Pantinin-3	13	Linear	L	None	Free	Free	Antimicrobial	Synthetic	DU-145	Prostate Cancer	MTS assay	IC₅₀ = 17.3 ± 1.0 µM	24-h	Prostate	None
5927	30409511	2018	FLSTIWNGIKSLL	Pantinin-3	13	Linear	L	None	Free	Free	Antimicrobial	Synthetic	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 13.5 ± 2.0 µM	24-h	Breast	None
5926	30409511	2018	IFGAIWKGISSLL	Pantinin-2	13	Linear	L	None	Free	Free	Antimicrobial	Synthetic	DU-145	Prostate Cancer	MTS assay	IC₅₀ = 16.5 ± 1.0 µM	24-h	Prostate	None
5925	30409511	2018	IFGAIWKGISSLL	Pantinin-2	13	Linear	L	None	Free	Free	Antimicrobial	Synthetic	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 12.5 ± 1.0 µM	24-h	Breast	None
5924	30409511	2018	GILGKLWEGFKSIV	Pantinin-1	14	Linear	L	None	Free	Free	Antimicrobial	Synthetic	DU-145	Prostate Cancer	MTS assay	IC₅₀ = 47.5 ± 2.0 µM	24-h	Prostate	None
5922	30318506	2018	GSETWKTIITKN	IL13Rα2 D1 peptide	12	Linear	L	None	Free	Free	Anticancer	Synthetic	U-118	Brain Cancer	MTT assay	inhibited IL13-stimulated cell adhesion	48-h	Brain	None
5923	30409511	2018	GILGKLWEGFKSIV	Pantinin-1	14	Linear	L	None	Free	Free	Antimicrobial	Synthetic	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 28.5 ± 1.0 µM	24-h	Breast	None
5921	30318506	2018	GSETWKTIITKN	IL13Rα2 D1 peptide	12	Linear	L	None	Free	Free	Anticancer	Synthetic	U-87	Brain Cancer	MTT assay	inhibited IL13-stimulated cell adhesion	48-h	Brain	None
5920	30318506	2018	GSETWKTIITKN	IL13Rα2 D1 peptide	12	Linear	L	None	Free	Free	Anticancer	Synthetic	SW-620	Colorectal Cancer	MTT assay	inhibited IL13-stimulated cell adhesion	48-h	Colon	None
5919	30318506	2018	GSETWKTIITKN	IL13Rα2 D1 peptide	12	Linear	L	None	Free	Free	Anticancer	Synthetic	KM12SM	Colorectal Cancer	MTT assay	inhibited IL13-stimulated cell adhesion	48-h	Colon	None
5903	30026168	2018	FLSGIVaMLaKLF	[G7,10a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	NCI-H-460	Lung Cancer	MTT assay	IC₅₀ >100 µM	24-h	Lung	None
5901	30026168	2018	FLSGIVaMLaKLF	[G7,10a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 21.3 ± 1.13 µM	24-h	Breast	None
5902	30026168	2018	FLSGIVaMLaKLF	[G7,10a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	HeLa	Cervical Cancer	MTT assay	IC₅₀ >100 µM	24-h	Cervix	None
5899	30026168	2018	FLSaIVaMLaKLF	[G4,7,10a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	HeLa	Cervical Cancer	MTT assay	IC₅₀ >100 µM	24-h	Cervix	None
5900	30026168	2018	FLSaIVaMLaKLF	[G4,7,10a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	NCI-H-460	Lung Cancer	MTT assay	IC₅₀ >100 µM	24-h	Lung	None
5898	30026168	2018	FLSaIVaMLaKLF	[G4,7,10a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 26.33 ± 5.8 µM	24-h	Breast	None
5896	30026168	2018	FLSaIVaMLGKLF	[G4,7a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	HeLa	Cervical Cancer	MTT assay	IC₅₀ >100 µM	24-h	Cervix	None
5897	30026168	2018	FLSaIVaMLGKLF	[G4,7a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	NCI-H-460	Lung Cancer	MTT assay	IC₅₀ = 37.3 ± 3.5 µM	24-h	Lung	None
5894	30026168	2018	FLSGIVGMLaKLF	[G10a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	NCI-H-460	Lung Cancer	MTT assay	IC₅₀ =24.3 ± 0.8 µM	24-h	Lung	None
5895	30026168	2018	FLSaIVaMLGKLF	[G4,7a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 29.5 ± 6.03 µM	24-h	Breast	None
5892	30026168	2018	FLSGIVGMLaKLF	[G10a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 16.2 ± 2.2 µM	24-h	Breast	None
5893	30026168	2018	FLSGIVGMLaKLF	[G10a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 22.7 ± 0.86 µM	24-h	Cervix	None
5891	30026168	2018	FLSGIVaMLGKLF	[G7a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	NCI-H-460	Lung Cancer	MTT assay	IC₅₀ >100 µM	24-h	Lung	None
5890	30026168	2018	FLSGIVaMLGKLF	[G7a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	HeLa	Cervical Cancer	MTT assay	IC₅₀ >100 µM	24-h	Cervix	None
5889	30026168	2018	FLSGIVaMLGKLF	[G7a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	MCF-7	Breast Cancer	MTT assay	IC₅₀ =22.4 ± 2.2 µM	24-h	Breast	None
5888	30026168	2018	FLSaIVGMLGKLF	[G4a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	NCI-H-460	Lung Cancer	MTT assay	IC₅₀ >100 µM	24-h	Lung	None
5887	30026168	2018	FLSaIVGMLGKLF	[G4a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	HeLa	Cervical Cancer	MTT assay	IC₅₀ >100 µM	24-h	Cervix	None
5886	30026168	2018	FLSaIVGMLGKLF	[G4a]SHa	13	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 17.9 ± 1.1 µM	24-h	Breast	None
5882	29842923	2018	IPPFIKKVLTTVF	Temporin-CPa	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	4T1	Breast Cancer	MTS assay	LC₅₀ = 80 μM	Not Available	Breast	None
5881	29842923	2018	FLPLLASLFSRLF	Temporin-1Oc	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTS assay	LC₅₀ = 50 μM	Not Available	Cervix	None
5878	29842923	2018	SILPTIVSFLSKVF	Temporin-1Ga	14	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	4T1	Breast Cancer	MTS assay	LC₅₀ = 20 μM	Not Available	Breast	None
5879	29842923	2018	FLPFLKSILGKIL	Temporin-1OLa	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTS assay	LC₅₀ = 25 μM	Not Available	Cervix	None
5880	29842923	2018	FLPLLASLFSRLF	Temporin-1Oc	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	4T1	Breast Cancer	MTS assay	LC₅₀ = 65 μM	Not Available	Breast	None
5872	29904274	2018	CLNLKALLAVAKKILC	cMP-C	16	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 13.66 μM	24-h	Breast	None
5869	29904274	2018	CLNLKALLAVAKKILC	cMP-C	16	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 13.87 μM	24-h	Skin	None
5870	29904274	2018	CLNLKALLAVAKKILC	cMP-C	16	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 13.87 μM	24-h	Prostate	None
5871	29904274	2018	CLNLKALLAVAKKILC	cMP-C	16	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	U-251-MG	Brain tumor	MTT assay	IC₅₀ = 8.56 μM	24-h	Brain	None
5866	29904274	2018	LNLKALLAVAKKIL	Mastoparan-C	14	Linear	L	None	Amidation	Free	Antimicrobial	Vespa crabro	U-251-MG	Brain tumor	MTT assay	IC₅₀ = 36.65 μM	24-h	Brain	None
5867	29904274	2018	LNLKALLAVAKKIL	Mastoparan-C	14	Linear	L	None	Amidation	Free	Antimicrobial	Vespa crabro	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 25.27 μM	24-h	Breast	None
5868	29904274	2018	CLNLKALLAVAKKILC	cMP-C	16	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 7.02 μM	24-h	Lung	None
5863	29904274	2018	LNLKALLAVAKKIL	Mastoparan-C	14	Linear	L	None	Amidation	Free	Antimicrobial	Vespa crabro	H-157	Lung Cancer	MTT assay	IC₅₀ = 13.57 μM	24-h	Lung	None
5864	29904274	2018	LNLKALLAVAKKIL	Mastoparan-C	14	Linear	L	None	Amidation	Free	Antimicrobial	Vespa crabro	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 27.70 μM	24-h	Skin	None
5865	29904274	2018	LNLKALLAVAKKIL	Mastoparan-C	14	Linear	L	None	Amidation	Free	Antimicrobial	Vespa crabro	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 6.29 μM	24-h	Prostate	None
5847	29191658	2018	FLYIVAKLLSGLL	temporin-PEa	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of Temporin-PE	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 27.62 μM	Not Available	Prostate	None
5848	29191658	2018	FLYIVAKLLSGLL	temporin-PEa	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of Temporin-PE	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 9.864 μM	Not Available	Skin	None
5846	29191658	2018	FLYIVAKLLSGLL	temporin-PEa	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of Temporin-PE	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 3.520 μM	Not Available	Brain	None
5845	29191658	2018	FLYIVAKLLSGLL	temporin-PEa	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of Temporin-PE	NCI-H-157	Lung Cancer	MTT assay	IC₅₀ = 3.398 μM	Not Available	Lung	None
5844	29191658	2018	FLPIVAKLLSGLL	Temporin-PE	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pelophylax kl. esculentus	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 33.23 μM	Not Available	Skin	None
5843	29191658	2018	FLPIVAKLLSGLL	Temporin-PE	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pelophylax kl. esculentus	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 38.56 μM	Not Available	Prostate	None
5842	29191658	2018	FLPIVAKLLSGLL	Temporin-PE	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pelophylax kl. esculentus	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 25.13 μM	Not Available	Brain	None
5841	29191658	2018	FLPIVAKLLSGLL	Temporin-PE	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pelophylax kl. esculentus	NCI-H-157	Lung Cancer	MTT assay	IC₅₀ = 34.56 μM	Not Available	Lung	None
5833	28636781	2018	IIGPVLGLIGKALGGLL	Bombinin H-BO	17	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	A-549	Lung Cancer	MTT assay	Cell Viability ~ 20% at 5 μM	48-h	Lung	None
5834	28636781	2018	IIGPVLGLIGKALGGLL	Bombinin H-BO	17	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	A-375	Skin Cancer	MTT assay	Cell Viability < 20% at 5 μM	48-h	Skin	None
5831	28636781	2018	IIGPVLGLIGKALGGLL	Bombinin H-BO	17	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	Huh-7	Liver Cancer	MTT assay	IC₅₀ = 3.87 μM	48-h	Liver	None
5832	28636781	2018	IIGPVLGLIGKALGGLL	Bombinin H-BO	17	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	PC-3	Prostate Cancer	MTT assay	Cell Viability ~ 40% at 2.5 μM	48-h	Prostate	None
5829	28636781	2018	IIGPVLGLIGKALGGLL	Bombinin H-BO	17	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	SK-HEP-1	Liver Cancer	MTT assay	IC₅₀ = 0.99 μM	48-h	Liver	None
5830	28636781	2018	IIGPVLGLIGKALGGLL	Bombinin H-BO	17	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.88 μM	48-h	Liver	None
5822	29515106	2018	RKKRRQRRREFLDCFQKF	TAT-327	18	Linear	L	None	Free	Free	Anticancer	Peptide-327	SW-620	Colorectal Cancer	CCK-8 assay	EC₅₀ = 64.61 ± 1.63 μM	12-h	Colon	None
5821	29515106	2018	RKKRRQRRREFLDCFQKF	TAT-327	18	Linear	L	None	Free	Free	Anticancer	Peptide-327	HT-29	Colon Cancer	CCK-8 assay	EC₅₀ = 74.08 ± 0.63 μM	12-h	Colon	None
5819	29515106	2018	RKKRRQRRREFLDCFQKF	TAT-327	18	Linear	L	None	Free	Free	Anticancer	Peptide-327	HepG-2	Liver Cancer	CCK-8 assay	EC₅₀ = 68.52 ± 2.96 μM	12-h	Liver	None
5820	29515106	2018	RKKRRQRRREFLDCFQKF	TAT-327	18	Linear	L	None	Free	Free	Anticancer	Peptide-327	Colo-320	Colon Cancer	CCK-8 assay	EC₅₀ = 68.40 ± 0.42 μM	12-h	Colon	None
5818	29515106	2018	RKKRRQRRREFLDCFQKF	TAT-327	18	Linear	L	None	Free	Free	Anticancer	Peptide-327	A-549	Lung Cancer	CCK-8 assay	EC₅₀ = 55.42 ± 0.84 μM	12-h	Lung	None
5811	29098406	2018	IIGPVLGLVGKALGGLL	Bombinin-H-BO1	17	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	Huh-7	Liver Cancer	MTT assay	IC₅₀ = 8.42 μM	48-h	Liver	None
5810	29098406	2018	IIGPVLGLVGKALGGLL	Bombinin-H-BO1	17	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 8.08 μM	48-h	Liver	None
5809	29098406	2018	IIGPVLGLVGKALGGLL	Bombinin-H-BO1	17	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	SK-HEP-1	Liver Cancer	MTT assay	IC₅₀ = 3.61 μM	48-h	Liver	None
5730	28811617	2017	IKKILSKIKKLLK	L-K6	13	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Temporin 1CEb analogue	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 31 μM	24-h	Breast	None
5726	28249727	2017	ILGPVLGLVSDTLDDVLGIL	Maximin H5	20	Linear	L	None	Amidation	Free	Host defense peptide	Bombina maxima	T98G	Human glioblastoma	MTS assay	IC₅₀ = 125 µM	72-h	Brain	None
5707	28719744	2017	EENFLGALFKALSKLL	PTP-7S	16	Linear	L	None	Free	Free	Anticancer	PTP-7	A-549	Lung Cancer	MTT assay	65% cell viability at 10 µΜ	6-h	Lung	None
5706	28719744	2017	EENFLGALFKALSKLL	PTP-7S	16	Linear	L	None	Free	Free	Anticancer	PTP-7	HeLa	Cervical Cancer	MTT assay	55 - 60% cell viability at 75 µM	24-h	Cervix	None
5658	28850103	2017	FLSLIPAAISAVSALANHF	Phylloseptin-PHa	19	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pithecopus hypochondrialis	NCI-H-157	Lung Cancer	MTT assay	IC₅₀ = 14.10 μM	24-h	Lung	None
5656	28850103	2017	FLSLIPKIAGGIAALAKHL	Phylloseptin-PTa	19	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Phyllomedusa tarsius	NCI-H-157	Lung Cancer	MTT assay	IC₅₀ = 6.73 μM	24-h	Lung	None
5655	36982972	2017	GCRRLCYKQRCVTYCRGR	cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 2.7 ± 0.1 μM	24-h	Blood	None
5654	36982972	2017	GCRRLCYKQRCVTYCRGR	cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MCF-7	Breast Cancer	Resazurin dye assay	CC₅₀ = 15.3 ± 1.4 μM	24-h	Breast	None
5652	36982972	2017	GCRRLCYKQRCVTYCRGR	cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.9 ± 0.1 μM	24-h	Skin	None
5653	36982972	2017	GCRRLCYKQRCVTYCRGR	cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ > 64 μM	24-h	Cervix	None
5651	36982972	2017	GCRRLCYKQRCVTYCRGR	cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 39.8 ± 1.0 μM	24-h	Stomach	None
5650	36982972	2017	GCRRLCWKQRCVTYCRGR	[Y7W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 3.9 ± 0.2 μM	24-h	Blood	None
5649	36982972	2017	GCRRLCWKQRCVTYCRGR	[Y7W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ > 64 μM	24-h	Cervix	None
5648	36982972	2017	GCRRLCWKQRCVTYCRGR	[Y7W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 5.1 ± 0.3 μM	24-h	Skin	None
5646	36982972	2017	GCRRLCYKQRCVTWCRGR	[Y14W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 2.7 ± 0.1 μM	24-h	Blood	None
5647	36982972	2017	GCRRLCWKQRCVTYCRGR	[Y7W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 23.3 ± 0.4 μM	24-h	Stomach	None
5645	36982972	2017	GCRRLCYKQRCVTWCRGR	[Y14W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 50.4 ± 2.4 μM	24-h	Cervix	None
5644	36982972	2017	GCRRLCYKQRCVTWCRGR	[Y14W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 4.0 ± 0.1 μM	24-h	Skin	None
5643	36982972	2017	GCRRLCYKQRCVTWCRGR	[Y14W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 30.3 ± 1.1 μM	24-h	Stomach	None
5642	36982972	2017	GCRRLCYRQRCVTYCRGR	[K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 3.1 ± 0.1 μM	24-h	Blood	None
5640	36982972	2017	GCRRLCYRQRCVTYCRGR	[K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 5.0 ± 0.3 μM	24-h	Skin	None
5641	36982972	2017	GCRRLCYRQRCVTYCRGR	[K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 39.4 ± 2.6 μM	24-h	Cervix	None
5639	36982972	2017	GCRRLCYRQRCVTYCRGR	[K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 29.4 ± 1.1 μM	24-h	Stomach	None
5638	36982972	2017	GCRRLCWRQRCVTWCRGR	[Y7W, K8R, Y14W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 3.9 ± 0.1 μM	24-h	Blood	None
5637	36982972	2017	GCRRLCWRQRCVTWCRGR	[Y7W, K8R, Y14W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MCF-7	Breast Cancer	Resazurin dye assay	CC₅₀ = 15.1 ± 1.4 μM	24-h	Breast	None
5636	36982972	2017	GCRRLCWRQRCVTWCRGR	[Y7W, K8R, Y14W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 41.0 ± 4.2 μM	24-h	Cervix	None
5634	36982972	2017	GCRRLCWRQRCVTWCRGR	[Y7W, K8R, Y14W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 31.6 ± 1.3 μM	24-h	Stomach	None
5635	36982972	2017	GCRRLCWRQRCVTWCRGR	[Y7W, K8R, Y14W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 5.4 ± 0.3 μM	24-h	Skin	None
5633	36982972	2017	GCRALCYKQRCVTYCRGA	[R4A, R18A]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HL-60	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 34.1 ± 3.9 μM	24-h	Blood	None
5632	36982972	2017	GCRALCYKQRCVTYCRGA	[R4A, R18A]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 11.5 ± 0.6 μM	24-h	Blood	None
5631	36982972	2017	GCRALCYKQRCVTYCRGA	[R4A, R18A]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MCF-7	Breast Cancer	Resazurin dye assay	CC₅₀ = 48.4 ± 0.7 μM	24-h	Breast	None
5629	36982972	2017	GCRALCYKQRCVTYCRGA	[R4A, R18A]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 10.3 ± 1.1 μM	24-h	Skin	None
5630	36982972	2017	GCRALCYKQRCVTYCRGA	[R4A, R18A]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ > 64 μM	24-h	Cervix	None
5628	36982972	2017	GCRALCYKQRCVTYCRGA	[R4A, R18A]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ > 64 μM	24-h	Stomach	None
5627	36982972	2017	KCRRLCYRQRCVTYCRGR	[G1K, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HL-60	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 9.0 ± 1.1μM	24-h	Blood	None
5626	36982972	2017	KCRRLCYRQRCVTYCRGR	[G1K, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 2.1 ± 0.2 μM	24-h	Blood	None
5625	36982972	2017	KCRRLCYRQRCVTYCRGR	[G1K, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MCF-7	Breast Cancer	Resazurin dye assay	CC₅₀ = 6.7 ± 0.7 μM	24-h	Breast	None
5624	36982972	2017	KCRRLCYRQRCVTYCRGR	[G1K, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 44.2 ± 2.2μM	24-h	Cervix	None
5622	36982972	2017	KCRRLCYRQRCVTYCRGR	[G1K, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 19.5 ± 0.5 μM	24-h	Stomach	None
5623	36982972	2017	KCRRLCYRQRCVTYCRGR	[G1K, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.7 ± 0.1 μM	24-h	Skin	None
5620	36982972	2017	GURRLUYKQRUVTYURGR	[C/U]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 1.4 ± 0.2 μM	24-h	Blood	None
5621	36982972	2017	GURRLUYKQRUVTYURGR	[C/U]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HL-60	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 38.5 ± 4.8 μM	24-h	Blood	None
5617	36982972	2017	GURRLUYKQRUVTYURGR	[C/U]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 4.6 ± 0.2 μM	24-h	Skin	None
5618	36982972	2017	GURRLUYKQRUVTYURGR	[C/U]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ > 64 μM	24-h	Cervix	None
5619	36982972	2017	GURRLUYKQRUVTYURGR	[C/U]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MCF-7	Breast Cancer	Resazurin dye assay	CC₅₀ = 37.5 ± 3.3 μM	24-h	Breast	None
5616	36982972	2017	GURRLUYKQRUVTYURGR	[C/U]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 51.0 ± 4.6 μM	24-h	Stomach	None
5615	36982972	2017	GCRRWCYKQRCVTYCRGR	[L5W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 1.0 ± 0.1 μM	24-h	Blood	None
5613	36982972	2017	GCRRWCYKQRCVTYCRGR	[L5W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 4.0 ± 0.1 μM	24-h	Skin	None
5614	36982972	2017	GCRRWCYKQRCVTYCRGR	[L5W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 17.1 ± 0.7 μM	24-h	Cervix	None
5612	36982972	2017	GCRRWCYKQRCVTYCRGR	[L5W]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 18.3 ± 1.4 μM	24-h	Stomach	None
5611	36982972	2017	GCRRLCYKQRCVTYCRGpPR	[D-P L-P]cGm	20	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 3.9 ± 0.2 μM	24-h	Blood	None
5610	36982972	2017	GCRRLCYKQRCVTYCRGpPR	[D-P L-P]cGm	20	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 51.5 ± 3.9 μM	24-h	Cervix	None
5609	36982972	2017	GCRRLCYKQRCVTYCRGpPR	[D-P L-P]cGm	20	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 3.0 ± 0.1 μM	24-h	Skin	None
5608	36982972	2017	GCRRLCYKQRCVTYCRGpPR	[D-P L-P]cGm	20	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 22.5 ± 3.3 μM	24-h	Stomach	None
5606	36982972	2017	KCRRYCYRQRCVTYCRGR	[G1K, L5Y, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 1.3 ± 0.1 μM	24-h	Blood	None
5607	36982972	2017	KCRRYCYRQRCVTYCRGR	[G1K, L5Y, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HL-60	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 15.7 ±1.1μM	24-h	Blood	None
5605	36982972	2017	KCRRYCYRQRCVTYCRGR	[G1K, L5Y, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MCF-7	Breast Cancer	Resazurin dye assay	CC₅₀ = 15.2 ± 1.9 μM	24-h	Breast	None
5604	36982972	2017	KCRRYCYRQRCVTYCRGR	[G1K, L5Y, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 20.9 ± 1.4 μM	24-h	Cervix	None
5603	36982972	2017	KCRRYCYRQRCVTYCRGR	[G1K, L5Y, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.0 ± 0.1 μM	24-h	Skin	None
5601	36982972	2017	KURRYUYRQRUVTYURGR	[C/U, G1K, L5Y, K8R]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HL-60	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 33.3 ±7.4μM	24-h	Blood	None
5602	36982972	2017	KCRRYCYRQRCVTYCRGR	[G1K, L5Y, K8R]cGm	18	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 26.5 ± 2.4 μM	24-h	Stomach	None
5598	36982972	2017	KURRYUYRQRUVTYURGR	[C/U, G1K, L5Y, K8R]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 36.2 ± 2.8 μM	24-h	Cervix	None
5599	36982972	2017	KURRYUYRQRUVTYURGR	[C/U, G1K, L5Y, K8R]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MCF-7	Breast Cancer	Resazurin dye assay	CC₅₀ = 29.0 ± 3.7 μM	24-h	Breast	None
5600	36982972	2017	KURRYUYRQRUVTYURGR	[C/U, G1K, L5Y, K8R]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	K-562	Leukemia Cancer	Resazurin dye assay	CC₅₀ = 6.4 ± 0.6 μM	24-h	Blood	None
5596	36982972	2017	KURRYUYRQRUVTYURGR	[C/U, G1K, L5Y, K8R]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	CRL-1739	Gastric Cancer	Resazurin dye assay	CC₅₀ = 46.2 ± 7.6 μM	24-h	Stomach	None
5597	36982972	2017	KURRYUYRQRUVTYURGR	[C/U, G1K, L5Y, K8R]cGm	18	Cyclic	L	U = SelenoCys	Cyclized	Cyclized	Antimicrobial	Synthetic Analogue of Gomesin	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.3 ± 0.2 μM	24-h	Skin	None
5594	36982972	2017	ZCRRLCYKQRCVTYCRGR	Gomesin	18	Cyclic	L	Z= pyroglutamic acid	Amidation	Free	Antimicrobial and Anticancer	Acanthoscurria gomesiana	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 5.5 ± 1.1 μM	24-h	Skin	None
5595	36982972	2017	ZCRRLCYKQRCVTYCRGR	Gomesin	18	Cyclic	L	Z= pyroglutamic acid	Amidation	Free	Antimicrobial and Anticancer	Acanthoscurria gomesiana	K-562	Blood Cancer	Resazurin dye assay	CC₅₀ = 5.5 ± 1.1 μM	24-h	Blood	None
5582	29183371;21530568	2017	LKCNKLVPLF	NN-32	10	Linear	L	None	Free	Free	Anticancer	Indian spectacled cobra venom Naja naja	MDA-MB-231	Breast Cancer	Anti-proliferation assay	Survival(%) = 64% at 10 μg/ml	72-h	Breast	None
5583	29183371;21530568	2017	LKCNKLVPLF	NN-32	10	Linear	L	None	Free	Free	Anticancer	Indian spectacled cobra venom Naja naja	MCF-7	Breast Cancer	LDH leakage assay	74% LDH Release at 2 μg/ml	72-h	Breast	None
5584	29183371;21530568	2017	LKCNKLVPLF	NN-32	10	Linear	L	None	Free	Free	Anticancer	Indian spectacled cobra venom Naja naja	MDA-MB-231	Breast Cancer	LDH leakage assay	66% LDH Release at 2 μg/ml	72-h	Breast	None
5579	29183371;21530568	2017	LKCNKLVPLF	NN-32	10	Linear	L	None	Free	Free	Anticancer	Indian spectacled cobra venom Naja naja	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 2.5 μg/ml	48-h	Breast	None
5580	29183371;21530568	2017	LKCNKLVPLF	NN-32	10	Linear	L	None	Free	Free	Anticancer	Indian spectacled cobra venom Naja naja	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 6.7 μg/ml	48-h	Breast	None
5581	29183371;21530568	2017	LKCNKLVPLF	NN-32	10	Linear	L	None	Free	Free	Anticancer	Indian spectacled cobra venom Naja naja	MCF-7	Breast Cancer	Anti-proliferation assay	Survival(%) = 68% at 10 μg/ml	48-h	Breast	None
5578	28123590	2017	KCRRWLKRMKKLG	LfcinB-P13	13	Linear	L	None	Free	Free	Anticancer	Synthetic analog of LFcinB	SMMC-7721	Liver Cancer	MTT assay	IC₅₀ = 41.8 µg/ml	24-h	Liver	None
5574	28483698	2017	FRRFFKWPRRPFKFF	FR8,11P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 15 μM	24-h	Liver	None
5572	28483698	2017	FRRFFKWPRRPFKFF	FR8,11P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 18.9 μM	24-h	Cervix	None
5573	28483698	2017	FRRFFKWPRRPFKFF	FR8,11P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	DLD-1	Colon Cancer	MTT assay	IC₅₀ = 22 μM	24-h	Colon	None
5571	28483698	2017	FRRFFKWPRRPFKFF	FR8,11P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 27 μM	24-h	Breast	None
5570	28483698	2017	FRRPFKWPRRFFKFF	FR4,8P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 5 μM	24-h	Liver	None
5568	28483698	2017	FRRPFKWPRRFFKFF	FR4,8P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 13.8 μM	24-h	Cervix	None
5569	28483698	2017	FRRPFKWPRRFFKFF	FR4,8P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	DLD-1	Colon Cancer	MTT assay	IC₅₀ = 15.3 μM	24-h	Colon	None
5567	28483698	2017	FRRPFKWPRRFFKFF	FR4,8P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 15.4 μM	24-h	Breast	None
5565	28483698	2017	FRRFFKWFRRPFKFF	FR11P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	DLD-1	Colon Cancer	MTT assay	IC₅₀ = 12.9 μM	24-h	Colon	None
5566	28483698	2017	FRRFFKWFRRPFKFF	FR11P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 4.8 μM	24-h	Liver	None
5564	28483698	2017	FRRFFKWFRRPFKFF	FR11P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 11 μM	24-h	Cervix	None
5562	28483698	2017	FRRFFKWPRRFFKFF	FR8P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 4.2 μM	24-h	Liver	None
5563	28483698	2017	FRRFFKWFRRPFKFF	FR11P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 7 μM	24-h	Breast	None
5561	28483698	2017	FRRFFKWPRRFFKFF	FR8P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	DLD-1	Colon Cancer	MTT assay	IC₅₀ = 10.8 μM	24-h	Colon	None
5560	28483698	2017	FRRFFKWPRRFFKFF	FR8P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 10.5 μM	24-h	Cervix	None
5558	28483698	2017	FRRPFKWFRRFFKFF	FR4P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.5 μM	24-h	Liver	None
5559	28483698	2017	FRRFFKWPRRFFKFF	FR8P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 6.4 μM	24-h	Breast	None
5557	28483698	2017	FRRPFKWFRRFFKFF	FR4P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	DLD-1	Colon Cancer	MTT assay	IC₅₀ = 9.4 μM	24-h	Colon	None
5555	28483698	2017	FRRPFKWFRRFFKFF	FR4P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 6.3 μM	24-h	Breast	None
5556	28483698	2017	FRRPFKWFRRFFKFF	FR4P	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of FR-15	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 7.7 μM	24-h	Cervix	None
5554	28483698	2017	FRRFFKWFRRFFKFF	FR-15	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.5 μM	24-h	Liver	None
5553	28483698	2017	FRRFFKWFRRFFKFF	FR-15	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	MTT assay	IC₅₀ = 6.7 μM	24-h	Colon	None
5552	28483698	2017	FRRFFKWFRRFFKFF	FR-15	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 4.9 μM	24-h	Cervix	None
5551	28483698	2017	FRRFFKWFRRFFKFF	FR-15	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 3.15 μM	24-h	Breast	None
5534	27778166	2017	FKIGGFIKKLWRSLAA	IL-5	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	LDH leakage assay	35% LDH release at 32 μM	2-h	Cervix	None
5533	27778166	2017	FKIGGFIKKLWRSLAA	IL-5	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 22.0 ± 2.6 μM	4-h	Prostate	None
5532	27778166	2017	FKIGGFIKKLWRSLAA	IL-5	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 28.0 ± 4.6 μM	4-h	Cervix	None
5531	27778166	2017	FKIGGFIKKLWRSALA	IL-4	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	LDH leakage assay	28% LDH release at 32 μM	2-h	Cervix	None
5530	27778166	2017	FKIGGFIKKLWRSALA	IL-4	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 35.5 ± 3.9 μM	4-h	Prostate	None
5529	27778166	2017	FKIGGFIKKLWRSALA	IL-4	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 54.4 ± 3.0 μM	4-h	Cervix	None
5528	27778166	2017	FKIGGFIKKAWRSLLA	IL-3	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	LDH leakage assay	35% LDH release at 32 μM	2-h	Cervix	None
5527	27778166	2017	FKIGGFIKKAWRSLLA	IL-3	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 74.9 ± 13.3 μM	4-h	Prostate	None
5526	27778166	2017	FKIGGFIKKAWRSLLA	IL-3	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 93.5 ± 19.4 μM	4-h	Cervix	None
5525	27778166	2017	FKIGGFAKKLWRSLLA	IL-2	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	LDH leakage assay	30% LDH release at 32 μM	2-h	Cervix	None
5524	27778166	2017	FKIGGFAKKLWRSLLA	IL-2	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 43.6 ± 7.9 μM	4-h	Prostate	None
5523	27778166	2017	FKIGGFAKKLWRSLLA	IL-2	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 52.0 ± 5.8 μM	4-h	Cervix	None
5522	27778166	2017	FKAGGFIKKLWRSLLA	IL-1	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	LDH leakage assay	30% LDH release at 32 μM	2-h	Cervix	None
5521	27778166	2017	FKAGGFIKKLWRSLLA	IL-1	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 58.4 ± 13.7 μM	4-h	Prostate	None
5520	27778166	2017	FKAGGFIKKLWRSLLA	IL-1	16	Linear	L	None	Free	Free	Anticancer	Synthetic; Mutant form of ZXR-II	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 73.9 ± 13.6 μM	4-h	Cervix	None
5519	27778166	2017	FKIGGFIKKLWRSLLA	ZXR-2	16	Linear	L	None	Free	Free	Antimicrobial	Synthetic; Mutant form of ZXR-I	HeLa	Cervical Cancer	LDH leakage assay	40% LDH release at 32 μM	2-h	Cervix	None
5518	28524273	2017	LKKLFKKILKY	B8	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	LDH leakage assay	~60-60% LDH release at 8 μM	24-h	Blood	None
5517	28524273	2017	LKKLFKKILKYL	B4	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	LDH leakage assay	~60-80% LDH release at 8 μM	24-h	Blood	None
5516	28524273	2017	KKLFKKILKYL	BP100	11	Linear	L	None	Amidation	Free	Antimicrobial	Icthyopthirius multifilis (Strain G5)	K-562	Leukemia Cancer	LDH leakage assay	~40-60% LDH release at 8 μM	24-h	Blood	None
5515	28524273	2017	KLKKLFKKILKY	B9	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562/ADM	Leukemia Cancer	MTT assay	IC₅₀ = 83.7 ± 5.3 μM	48-h	Blood	None
5514	28524273	2017	KLKKLFKKILKY	B9	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 30.6 ± 5.7 μM	48-h	Breast	None
5513	28524273	2017	KLKKLFKKILKY	B9	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 38.3 ± 2.5 μM	48-h	Breast	None
5512	28524273	2017	KLKKLFKKILKY	B9	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 60.7 ± 5.4 μM	48-h	Blood	None
5511	28524273	2017	LKKLFKKILKY	B8	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562/ADM	Leukemia Cancer	MTT assay	IC₅₀ = 8.1 ± 0.9 μM	48-h	Blood	None
5510	28524273	2017	LKKLFKKILKY	B8	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 10.9 ± 1.2 μM	48-h	Breast	None
5509	28524273	2017	LKKLFKKILKY	B8	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 7.6 ± 1.4 μM	48-h	Breast	None
5508	28524273	2017	LKKLFKKILKY	B8	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 7.7 ± 1.2 μM	48-h	Blood	None
5506	28524273	2017	KKLFKKILKY	B7	10	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 97.3 ± 11.4 μM	48-h	Breast	None
5504	28524273	2017	KKLFKKILKY	B7	10	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 73.7 ± 6.1 μM	48-h	Blood	None
5505	28524273	2017	KKLFKKILKY	B7	10	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 77.3 ± 5.6 μM	48-h	Breast	None
5503	28524273	2017	LKKLFKKILKYLKK	B6	14	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562/ADM	Leukemia Cancer	MTT assay	IC₅₀ = 22.7 ± 2.3 μM	48-h	Blood	None
5502	28524273	2017	LKKLFKKILKYLKK	B6	14	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 20.7 ± 1.6 μM	48-h	Breast	None
5501	28524273	2017	LKKLFKKILKYLKK	B6	14	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 18.4 ± 1.5 μM	48-h	Breast	None
5500	28524273	2017	LKKLFKKILKYLKK	B6	14	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 19.2 ± 2.3 μM	48-h	Blood	None
5499	28524273	2017	LKKLFKKILKYLK	B5	13	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562/ADM	Leukemia Cancer	MTT assay	IC₅₀ = 28.3 ± 2.3 μM	48-h	Blood	None
5498	28524273	2017	LKKLFKKILKYLK	B5	13	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 28.2 ± 2.7 μM	48-h	Breast	None
5497	28524273	2017	LKKLFKKILKYLK	B5	13	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 27.3 ± 2.4 μM	48-h	Breast	None
5496	28524273	2017	LKKLFKKILKYLK	B5	13	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 26.5 ± 1.5 μM	48-h	Blood	None
5495	28524273	2017	LKKLFKKILKYL	B4	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562/ADM	Leukemia Cancer	MTT assay	IC₅₀ = 7.7 ± 0.4 μM	48-h	Blood	None
5494	28524273	2017	LKKLFKKILKYL	B4	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 6.3 ± 0.4 μM	48-h	Breast	None
5493	28524273	2017	LKKLFKKILKYL	B4	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 5.9 ± 0.2 μM	48-h	Breast	None
5492	28524273	2017	LKKLFKKILKYL	B4	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 6.6 ± 0.5 μM	48-h	Blood	None
5489	28524273	2017	KKLFKKILKYLKKL	B3	14	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 25.3 ± 3.2 μM	48-h	Breast	None
5490	28524273	2017	KKLFKKILKYLKKL	B3	14	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 28.4 ± 3.1 μM	48-h	Breast	None
5488	28524273	2017	KKLFKKILKYLKKL	B3	14	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 47.4 ± 12.5 μM	48-h	Blood	None
5487	28524273	2017	KKLFKKILKYLKK	B2	13	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562/ADM	Leukemia Cancer	MTT assay	IC₅₀ = 39.6 ± 5.7 μM	48-h	Blood	None
5486	28524273	2017	KKLFKKILKYLKK	B2	13	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 36.1 ± 6.7 μM	48-h	Breast	None
5485	28524273	2017	KKLFKKILKYLKK	B2	13	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 30.8 ± 3.4 μM	48-h	Breast	None
5484	28524273	2017	KKLFKKILKYLKK	B2	13	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 33.6 ± 4.2 μM	48-h	Blood	None
5483	28524273	2017	KKLFKKILKYLK	B1	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562/ADM	Leukemia Cancer	MTT assay	IC₅₀ = 19.1 ± 2.1 μM	48-h	Blood	None
5482	28524273	2017	KKLFKKILKYLK	B1	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 18.2 ± 1.3 μM	48-h	Breast	None
5481	28524273	2017	KKLFKKILKYLK	B1	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 15.7 ± 1.5 μM	48-h	Breast	None
5479	28524273	2017	KKLFKKILKYL	BP100	11	Linear	L	None	Amidation	Free	Antimicrobial	Icthyopthirius multifilis (Strain G5)	K-562/ADM	Leukemia Cancer	MTT assay	IC₅₀ = 32.6 ± 3.4 μM	48-h	Blood	None
5480	28524273	2017	KKLFKKILKYLK	B1	12	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of BP 100	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 17.9 ± 1.4 μM	48-h	Blood	None
5478	28524273	2017	KKLFKKILKYL	BP100	11	Linear	L	None	Amidation	Free	Antimicrobial	Icthyopthirius multifilis (Strain G5)	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 25.3 ± 2.5 μM	48-h	Breast	None
5477	28524273	2017	KKLFKKILKYL	BP100	11	Linear	L	None	Amidation	Free	Antimicrobial	Icthyopthirius multifilis (Strain G5)	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 27.6 ± 3.0 μM	48-h	Breast	None
5476	28524273	2017	KKLFKKILKYL	BP100	11	Linear	L	None	Amidation	Free	Antimicrobial	Icthyopthirius multifilis (Strain G5)	K-562	Leukemia Cancer	MTT assay	IC₅₀ = 30.4 ± 2.7 μM	48-h	Blood	None
5467	27933724	2016	HARIKpTFRRlKWKYKGKFW	CIGB-552	20	Linear	Mix	None	Free	Acetylation	Anticancer	Synthetic	MCF-7	Breast Cancer	Sulforhodamine B assay	IC₅₀ = 379.1 ± 8.6 µM	48-h	Breast	None
5459	27039838	2016	XGLUKKLUGI	[TOAC1, Lys5,6] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	T-67	Brain Tumor	MTT assay	EC₅₀ = 10 µM	24-h	Brain	None
5460	27039838	2016	XGLUKKLUGI	[TOAC1, Lys5,6] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 6 µM	24-h	Cervix	None
5461	27039838	2016	XGLZGGLUGI	[TOAC1, Api4] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, Z = 4-aminopiperidine-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	T-67	Brain Tumor	MTT assay	EC₅₀ = 13 µM	24-h	Brain	None
5456	27039838	2016	XGLUGGLURI	[TOAC1, Arg9] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 5 µM	24-h	Cervix	None
5457	27039838	2016	UGLUKKLUGI	[Lys5,6] TG	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	T-67	Brain Tumor	MTT assay	EC₅₀ = 7 µM	24-h	Brain	None
5458	27039838	2016	UGLUKKLUGI	[Lys5,6] TG	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 10 µM	24-h	Cervix	None
5454	27039838	2016	XRLUGGLUGI	[TOAC1, Arg2] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 9 µM	24-h	Cervix	None
5455	27039838	2016	XGLUGGLURI	[TOAC1, Arg9] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	T-67	Brain Tumor	MTT assay	EC₅₀ = 8 µM	24-h	Brain	None
5451	27039838	2016	URLUGGLUGI	[Arg2] TG	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	T-67	Brain Tumor	MTT assay	EC₅₀ = 8 µM	24-h	Brain	None
5452	27039838	2016	URLUGGLUGI	[Arg2] TG	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 4 µM	24-h	Cervix	None
5453	27039838	2016	XRLUGGLUGI	[TOAC1, Arg2] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	T-67	Brain Tumor	MTT assay	EC₅₀ = 8 µM	24-h	Brain	None
5448	27039838	2016	UGLUGKLUGI	[Lys6] TG	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 2 µM	24-h	Cervix	None
5449	27039838	2016	XGLUGKLUGI	[TOAC1, Lys6] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	T-67	Brain Tumor	MTT assay	EC₅₀ = 1 µM	24-h	Brain	None
5450	27039838	2016	XGLUGKLUGI	[TOAC1, Lys6] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 3 µM	24-h	Cervix	None
5445	27039838	2016	XGLUGGLUGI	[TOAC1] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	T-67	Brain Tumor	MTT assay	EC₅₀ = 1 µM	24-h	Brain	None
5446	27039838	2016	XGLUGGLUGI	[TOAC1] TG	10	Linear	L	X = 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid, U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 3 µM	24-h	Cervix	None
5447	27039838	2016	UGLUGKLUGI	[Lys6] TG	10	Linear	L	U = 2-Aminoisobutyric acid	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichogin GA	T-67	Brain Tumor	MTT assay	EC₅₀ = 4 µM	24-h	Brain	None
5443	27039838	2016	UGLUGGLUGI	Trichogin GA	10	Linear	L	U = 2-Aminoisobutyric acid (Aib)	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichoderma longibrachiatum	T-67	Brain Tumor	MTT assay	EC₅₀ = 2 µM	24-h	Brain	None
5444	27039838	2016	UGLUGGLUGI	Trichogin GA	10	Linear	L	U = 2-Aminoisobutyric acid (Aib)	Lol = leucinol	Oct = 1-octanoyl	AMP, Anticancer	Trichoderma longibrachiatum	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 8 µM	24-h	Cervix	None
5437	27387357	2016	KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c)	Peptide - 11	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ = 4.2 µM	72-h	Kidney	None
5436	27387357	2016	KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c)	Peptide - 11	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5434	27387357	2016	KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c)	Peptide - 11	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5435	27387357	2016	KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c)	Peptide - 11	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ = 6.4 µM	72-h	Skin	None
5433	27387357	2016	KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c)	Peptide - 11	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ = 6.7 µM	72-h	Colon	None
5432	27387357	2016	KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c)	Peptide - 11	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Ovary	None
5430	27387357	2016	KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c)	Peptide - 11	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5431	27387357	2016	KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c)	Peptide - 11	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ = 7.3 µM	72-h	Breast	None
5424	27387357	2016	GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK	Peptide - 10	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5425	27387357	2016	GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK	Peptide - 10	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Kidney	None
5422	27387357	2016	GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK	Peptide - 10	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5423	27387357	2016	GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK	Peptide - 10	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Skin	None
5419	27387357	2016	GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK	Peptide - 10	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Breast	None
5420	27387357	2016	GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK	Peptide - 10	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Ovary	None
5421	27387357	2016	GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK	Peptide - 10	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5413	27387357	2016	GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK	Peptide - 9	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Oic = octahydroindolecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Kidney	None
5418	27387357	2016	GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK	Peptide - 10	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid, A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5412	27387357	2016	GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK	Peptide - 9	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Oic = octahydroindolecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5410	27387357	2016	GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK	Peptide - 9	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Oic = octahydroindolecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5411	27387357	2016	GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK	Peptide - 9	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Oic = octahydroindolecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Skin	None
5409	27387357	2016	GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK	Peptide - 9	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Oic = octahydroindolecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5408	27387357	2016	GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK	Peptide - 9	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Oic = octahydroindolecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Ovary	None
5407	27387357	2016	GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK	Peptide - 9	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Oic = octahydroindolecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Breast	None
5401	27387357	2016	GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK	Peptide - 8	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid; Tic = tetrahydroisoquinolinecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Kidney	None
5406	27387357	2016	GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK	Peptide - 9	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Oic = octahydroindolecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5400	27387357	2016	GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK	Peptide - 8	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid; Tic = tetrahydroisoquinolinecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5399	27387357	2016	GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK	Peptide - 8	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid; Tic = tetrahydroisoquinolinecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Skin	None
5397	27387357	2016	GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK	Peptide - 8	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid; Tic = tetrahydroisoquinolinecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5398	27387357	2016	GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK	Peptide - 8	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid; Tic = tetrahydroisoquinolinecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5396	27387357	2016	GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK	Peptide - 8	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid; Tic = tetrahydroisoquinolinecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Ovary	None
5394	27387357	2016	GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK	Peptide - 8	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid; Tic = tetrahydroisoquinolinecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5395	27387357	2016	GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK	Peptide - 8	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid; Tic = tetrahydroisoquinolinecarboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Breast	None
5388	27387357	2016	GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR	Peptide - 7	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5389	27387357	2016	GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR	Peptide - 7	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Kidney	None
5386	27387357	2016	GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR	Peptide - 7	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5387	27387357	2016	GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR	Peptide - 7	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Skin	None
5385	27387357	2016	GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR	Peptide - 7	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5383	27387357	2016	GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR	Peptide - 7	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Breast	None
5384	27387357	2016	GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR	Peptide - 7	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Ovary	None
5377	27387357	2016	GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK	Peptide - 6	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Kidney	None
5382	27387357	2016	GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR	Peptide - 7	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5375	27387357	2016	GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK	Peptide - 6	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Skin	None
5376	27387357	2016	GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK	Peptide - 6	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5373	27387357	2016	GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK	Peptide - 6	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5374	27387357	2016	GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK	Peptide - 6	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5372	27387357	2016	GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK	Peptide - 6	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Ovary	None
5370	27387357	2016	GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK	Peptide - 6	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5371	27387357	2016	GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK	Peptide - 6	20	Cyclic	L	A5c = 1-aminocyclopentane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Breast	None
5365	27387357	2016	GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab	Peptide - 4	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Dab = diaminobutyric acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ = 2.1 µM	72-h	Kidney	None
5364	27387357	2016	GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab	Peptide - 4	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Dab = diaminobutyric acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ = 4.4 µM	72-h	Pancreas	None
5363	27387357	2016	GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab	Peptide - 4	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Dab = diaminobutyric acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ = 1.9 µM	72-h	Skin	None
5362	27387357	2016	GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab	Peptide - 4	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Dab = diaminobutyric acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ = 2.6 µM	72-h	Colon	None
5361	27387357	2016	GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab	Peptide - 4	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Dab = diaminobutyric acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ = 6.4 µM	72-h	Colon	None
5360	27387357	2016	GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab	Peptide - 4	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Dab = diaminobutyric acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ = 2.3 µM	72-h	Ovary	None
5359	27387357	2016	GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab	Peptide - 4	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Dab = diaminobutyric acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ = 3.0 µM	72-h	Breast	None
5358	27387357	2016	GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab	Peptide - 4	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Dab = diaminobutyric acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ = 2.7 µM	72-h	Pancreas	None
5352	27387357	2016	GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn	Peptide - 3	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Orn = Ornithine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ = 3.6 µM	72-h	Pancreas	None
5353	27387357	2016	GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn	Peptide - 3	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Orn = Ornithine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ = 4.7 µM	72-h	Kidney	None
5350	27387357	2016	GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn	Peptide - 3	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Orn = Ornithine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ = 6.2 µM	72-h	Colon	None
5351	27387357	2016	GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn	Peptide - 3	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Orn = Ornithine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ = 3.1 µM	72-h	Skin	None
5348	27387357	2016	GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn	Peptide - 3	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Orn = Ornithine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ = 5.4 µM	72-h	Ovary	None
5349	27387357	2016	GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn	Peptide - 3	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Orn = Ornithine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ = 3.2 µM	72-h	Colon	None
5346	27387357	2016	GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn	Peptide - 3	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Orn = Ornithine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ = 5.9 µM	72-h	Pancreas	None
5347	27387357	2016	GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn	Peptide - 3	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid, Orn = Ornithine	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ = 4.6 µM	72-h	Breast	None
5340	27387357	2016	GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR	Peptide - 2	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ = 5.0 µM	72-h	Pancreas	None
5341	27387357	2016	GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR	Peptide - 2	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ = 5.6 µM	72-h	Kidney	None
5337	27387357	2016	GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR	Peptide - 2	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ = 6.6 µM	72-h	Colon	None
5338	27387357	2016	GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR	Peptide - 2	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ = 6.4 µM	72-h	Colon	None
5339	27387357	2016	GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR	Peptide - 2	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ = 6.4 µM	72-h	Skin	None
5335	27387357	2016	GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR	Peptide - 2	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ = 7.0 µM	72-h	Breast	None
5336	27387357	2016	GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR	Peptide - 2	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ = 6.0 µM	72-h	Ovary	None
5333	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	RL	Lymphoma Cancer	CellTiter-Glo assay	Not Available	72-h	Blood	None
5334	27387357	2016	GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR	Peptide - 2	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ = 2.6 µM	72-h	Pancreas	None
5330	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	PC-3	Prostate Cancer	CellTiter-Glo assay	Not Available	72-h	Prostate	None
5331	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	CellTiter-Glo assay	Not Available	72-h	Lung	None
5332	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	NCI-H69	Lung Cancer	CellTiter-Glo assay	Not Available	72-h	Lung	None
5328	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ = 7.3 µM	72-h	Pancreas	None
5329	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	A-498	Renal Cancer	CellTiter-Glo assay	IC₅₀ = 3.0 µM	72-h	Kidney	None
5325	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	COLO-205	Colon Cancer	CellTiter-Glo assay	IC₅₀ = 5.4 µM	72-h	Colon	None
5326	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	DLD-1	Colon Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Colon	None
5327	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	UACC-62	Skin Cancer	CellTiter-Glo assay	IC₅₀ = 2.6 µM	72-h	Skin	None
5323	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	CellTiter-Glo assay	IC₅₀ = 6.2 µM	72-h	Breast	None
5324	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	IGROV-1	Ovarian Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Ovary	None
5322	27387357	2016	GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK	Peptide - 1	20	Cyclic	L	A6c = 1-aminocyclohexane carboxylic acid	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	CPFAC-1	Pancreatic Cancer	CellTiter-Glo assay	IC₅₀ > 7.5 µM	72-h	Pancreas	None
5296	27129462	2016	NGVQPKYRWWRWWRRWW	RT2	17	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Crocodylus siamensis	CaSki	Cervical Cancer	Sulforhodamine B assay	IC₅₀ = 17.28 ± 0.2 µM	24-h	Cervix	None
5295	27129462	2016	NGVQPKYRWWRWWRRWW	RT2	17	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Crocodylus siamensis	HeLa	Cervical Cancer	Sulforhodamine B assay	IC₅₀ = 28.67 ± 0.4 µM	24-h	Cervix	None
5294	27129462	2016	NGVQPKYKWWKWWKKWW	KT2	17	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Crocodylus siamensis	CaSki	Cervical Cancer	Sulforhodamine B assay	IC₅₀ = 30.81 ± 0.2 µM	24-h	Cervix	None
5293	27129462	2016	NGVQPKYKWWKWWKKWW	KT2	17	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Crocodylus siamensis	HeLa	Cervical Cancer	Sulforhodamine B assay	IC₅₀ = 53.41 ± 1.0 µM	24-h	Cervix	None
5283	27207743	2016	FKIGGFIKKLWRSLLA	ZXR-2	16	Linear	L	None	Free	Free	Antimicrobial	Synthetic; Mutant form of ZXR-I	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 14.2 ± 0.5 μM	4-h	Prostate	None
5284	27207743	2016	FKIGGFIKKLWRSLLA	ZXR-2	16	Linear	L	None	Free	Free	Antimicrobial	Synthetic; Mutant form of ZXR-I	293T	Kidney Cancer	MTT assay	IC₅₀ = 6.3 ± 0.7 μM	4-h	Kidney	None
5282	27207743	2016	FKIGGFIKKLWRSLLA	ZXR-2	16	Linear	L	None	Free	Free	Antimicrobial	Synthetic; Mutant form of ZXR-I	Huh-7	Liver Cancer	MTT assay	IC₅₀ = 8.4 ± 1.1 μM	4-h	Liver	None
5281	27207743	2016	FKIGGFIKKLWRSLLA	ZXR-2	16	Linear	L	None	Free	Free	Antimicrobial	Synthetic; Mutant form of ZXR-I	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 7.5 ± 1.2 μM	4-h	Liver	None
5280	27207743	2016	FKIGGFIKKLWRSLLA	ZXR-2	16	Linear	L	None	Free	Free	Antimicrobial	Synthetic; Mutant form of ZXR-I	SACC-83	Salivary Cancer	MTT assay	IC₅₀ = 9.9 ± 1.7 μM	4-h	Salivary gland	None
5278	27207743	2016	FKIGGFIKKLWRSKLA	ZXR-1	16	Linear	L	None	Free	Free	Antimicrobial	Mauriporin	293T	Kidney Cancer	MTT assay	IC₅₀ = 186.7 ± 13.1 μM	4-h	Kidney	None
5279	27207743	2016	FKIGGFIKKLWRSLLA	ZXR-2	16	Linear	L	None	Free	Free	Antimicrobial	Synthetic; Mutant form of ZXR-I	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 8.1 ± 1.6 μM	4-h	Cervix	None
5277	27207743	2016	FKIGGFIKKLWRSKLA	ZXR-1	16	Linear	L	None	Free	Free	Antimicrobial	Mauriporin	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 69.1 ± 1.6 μM	4-h	Prostate	None
5276	27207743	2016	FKIGGFIKKLWRSKLA	ZXR-1	16	Linear	L	None	Free	Free	Antimicrobial	Mauriporin	Huh-7	Liver Cancer	MTT assay	IC₅₀ = 77.9 ± 0.9 μM	4-h	Liver	None
5274	27207743	2016	FKIGGFIKKLWRSKLA	ZXR-1	16	Linear	L	None	Free	Free	Antimicrobial	Mauriporin	SACC-83	Salivary Cancer	MTT assay	IC₅₀ = 27.9 ± 7.7 μM	4-h	Salivary gland	None
5275	27207743	2016	FKIGGFIKKLWRSKLA	ZXR-1	16	Linear	L	None	Free	Free	Antimicrobial	Mauriporin	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 141.7 ± 12.2 μM	4-h	Liver	None
5273	27207743	2016	FKIGGFIKKLWRSKLA	ZXR-1	16	Linear	L	None	Free	Free	Antimicrobial	Mauriporin	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 62.6 ± 8.4 μM	4-h	Cervix	None
5272	None	2015	CHYRVKPKIKRFEKYKGRMW	LPSBD-2	20	Linear	L	None	Free	Free	Anticancer	Synthetic	Hep3B	Liver Cancer	Cell Proliferation assay	~40% cell survival at 60 µg/ml	24-h	Liver	None
5271	None	2015	CHYRVKPKIKRFEKYKGRMW	LPSBD-2	20	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	Cell Proliferation assay	~20% cell survival at 60 µg/ml	24-h	Lung	None
5266	25854366	2015	FIGAIARLLSKI	Bmkn-21	12	Linear	L	None	Free	Free	Antimicrobial	Derivative of Bmkn-2	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ between 29-97 µg/ml	24-h	Tongue	None
5267	25854366	2015	FIGAIARLLS	BmKn-23	10	Linear	L	None	Free	Free	Antimicrobial	Derivative of Bmkn-2	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ between 29-97 µg/ml	24-h	Tongue	None
5264	25854366	2015	FIGAIARLLSKIF	BmKn2	13	Linear	L	None	Free	Free	Antimicrobial	Mesobuthus martensii Karsch	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ = 29 µg/mL	24-h	Tongue	None
5265	25854366	2015	FIGAIARLLSK	Bmkn-22	11	Linear	L	None	Free	Free	Antimicrobial	Derivative of Bmkn-2	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ between 29-97 µg/ml	24-h	Tongue	None
5257	25462264	2015	VKRFKKFFRKLKKEV	B1-Glu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 36.6 µM	24-h	Blood	None
5256	25462264	2015	VKRFKKFFRKLKKEV	B1-Glu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 38.9 µM	24-h	Breast	None
5254	25462264	2015	VKRFKKFFRKLKKDV	B1-Asp	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 19.9 µM	24-h	Breast	None
5255	25462264	2015	VKRFKKFFRKLKKDV	B1-Asp	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 44.7 µM	24-h	Blood	None
5253	25462264	2015	VKRFKKFFRKLKKHV	B1-His	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 10.5 µM	24-h	Blood	None
5252	25462264	2015	VKRFKKFFRKLKKHV	B1-His	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 5.0µM	24-h	Breast	None
5250	25462264	2015	VKRFKKFFRKLKKRV	B1-Arg	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 5.5 µM	24-h	Breast	None
5251	25462264	2015	VKRFKKFFRKLKKRV	B1-Arg	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 8.7 µM	24-h	Blood	None
5249	25462264	2015	VKRFKKFFRKLKKKV	B1-Lys	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562/ADM	Leukemia cancer	MTT assay	IC₅₀ = 5.5 µM	24-h	Blood	None
5247	25462264	2015	VKRFKKFFRKLKKKV	B1-Lys	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 5.5 µM	24-h	Blood	None
5248	25462264	2015	VKRFKKFFRKLKKKV	B1-Lys	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 8.6 µM	24-h	Breast	None
5246	25462264	2015	VKRFKKFFRKLKKKV	B1-Lys	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 8.3 µM	24-h	Breast	None
5245	25462264	2015	VKRFKKFFRKLKKTV	B1-Thr	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 17.0 µM	24-h	Blood	None
5243	25462264	2015	VKRFKKFFRKLKKQV	B1-Gln	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 16.2 µM	24-h	Blood	None
5244	25462264	2015	VKRFKKFFRKLKKTV	B1-Thr	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 19.1 µM	24-h	Breast	None
5242	25462264	2015	VKRFKKFFRKLKKQV	B1-Gln	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 14.5 µM	24-h	Breast	None
5241	25462264	2015	VKRFKKFFRKLKKGV	B1-Gly	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 14.8 µM	24-h	Blood	None
5239	25462264	2015	VKRFKKFFRKLKKFV	B1-Phe	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 3.7 µM	24-h	Blood	None
5240	25462264	2015	VKRFKKFFRKLKKGV	B1-Gly	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 15.8 µM	24-h	Breast	None
5238	25462264	2015	VKRFKKFFRKLKKFV	B1-Phe	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 1.3 µM	24-h	Breast	None
5237	25462264	2015	VKRFKKFFRKLKKLV	B1-Leu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562/ADM	Leukemia cancer	MTT assay	IC₅₀ = 3.3 µM	24-h	Blood	None
5236	25462264	2015	VKRFKKFFRKLKKLV	B1-Leu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 4.4 µM	24-h	Breast	None
5235	25462264	2015	VKRFKKFFRKLKKLV	B1-Leu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 1.1 µM	24-h	Blood	None
5233	25462264	2015	VKRFKKFFRKLKKVV	B1-Val	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 5.0 µM	24-h	Blood	None
5234	25462264	2015	VKRFKKFFRKLKKLV	B1-Leu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 3.6 µM	24-h	Breast	None
5232	25462264	2015	VKRFKKFFRKLKKVV	B1-Val	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 4.9 µM	24-h	Breast	None
5231	25462264	2015	VKRFKKFFRKLKKAV	B1-Ala14	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 8.6 µM	24-h	Blood	None
5230	25462264	2015	VKRFKKFFRKLKKAV	B1-Ala14	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 8.9 µM	24-h	Breast	None
5228	25462264	2015	VKRFKKFFRKLKKSV	B1	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Cathelicidin-BF15	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 24.1 µM	24-h	Breast	None
5229	25462264	2015	VKRFKKFFRKLKKSV	B1	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Cathelicidin-BF15	K-562/ADM	Leukemia cancer	MTT assay	IC₅₀ = 31.6 µM	24-h	Blood	None
5227	25462264	2015	VKRFKKFFRKLKKSV	B1	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Cathelicidin-BF15	K-562	Leukemia cancer	MTT assay	IC₅₀ = 26.9 µM	24-h	Blood	None
5226	25462264	2015	VKRFKKFFRKLKKSV	B1	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Cathelicidin-BF15	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 21.9 µM	24-h	Breast	None
5167	25626077	2015	FLFKLIPKVIKGLVKAIRK	AaeAP2a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP2	MCF-7	Breast Cancer	MTT assay	Graph Figure 4	24-h	Breast	None
5168	25626077	2015	FLFKLIPKVIKGLVKAIRK	AaeAP2a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP2	PC-3	Prostate Cancer	MTT assay	Graph Figure 4	24-h	Prostate	None
5166	25626077	2015	FLFKLIPKVIKGLVKAIRK	AaeAP2a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP2	MDA-MB-435S	Skin Cancer	MTT assay	Graph Figure 4	24-h	Skin	None
5164	25626077	2015	FLFKLIPKAIKGLVKAIRK	AaeAP1a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP1	MCF-7	Breast Cancer	MTT assay	Graph Figure 4	24-h	Breast	None
5165	25626077	2015	FLFKLIPKAIKGLVKAIRK	AaeAP1a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP1	PC-3	Prostate Cancer	MTT assay	Graph Figure 4	24-h	Prostate	None
5163	25626077	2015	FLFKLIPKAIKGLVKAIRK	AaeAP1a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP1	MDA-MB-435S	Skin Cancer	MTT assay	Graph Figure 4	24-h	Skin	None
5149	26402731	2015	GFGSKPLDSFGLNFF	Chaxapeptin	15	Mix	L	None	Free	Cyclized to form macrolactam ring	Antimicrobial and Anticancer	Streptomyces leeuwenhoekii Strain C58	A-549	Lung Cancer	CyQUANT Direct assay	Cell invasion < 50% at 50 μM	36-h	Lung	None
5148	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-668	Gastric cancer	LDH release assay	Cytotoxicity ~ 60-80% at 50 μM	24-h	Stomach	None
5147	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-638	Gastric cancer	LDH release assay	Cytotoxicity ~ 60-80% at 50 μM	24-h	Stomach	None
5146	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-601	Gastric cancer	LDH release assay	Cytotoxicity ~ 60-80% at 50 μM	24-h	Stomach	None
5145	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-484	Gastric cancer	LDH release assay	Cytotoxicity ~ 60-80% at 50 μM	24-h	Stomach	None
5144	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-668	Gastric cancer	MTS assay	IC₅₀ ~ 20-50 μM	24-h	Stomach	None
5143	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-638	Gastric cancer	MTS assay	IC₅₀ ~ 20-50 μM	24-h	Stomach	None
5142	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-601	Gastric cancer	MTS assay	IC₅₀ ~ 20-50 μM	24-h	Stomach	None
5141	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-484	Gastric cancer	MTS assay	IC₅₀ ~ 20-50 μM	24-h	Stomach	None
5135	26405806	2015	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	Helicobacter pylori	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 3.5 ± 0.03 μM	24-h	Cervix	None
5134	26405806	2015	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	Helicobacter pylori	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 7.7 ± 0.23 μM	24-h	Liver	None
5133	26405806	2015	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	Helicobacter pylori	SGC-7901	Gastric cancer	MTT assay	IC₅₀ = 5.2 ± 0.14 μM	24-h	Stomach	None
5132	26405806	2015	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	Helicobacter pylori	B-16	Skin Cancer	MTT assay	IC₅₀ = 6.1 ± 0.02 μM	24-h	Skin	None
5131	26239537	2015	WWRRWWRRWRRWWRRWWR	RW-AH	18	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 4.6 ± 0.2 μM	24-h	Skin	None
5130	26239537	2015	WWRRWWRRWRRWWRRWWR	RW-AH	18	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 8.4 ± 0.5 μM	24-h	Skin	None
5129	26239537	2015	WWRRWWRRWRRWWRRWWR	RW-AH	18	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	PI uptake assay	LC₅₀ = 4.5 ± 0.02 μM	8-h	Skin	None
5122	26239537	2015	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 10.4 ± 0.7 μM	24-h	Skin	EP_2943215_B1
5121	26239537	2015	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 23.3 ± 1.7 μM	24-h	Skin	EP_2943215_B1
5120	26239537	2015	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	PI uptake assay	LC₅₀ = 5.9 ± 0.3 μM	8-h	Skin	EP_2943215_B1
5119	26239537	2015	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	PI uptake assay	LC₅₀ = 9.5 ± 0.3 μM	8-h	Skin	EP_2943215_B1
5115	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	SAS	Oral Cancer	MTT assay	Graph Figure 2	24-h	Tongue	None
5114	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	OECM-1	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	None
5113	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	C9	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	None
5112	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5111	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9G	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5110	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5109	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	SAS	Oral Cancer	MTT assay	Graph Figure 2	24-h	Tongue	None
5108	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	OECM-1	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	None
5107	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	C9	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	None
5106	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5105	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9G	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5104	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5103	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	SAS	Oral Cancer	MTT assay	Graph Figure 2	24-h	Tongue	US_10093699_B2
5102	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	OECM-1	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	US_10093699_B2
5101	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	C9	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	US_10093699_B2
5100	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	US_10093699_B2
5099	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9G	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	US_10093699_B2
5098	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	US_10093699_B2
5081	24704757	2014	GLVGTLLGHIGKAILG	Frenatin 2.1S	16	Linear	L	None	alpha-amidation	Free	Antimicrobial	Sphaenorhynchus lacteus	A-549	Lung Cancer	Trypan blue assay	LC₅₀ = 80 ± 6 μM	24-h	Lung	None
5080	24704757	2014	GLVGTLLGHIGKAILS	Frenatin 2.2S	16	Linear	L	None	alpha-amidation	Free	Antimicrobial	Sphaenorhynchus lacteus	A-549	Lung Cancer	Trypan blue assay	LC₅₀ = 75 ± 5 μM	24-h	Lung	None
5061	24830845	2014	ETFADWWKLLAE	mt_S20A/L22 W/P27A	12	Linear	L	None	Free	Free	Anticancer	MDM5	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= 8.7 µM	Not Available	Breast	None
5060	24830845	2014	ESFSDWWKLLAE	mt_T18S/L22 W/P27A	12	Linear	L	None	Free	Free	Anticancer	MDM4	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=27 µM	Not Available	Breast	None
5059	24830845	2014	LTFSDWWKLLAE	mt_E17L/L22 W/P27A	12	Linear	L	None	Free	Free	Anticancer	MDM3	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=15.1 µM	Not Available	Breast	None
5058	24830845	2014	ETFSDWWKLLAE	mt_L22 W/P27A	12	Linear	L	None	Free	Free	Anticancer	MDM2	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=16.3 µM	Not Available	Breast	None
5057	24714081	2014	TKPRKTKPRKTKPRKTKPR	T Peptide	19	Linear	L	None	Free	Free	Anticancer	Tuftsin derivative	BGC-823	Gastric Cancer	MTT/MTS assay	67.2% maximum inhibitory rate at 8 mg/kg	48-h	Stomach	None
5056	24714081	2014	TKPRKTKPRKTKPRKTKPR	T Peptide	19	Linear	L	None	Free	Free	Anticancer	Tuftsin derivative	HT-29	Colon Cancer	MTT/MTS assay	70% maximum inhibitory rate at 8 mg/kg	48-h	Colon	None
5055	24714081	2014	TKPRKTKPRKTKPRKTKPR	T Peptide	19	Linear	L	None	Free	Free	Anticancer	Tuftsin derivative	HepG-2	Liver Cancer	MTT/MTS assay	69.6% maximum inhibitory rate at 8 mg/kg	48-h	Liver	None
4608	12417587	2003	YGRKKRRQRRR	Tat (47-57)	11	Linear	L	None	Free	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 100 µM 60% viablity	6-h	Cervix	None
4606	12417587	2003	YGRKKRRQRRR	Tat (47-57)	11	Linear	L	None	Free	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 10 µM 80% viablity	6-h	Cervix	None
4604	12417587	2003	YGRKKRRQRRR	Tat (47-57)	11	Linear	L	None	Free	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 1 µM 90-100% viablity	6-h	Cervix	None
4598	21403917	2011	FLPLIGRVLSGIL	Temporin A	13	Linear	L	None	Amidation	Free	Antimicrobial	Frog Rana temporaria	U-943	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =80-90 µg/ml	Not Available	Blood	None
4597	21403917	2011	RGGRLCYCRRRFCVCVGR	Protegrin 1	18	Linear	L	None	Amidation	Free	Antimicrobial	alpha helical peptide without cysteines	U-942	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =30-40 µg/ml	Not Available	Blood	None
4596	21403917	2011	GIGKFLKKAKKFGKAFVKILKK	Pexiganan MSI-78	18	Linear	L	None	Amidation	Free	Antimicrobial	Analog of Magainin	U-941	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =20-30 µg/ml	Not Available	Blood	None
4595	21403917	2011	ILRWPWWPWRRK	Omiganan MBI-226	12	Linear	L	None	Amidation	Free	Antimicrobial	Bovine neutrophils	U-937	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =80-85 µg/ml	Not Available	Blood	None
4594	21403917	2011	AKRHHGYKRKFH	Demegen P-113	12	Linear	L	None	Amidation	Free	Antimicrobial	Canaida albicans	U-939	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =85-90 µg/ml	Not Available	Blood	None
4593	21403917	2011	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial	Australian blue mountains tree frog, Litoria citropa	U-938	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =40 µg/ml	Not Available	Blood	None
4591	21423613	2011	QETFSDLWKLLP	P5317-28	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =30 µM	Not Available	Colon	None
4590	21423613	2011	LTAEHYAAQATS	3A	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ >100 µM	Not Available	Colon	None
4588	21423613	2011	PRFWEYWLRLME	MIP	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.12 µM	Not Available	Colon	None
4589	21423613	2011	LTFEHYWAQLTS	DI	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =1.6 µM	Not Available	Colon	None
4587	21423613	2011	PRFWEYWLRLAE	MIP(M11A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.4 µM	Not Available	Colon	None
4585	21423613	2011	PRFWEYWLALME	MIP(R9A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.02 µM	Not Available	Colon	None
4586	21423613	2011	PRFWEYWLRAME	MIP(L10A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =1.14 µM	Not Available	Colon	None
4584	21423613	2011	PRFWEYALRLME	MIP(W7A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ >100 µM	Not Available	Colon	None
4583	21423613	2011	PRFWEAWLRLME	MIP(Y6A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ >100 µM	Not Available	Colon	None
4582	21423613	2011	PRAWEYWLRLME	MIP(F3A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.57 µM	Not Available	Colon	None
4580	21423613	2011	LTAEHYAAQATS	3A	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ >100 µM	Not Available	Colon	None
4581	21423613	2011	QETFSDLWKLLP	P5317-28	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =4.7 µM	Not Available	Colon	None
4579	21423613	2011	LTFEHYWAQLTS	DI	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.29 µM	Not Available	Colon	None
4577	21928125	2012	GVGSPYVSRLLGICL	p776	15	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	Not Available	Tumor	ELISPOT assay	Not Available	Not Available	Not Available	None
4578	21423613	2011	PRFWEYWLRLME	MIP	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.01 µM	Not Available	Colon	None
4576	21928125	2012	LIAHNQVRQV	p85	10	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	Not Available	Tumor	ELISPOT assay	Not Available	Not Available	Not Available	None
4474	22076954	2011	RRRRRRRRGGC-Pem	Peptide-3	11	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	NCI-H358	Lung Cancer	MTT/MTS assay	IC₅₀ = 8.41 µM	3-h	Lung	None
4473	22076954	2011	IELLQARGGC-Pem-GGRRRRRRRR	Peptide-2	20	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	NCI-H358	Lung Cancer	MTT/MTS assay	IC₅₀ = 2.19 µM	3-h	Lung	None
4472	22076954	2011	IELLQARGGC-Pem	Peptide-1	10	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	NCI-H358	Lung Cancer	MTT/MTS assay	IC₅₀ = 4.63 mM	3-h	Lung	None
4471	22076954	2011	RRRRRRRRGGC-Pem	Peptide-3	11	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 6.24 µM	3-h	Blood	None
4470	22076954	2011	IELLQARGGC-Pem-GGRRRRRRRR	Peptide-2	10	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 2.64 µM	3-h	Blood	None
4469	22076954	2011	IELLQARGGC-Pem	Peptide-1	10	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 2.17 µM	3-h	Blood	None
4451	8555423, 18957441	1995	LKLKSIVSWAKKVL	Mastoparan B	14	Not Available	L	None	Free	Free	Antimicrobial	Hornet,Vespa basalis	Not Available	Colorectal Cancer	Not Available	Not Available	Not Available	Not Available	None
4450	15949629, 18957441	2005	KTCENLADTY	Sesquin	10	Not Available	L	None	Free	Free	Antimicrobial	Seeds, Vigna sesquipedalis, ground bean	Not Available	Colorectal Cancer	Not Available	Not Available	Not Available	Not Available	None
4449	16269344, 18957441	2005	KTCENLADTFRGPCFATSNC	Lunatusin	20	Not Available	L	None	Free	Free	Antimicrobial	Phaseolus lunatus L. (lima bean)	Not Available	Colorectal Cancer	Not Available	Not Available	Not Available	Not Available	None
4439	19341344, 18957441	2009	ILPILSLIGGLLGK	Temporin-1CEb	17	Not Available	L	None	Free	Free	Antimicrobial	Rana chensinensis, China, Asia	Not Available	Breast Cancer	Not Available	Not Available	Not Available	Not Available	None
4438	16129513, 18957441	2005	IDWKKLLDAAKQIL	Polybia-MPI	14	Not Available	L	None	Free	Free	Antibacterial	venom, social wasp,Polybia paulista	Not Available	Breast Cancer	Not Available	Not Available	Not Available	Not Available	None
4435	10942757, 18957441	2000	ECRRLCYKQRCVTYCRGR	Gomesin	18	Not Available	L	None	Free	Free	Antibacterial	Hemocytes, Acanthoscurria gomesiana	Not Available	Breast Cancer	Not Available	Not Available	Not Available	Not Available	None
4419	12235362, 18957441	2002	HGVSGHGQHGVHG	Alloferon 1	13	Not Available	L	None	Free	Free	Antibacterial	Blow flyCalliphora vicina	Not Available	Skin Cancer	Not Available	Not Available	Not Available	Not Available	None
4417	11738090, 18957441	2001	GLLGPLLKIAAKVGSNLL	CPF-ST3	18	Not Available	L	None	Free	Free	Anticancer	Diploid clawed frogXenopus tropicalis, Africa	Not Available	Skin Cancer	Not Available	Not Available	Not Available	Not Available	None
4414	10951191, 18957441	2000	GLLDIVKKVVGAFGSL	Aurein 2.1	16	Not Available	L	None	Free	Free	Anticancer	Southern bell frogLitoria aureaorLitoria raniformis, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4409	10951191, 18957441	2000	GLFDIVKKVVGTLAGL	Aurein 2.4	16	Not Available	L	None	Free	Free	Anticancer	Litoria aureaandLitoria raniformis, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4408	10951191, 18957441	2000	GLFDIVKKVVGALGSL	Aurein 2.2	16	Not Available	L	None	Free	Free	Anticancer	Litoria aureaandLitoria raniformis, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4407	10951191, 18957441	2000	GLFDIVKKVVGAIGSL	Aurein 2.3	16	Not Available	L	None	Free	Free	Anticancer	Litoria aureaandLitoria raniformis, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4406	10504394, 18957441	1999	GLFDIIKKVASVVGGL	Citropin 1.2	16	Not Available	L	None	Free	Free	Anticancer	Australian blue mountains tree frog, Litoria citropa	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4405	10504394, 18957441	1999	GLFDIIKKVASVIGGL	Citropin 1.3	16	Not Available	L	None	Free	Free	Anticancer	Australian blue mountains tree frog, Litoria citropa	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4404	10951191, 18957441	2000	GLFDIIKKIAESI	Aurein 1.1	13	Not Available	L	None	Free	Free	Anticancer	Litoria aureaandLitoria raniformis, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4403	20198492, 18957441	2010	GKWMSLLKHILK	Halictine 2	12	Not Available	L	None	Free	Free	Anticancer	Venom, the eusocial bee, Halictus sexcinctus	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4402	20198492, 18957441	2010	GMWSKILGHLIR	Halictine 1	12	Not Available	L	None	Free	Free	Anticancer	venom, the eusocial bee, Halictus sexcinctus	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4389	9620615, 18957441	1998	GFVDFLKKVAGTIANVVT	Maculatin 2.1	18	Not Available	L	None	Free	Free	Antibacterial	Litoria genimaculate, Litoria eucnemis, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4388	15207717, 18957441	2004	GFKDLLKGAAKALVKTVLF	Ascaphin-8	19	Not Available	L	None	Free	Free	Antibacterial	Coastal Tailed Frog,Ascaphus truei, Pacific Northwest, USA, North America	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4387	22100226, 18957441	2012	GFGMALKLLKKVL	Macropin 1	13	Not Available	L	None	Free	Free	Antibacterial	Venom, the solitary beeMacropis fulvipes	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4386	22100226, 18957441	2012	GTGLPMSERRKIMLMMR	Macropin 2	17	Not Available	L	None	Free	Free	Antibacterial	Venom, the solitary beeMacropis fulvipes	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4363	9022710, 18957441	1996	FVQWFSKFLGRIL	Temporin L	13	Not Available	L	None	Free	Free	Antibacterial	European common frog,Rana temporaria	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4355	17698251, 18957441	2007	FLIGMTQGLICLITRKC	Dybowskin-2	17	Not Available	L	None	Free	Free	Antibacterial	Rana dybowskii, Rana chensinensis, Asia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4279	None	2004	DDAlRRllRRllRRl	DDA-DL6R6-25	15	Linear	Mix	None	Free	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀=3.125 µM	Not Available	Pancreatic	AU_2004_246909_A1
4278	None	2004	DDAlRRllRRllRRl	DDA-DL6R6-25	15	Linear	Mix	None	Free	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀=3.125 µM	Not Available	Prostate	AU_2004_246909_A1
4275	None	2004	lRRllRRllRRl	DL6R6	12	Linear	Mix	None	Free	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀=50 µM	Not Available	Prostate	AU_2004_246909_A1
4276	None	2004	lRRllRRllRRl	DL6R6	12	Linear	Mix	None	Free	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀>100 µM	Not Available	Pancreatic	AU_2004_246909_A1
4272	None	2004	lKKllKKllKKl	PA-DL6K6-24	12	Linear	Mix	None	Amidation	CH3(CH2)14CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Prostate	AU_2004_246909_A1
4273	None	2004	lKKllKKllKKl	PA-DL6K6-24	12	Linear	Mix	None	Amidation	CH3(CH2)14CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀=3.125 µM	Not Available	Pancreatic	AU_2004_246909_A1
4269	None	2004	lKKllKKllKKl	MA-DL6K6-23	12	Linear	Mix	None	Amidation	CH3(CH2)12CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Prostate	AU_2004_246909_A1
4270	None	2004	lKKllKKllKKl	MA-DL6K6-23	12	Linear	Mix	None	Amidation	CH3(CH2)12CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Pancreatic	AU_2004_246909_A1
4266	None	2004	lKKllKKllKKl	DDA-DL6K6-22	12	Linear	Mix	None	Amidation	CH3(CH2)10CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Prostate	AU_2004_246909_A1
4267	None	2004	lKKllKKllKKl	DDA-DL6K6-22	12	Linear	Mix	None	Amidation	CH3(CH2)10CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Pancreatic	AU_2004_246909_A1
4264	None	2004	lKKllKKllKKl	DL6K6	12	Linear	Mix	None	Amidation	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀>100 µM	Not Available	Pancreatic	AU_2004_246909_A1
4263	None	2004	lKKllKKllKKl	DL6K6	12	Linear	Mix	None	Amidation	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀>100 µM	Not Available	Prostate	AU_2004_246909_A1
4216	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VM1	Leukemia Cancer	Cell Viability assay	40% inhibition at 1 µM	96-h	Blood	None
4217	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VLB	Leukemia Cancer	Cell Viability assay	40% inhibition at 1 µM	96-h	Blood	None
4214	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VLB	Leukemia Cancer	Cell Viability assay	44% inhibition at 1 µM	96-h	Blood	None
4215	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-WT	Leukemia Cancer	Cell Viability assay	40% inhibition at 1 µM	96-h	Blood	None
4212	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-WT	Leukemia Cancer	Cell Viability assay	44% inhibition at 1 µM	96-h	Blood	None
4213	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VM1	Leukemia Cancer	Cell Viability assay	44% inhibition at 1 µM	96-h	Blood	None
4210	15875779, 1429232	2005	Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG	Laxaphycin A	12	Cyclic	L	Aoc = 3-aminooctanoic acid ,Hyp = 4- hydroxyproline, Dhb = didehydrobutyrine, Hse = Homoserine	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VM1	Leukemia Cancer	Cell Viability assay	No inhibition at 4 µM	96-h	Blood	None
4211	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-WT	Leukemia Cancer	Cell Viability assay	50% inhibition at 1 µM	96-h	Blood	None
4208	15875779, 1429232	2005	Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG	Laxaphycin A	12	Cyclic	L	Aoc = 3-aminooctanoic acid ,Hyp = 4- hydroxyproline, Dhb = didehydrobutyrine, Hse = Homoserine	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-WT	Leukemia Cancer	Cell Viability assay	No inhibition at 4 µM	96-h	Blood	None
4209	15875779, 1429232	2005	Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG	Laxaphycin A	12	Cyclic	L	Aoc = 3-aminooctanoic acid ,Hyp = 4- hydroxyproline, Dhb = didehydrobutyrine, Hse = Homoserine	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VLB	Leukemia Cancer	Cell Viability assay	No inhibition at 4 µM	96-h	Blood	None
4194	15467750	2004	GRKKRRQRRR	HIV-TAT48-57	10	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	65% apoptosis at 50 µM	16 to 24-h	Cervix	None
4192	15467750	2004	GRKKRRQRRR	HIV-TAT48-57	10	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	15% apoptosis at 20 µM	16 to 24-h	Cervix	None
4193	15467750	2004	GRKKRRQRRR	HIV-TAT48-57	10	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	35% apoptosis at 30 µM	16 to 24-h	Cervix	None
4191	15467750	2004	GRKKRRQRRR	HIV-TAT48-57	10	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	7% apoptosis at 10 µM	16 to 24-h	Cervix	None
4190	15313924	2004	HHPHGHHPHGHHPHGHHPHG	(HHPHG)4	20	Linear	L	None	Amidation	Acetylation	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=0.245 µM	Not Available	Not Available	None
4189	15313924	2004	HHPHGHHPHGHHPHGHHPHG	(HHPHG)4	20	Linear	L	None	Free	Free	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=0.256 µM	Not Available	Not Available	None
4187	15313924	2004	HHPHGHHPHGHHPHG	(HHPHG)3	15	Linear	L	None	Free	Free	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=1.25 µM	Not Available	Not Available	None
4188	15313924	2004	HHPHGHHPHGHHPHG	(HHPHG)3	15	Linear	L	None	Amidation	Acetylation	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=1.56 µM	Not Available	Not Available	None
4185	15313924	2004	HHPHGHHPHG	(HHPHG)2	10	Linear	L	None	Free	Free	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=11.6 µM	Not Available	Not Available	None
4186	15313924	2004	HHPHGHHPHG	(HHPHG)2	10	Linear	L	None	Amidation	Acetylation	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=26.9 µM	Not Available	Not Available	None
4173	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Breast	None
4172	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Prostate	None
4171	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Liver	None
4170	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4169	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4167	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Colon	None
4168	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4166	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4165	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4163	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4164	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4162	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Liver	None
4160	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4161	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4159	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4157	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4158	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4156	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4155	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4153	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Liver	None
4154	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Prostate	None
4152	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4150	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4151	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4149	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4147	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4148	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4146	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4145	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4144	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4143	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4142	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4140	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4141	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4139	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Lung	None
4138	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4137	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4135	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Liver	None
4136	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4134	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4133	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4132	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4131	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4130	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4129	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4128	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4127	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4126	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4124	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4125	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4123	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4122	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4120	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4121	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4119	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4118	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4116	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4117	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4114	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4115	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4113	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4111	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4112	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4110	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4108	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4109	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4107	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4105	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4106	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4103	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4104	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4100	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4101	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4102	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4099	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4098	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4097	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4096	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4094	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4095	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4093	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4092	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4090	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4091	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4089	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4088	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4086	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4087	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4085	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4083	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4084	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4082	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4081	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4079	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4080	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4078	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4077	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4076	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4075	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4074	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4073	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4072	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4071	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4070	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4068	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4069	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4067	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4065	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4066	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4064	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4063	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >100 µM	Not Available	Liver	None
4062	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4060	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4061	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= >100 µM	Not Available	Skin	None
4059	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4058	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4056	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Breast	None
4057	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4054	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= > 1 µM	Not Available	Liver	None
4055	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Prostate	None
4053	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Ovary	None
4051	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Brain	None
4052	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Skin	None
4050	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Colon	None
4048	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Blood	None
4049	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Lung	None
4047	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4045	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4046	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4043	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4044	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4041	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4042	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4040	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4038	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4039	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4037	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4036	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4035	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4033	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4034	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4032	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4031	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4030	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
3836	20515045	2010	IVRRADRAAVP	ES-2	11	Linear	L	None	Free	Free	Antitumor	Endostatin derived synthetic peptide	BAE	Tumor	MTT/MTS assay	60% inhibition at 10µg/ml	NA	Not Available	None
3835	20515045	2010	IVRRADRAAVP	ES-2	11	Linear	L	None	Free	Free	Antitumor	Endostatin derived synthetic peptide	BAE	Tumor	MTT/MTS assay	60% inhibition at 5µg/ml	NA	Not Available	None
3834	20515045	2010	IVRRADRAAVP	ES-2	11	Linear	L	None	Free	Free	Antitumor	Endostatin derived synthetic peptide	BAE	Tumor	MTT/MTS assay	60% inhibition at 2.5µg/ml	NA	Not Available	None
3814	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >> 100 µM	24-h	Skin	None
3808	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC-50 >> 100 µM	4-h	Skin	None
3802	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC-50 >> 100 µM	2-h	Skin	None
3796	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC-50>> 100 µM	30-Min	Skin	None
3790	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC-50 >> 100 µM	4-h	Skin	None
3753	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀= 22.25 µM	72-h	Skin	None
3754	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀= 12.55 µM	72-h	Ovary	None
3751	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀= 22.51 µM	72-h	Stomach	None
3752	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀= 29.10 µM	72-h	Prostate	None
3750	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀= 14.8 µM	72-h	Colon	None
3748	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀= 21.48 µM	72-h	Renal	None
3749	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= 14.53 µM	72-h	Lung	None
3746	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀= 27.39 µM	72-h	Skin	None
3747	22644847	2012	FLKWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀= 24.76 µM	72-h	Ovary	None
3745	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀= 47.69 µM	72-h	Prostate	None
3743	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀= 27.00 µM	72-h	Colon	None
3744	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀= 26.70 µM	72-h	Stomach	None
3741	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀= 41.21 µM	72-h	Renal	None
3742	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= 25.20 µM	72-h	Lung	None
3740	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀= 14.58 µM	72-h	Ovary	None
3738	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀= 24.32 µM	72-h	Prostate	None
3739	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀= 13.16 µM	72-h	Skin	None
3736	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀= 14.80 µM	72-h	Colon	None
3737	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀= 13.77 µM	72-h	Stomach	None
3735	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= 15.88 µM	72-h	Lung	None
3733	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀= 22.06 µM	72-h	Ovary	None
3734	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀= 22.59 µM	72-h	Renal	None
3732	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀= 13.97 µM	72-h	Skin	None
3730	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀= 24.31 µM	72-h	Stomach	None
3731	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀= 46.51 µM	72-h	Prostate	None
3728	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= 20.36 µM	72-h	Lung	None
3729	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀= 24.63 µM	72-h	Colon	None
3726	22481251	2012	PLLQATLGGGS	P7	11	Linear	L	None	Free	Free	Antiproliferative and Antiangiogenic	NA	B16-F10	Skin Cancer	WST-1 assay	IC₅₀= 1 µM	48-h	Skin	None
3727	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀= 22.88 µM	72-h	Renal	None
3717	22100226	2012	GKWLSLLKHILK	HAL-2/11	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3716	22100226	2012	GKWMTLLKHILK	HAL-2/13	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3714	22100226	2012	GKFMSLLKHILK	HAL-2/24	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3715	22100226	2012	GKWMSFLKHILK	HAL-2/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3713	22100226	2012	GKWMSLWKHILK	HAL-2/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3711	22100226	2012	GKWMSLLKHIWK	HAL-2/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3712	22100226	2012	GKWMSLLKHWLK	HAL-2/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3709	22100226	2012	GKWKSLLKHILK	HAL-2/1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3710	22100226	2012	GKWMSLLKHILK	HAL-2/8	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3708	22100226	2012	GKWMKLLKHILK	HAL-2/2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3706	22100226	2012	gkwmsllkhilk	HAL-2/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3707	22100226	2012	GKWMSLLKKILK	HAL-2/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3704	22100226	2012	GMWSKLLGHLLR	HAL-1/15	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3705	22100226	2012	GKWMSLLKHILK	HAL-2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 34 µM	48-h	Blood	None
3703	22100226	2012	GMWSKILGHLIR	HAL-1/29	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3701	22100226	2012	GKWKKILGHLIR	HAL-1/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3702	22100226	2012	GKWKKILGKLIR	HAL-1/21	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3700	22100226	2012	GKWSKILGKLIR	HAL-1/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3698	22100226	2012	KMWSKILGHLIR	HAL-1/17	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3699	22100226	2012	GMWKKILGKLIR	HAL-1/10	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3696	22100226	2012	GMWKKILGHLIR	HAL-1/5	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3697	22100226	2012	GKWSKILGHLIR	HAL-1/12	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3695	22100226	2012	GMWSKILKHLIR	HAL-1/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3693	22100226	2012	GMWSKILGHLKR	HAL-1/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3694	22100226	2012	GMWSKILGKLIR	HAL-1/9	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 30±10 µM	48-h	Blood	None
3692	22100226	2012	GMWSKILGHLIK	HAL-1/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3691	22100226	2012	gmwskilghlir	HAL-1/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3689	22100226	2012	GKWLSLLKHILK	HAL-2/11	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 40 µM	48-h	Colon	None
3690	22100226	2012	GMWSKILGHLIR	HAL-1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 49±9 µM	48-h	Blood	None
3688	22100226	2012	GKWMTLLKHILK	HAL-2/13	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 60 µM	48-h	Colon	None
3687	22100226	2012	GKWMSFLKHILK	HAL-2/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3686	22100226	2012	GKFMSLLKHILK	HAL-2/24	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3685	22100226	2012	GKWMSLWKHILK	HAL-2/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3684	22100226	2012	GKWMSLLKHWLK	HAL-2/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3683	22100226	2012	GKWMSLLKHIWK	HAL-2/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3682	22100226	2012	GKWMSLLKHILK	HAL-2/8	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3681	22100226	2012	GKWKSLLKHILK	HAL-2/1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3680	22100226	2012	GKWMKLLKHILK	HAL-2/2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 35±5 µM	48-h	Colon	None
3679	22100226	2012	GKWMSLLKKILK	HAL-2/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 38±6 µM	48-h	Colon	None
3678	22100226	2012	gkwmsllkhilk	HAL-2/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3677	22100226	2012	GKWMSLLKHILK	HAL-2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 35±3 µM	48-h	Colon	None
3676	22100226	2012	GMWSKLLGHLLR	HAL-1/15	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3675	22100226	2012	GMWSKILGHLIR	HAL-1/29	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3674	22100226	2012	GKWKKILGKLIR	HAL-1/21	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3673	22100226	2012	GKWKKILGHLIR	HAL-1/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3672	22100226	2012	GKWSKILGKLIR	HAL-1/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3671	22100226	2012	GMWKKILGKLIR	HAL-1/10	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 60 µM	48-h	Colon	None
3666	22100226	2012	GMWSKILGKLIR	HAL-1/9	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 50 µM	48-h	Colon	None
3667	22100226	2012	GMWSKILKHLIR	HAL-1/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 18±2 µM	48-h	Colon	None
3668	22100226	2012	GMWKKILGHLIR	HAL-1/5	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 44±5 µM	48-h	Colon	None
3669	22100226	2012	GKWSKILGHLIR	HAL-1/12	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3670	22100226	2012	KMWSKILGHLIR	HAL-1/17	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3661	22100226	2012	GKWLSLLKHILK	HAL-2/11	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 14±3 µM	48-h	Cervix	None
3662	22100226	2012	GMWSKILGHLIR	HAL-1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 44±8 µM	48-h	Colon	None
3663	22100226	2012	gmwskilghlir	HAL-1/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3664	22100226	2012	GMWSKILGHLIK	HAL-1/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3665	22100226	2012	GMWSKILGHLKR	HAL-1/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3656	22100226	2012	GKWMSLLKHWLK	HAL-2/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 16±4 µM	48-h	Cervix	None
3657	22100226	2012	GKWMSLWKHILK	HAL-2/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 30±5 µM	48-h	Cervix	None
3658	22100226	2012	GKFMSLLKHILK	HAL-2/24	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 34 µM	48-h	Cervix	None
3659	22100226	2012	GKWMSFLKHILK	HAL-2/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 23±3 µM	48-h	Cervix	None
3660	22100226	2012	GKWMTLLKHILK	HAL-2/13	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 13±3 µM	48-h	Cervix	None
3652	22100226	2012	GKWMKLLKHILK	HAL-2/2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 6±1 µM	48-h	Cervix	None
3653	22100226	2012	GKWKSLLKHILK	HAL-2/1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 14±2 µM	48-h	Cervix	None
3654	22100226	2012	GKWMSLLKHILK	HAL-2/8	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±3 µM	48-h	Cervix	None
3655	22100226	2012	GKWMSLLKHIWK	HAL-2/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 14±2 µM	48-h	Cervix	None
3647	22100226	2012	GMWSKILGHLIR	HAL-1/29	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Cervix	None
3648	22100226	2012	GMWSKLLGHLLR	HAL-1/15	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 14±2 µM	48-h	Cervix	None
3649	22100226	2012	GKWMSLLKHILK	HAL-2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 12±1 µM	48-h	Cervix	None
3650	22100226	2012	gkwmsllkhilk	HAL-2/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 12 µM	48-h	Cervix	None
3651	22100226	2012	GKWMSLLKKILK	HAL-2/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Cervix	None
3645	22100226	2012	GKWKKILGHLIR	HAL-1/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Cervix	None
3646	22100226	2012	GKWKKILGKLIR	HAL-1/21	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 30±3 µM	48-h	Cervix	None
3644	22100226	2012	GKWSKILGKLIR	HAL-1/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 22±3 µM	48-h	Cervix	None
3643	22100226	2012	GMWKKILGKLIR	HAL-1/10	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 13±2 µM	48-h	Cervix	None
3642	22100226	2012	KMWSKILGHLIR	HAL-1/17	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 35±3 µM	48-h	Cervix	None
3640	22100226	2012	GMWKKILGHLIR	HAL-1/5	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±1 µM	48-h	Cervix	None
3641	22100226	2012	GKWSKILGHLIR	HAL-1/12	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 43±14 µM	48-h	Cervix	None
3639	22100226	2012	GMWSKILKHLIR	HAL-1/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 4±2 µM	48-h	Cervix	None
3638	22100226	2012	GMWSKILGKLIR	HAL-1/9	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±1 µM	48-h	Cervix	None
3637	22100226	2012	GMWSKILGHLKR	HAL-1/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Cervix	None
3636	22100226	2012	GMWSKILGHLIK	HAL-1/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±1 µM	48-h	Cervix	None
3634	22100226	2012	GMWSKILGHLIR	HAL-1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 11±2 µM	48-h	Cervix	None
3635	22100226	2012	gmwskilghlir	HAL-1/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±3 µM	48-h	Cervix	None
3633	22100226	2012	GFGMA-(AC6C)-KLLKKVL	MAC1/26	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 9±2 µM	48-h	Blood	None
3631	22100226	2012	GFGMALKL-(AC6C)-KKVL	MAC1/24	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 11 µM	48-h	Blood	None
3632	22100226	2012	GFGMALK-(AC6C)-LKKVL	MAC1/25	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 12±2 µM	48-h	Blood	None
3630	22100226	2012	GFGMALRLLRRVL	MAC1/21	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 22±4 µM	48-h	Blood	None
3629	22100226	2012	GFGMALOLLOOVL	MAC1/20	13	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 25±3 µM	48-h	Blood	None
3628	22100226	2012	GFGMALKLLKKVL	MAC1/19	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 43±11 µM	48-h	Blood	None
3626	22100226	2012	GFKMALKLLKKVL	MAC1/10	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 16 µM	48-h	Blood	None
3627	22100226	2012	GFGMALKLLKKVL	MAC1/16	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 70 µM	48-h	Blood	None
3625	22100226	2012	GFKMALKLLKKVL	MAC1/9	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 14±4 µM	48-h	Blood	None
3624	22100226	2012	GFGMALKLLKKVL	MAC1/6	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 15 µM	48-h	Blood	None
3622	22100226	2012	LFGMALKLLKKVL	MAC1/3	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 22 µM	48-h	Blood	None
3623	22100226	2012	GFGMALKLLKKVL	MAC1/4	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 29 µM	48-h	Blood	None
3621	22100226	2012	AFGMALKLLKKVL	MAC1/2	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 17 µM	48-h	Blood	None
3620	22100226	2012	gfgmalkllkkvl	MAC1/1	13	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 11 µM	48-h	Blood	None
3619	22100226	2012	GTGLPMSERRKIMLMMR	MAC2	17	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 32 µM	48-h	Blood	None
3616	22100226	2012	GFGMALK-(AC6C)-LKKVL	MAC1/25	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 14±1 µM	48-h	Colon	None
3617	22100226	2012	GFGMA-(AC6C)-KLLKKVL	MAC1/26	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 18±1 µM	48-h	Colon	None
3618	22100226	2012	GFGMALKLLKKVL	MAC1	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 12±6 µM	48-h	Blood	None
3615	22100226	2012	GFGMALKL-(AC6C)-KKVL	MAC1/24	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 16±1 µM	48-h	Colon	None
3613	22100226	2012	GFGMALOLLOOVL	MAC1/20	13	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 35±4 µM	48-h	Colon	None
3614	22100226	2012	GFGMALRLLRRVL	MAC1/21	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 17±2 µM	48-h	Colon	None
3612	22100226	2012	GFGMALKLLKKVL	MAC1/19	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 68±2 µM	48-h	Colon	None
3611	22100226	2012	GFGMALKLLKKVL	MAC1/16	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3610	22100226	2012	GFKMALKLLKKVL	MAC1/10	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3609	22100226	2012	GFKMALKLLKKVL	MAC1/9	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 13±3 µM	48-h	Colon	None
3607	22100226	2012	GFGMALKLLKKVL	MAC1/4	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 49±9 µM	48-h	Colon	None
3608	22100226	2012	GFGMALKLLKKVL	MAC1/6	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 29±3 µM	48-h	Colon	None
3606	22100226	2012	LFGMALKLLKKVL	MAC1/3	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 11±1 µM	48-h	Colon	None
3604	22100226	2012	gfgmalkllkkvl	MAC1/1	13	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 19±2 µM	48-h	Colon	None
3605	22100226	2012	AFGMALKLLKKVL	MAC1/2	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 16 µM	48-h	Colon	None
3603	22100226	2012	GTGLPMSERRKIMLMMR	MAC2	17	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3601	22100226	2012	GFGMA-(AC6C)-KLLKKVL	MAC1/26	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±2 µM	48-h	Cervix	None
3602	22100226	2012	GFGMALKLLKKVL	MAC1	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 23±4 µM	48-h	Colon	None
3599	22100226	2012	GFGMALKL-(AC6C)-KKVL	MAC1/24	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±2 µM	48-h	Cervix	None
3600	22100226	2012	GFGMALK-(AC6C)-LKKVL	MAC1/25	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 7±1 µM	48-h	Cervix	None
3597	22100226	2012	GFGMALOLLOOVL	MAC1/20	13	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 10±1 µM	48-h	Cervix	None
3598	22100226	2012	GFGMALRLLRRVL	MAC1/21	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±3 µM	48-h	Cervix	None
3595	22100226	2012	GFGMALKLLKKVL	MAC1/16	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 32±2 µM	48-h	Cervix	None
3596	22100226	2012	GFGMALKLLKKVL	MAC1/19	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 21±4 µM	48-h	Cervix	None
3594	22100226	2012	GFKMALKLLKKVL	MAC1/10	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±6 µM	48-h	Cervix	None
3592	22100226	2012	GFGMALKLLKKVL	MAC1/6	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±2 µM	48-h	Cervix	None
3593	22100226	2012	GFKMALKLLKKVL	MAC1/9	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±1 µM	48-h	Cervix	None
3591	22100226	2012	GFGMALKLLKKVL	MAC1/4	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±5 µM	48-h	Cervix	None
3589	22100226	2012	AFGMALKLLKKVL	MAC1/2	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 16±3 µM	48-h	Cervix	None
3590	22100226	2012	LFGMALKLLKKVL	MAC1/3	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±2 µM	48-h	Cervix	None
3588	22100226	2012	gfgmalkllkkvl	MAC1/1	13	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 12±4 µM	48-h	Cervix	None
3587	22100226	2012	GTGLPMSERRKIMLMMR	MAC2	17	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Cervix	None
3586	22100226	2012	GFGMALKLLKKVL	MAC1	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 10±4 µM	48-h	Cervix	None
3569	22100226	2012	VNWKKILGKIIKVVK	LL-III/37	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀= 4±1 µM	48-h	Blood	None
3567	22100226	2012	NKWKKILGKIIKVVK	LL-III/34	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 5±3 µM	48-h	Blood	None
3568	22100226	2012	VNWKKILAKIIKVVK	LL-III/36	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3566	22100226	2012	VNWKKVLGKVVKVVK	LL-III/27	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 18 µM	48-h	Blood	None
3565	22100226	2012	VYWKKILGKIIKVVK	LL-III/26	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 6 µM	48-h	Blood	None
3563	22100226	2012	VNWOOILGOIIOVVO	LL-III/24	15	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 5±2 µM	48-h	Blood	None
3564	22100226	2012	vnwkkllgkllkvvk	LL-III/25	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 4 µM	48-h	Blood	None
3562	22100226	2012	VNWKKLLGKLLKVVK	LL-III/23	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 6 µM	48-h	Blood	None
3561	22100226	2012	KNWKK-Aib-LKK-Aib-IK-Aib-VK	LL-III/22	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 25±4 µM	48-h	Blood	None
3560	22100226	2012	VNWKK-Aib-LGK-Aib-IK-Aib-VK	LL-III/19	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 8±2 µM	48-h	Blood	None
3559	22100226	2012	KNWKKILKKIIKVVK	LL-III/18	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 7±2 µM	48-h	Blood	None
3558	22100226	2012	VNWRRILGRIIRVVR	LL-III/17	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3557	22100226	2012	VN-Nal-KKLLGKLLKVVK	LL-III/16	15	Linear	L	Nal = 3-(1-naphthyl)alanine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3556	22100226	2012	VNFKKLLGKLLKVVK	LL-III/15	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 9±3 µM	48-h	Blood	None
3555	22100226	2012	vnwkkilgkiikvvk	LL-III/12	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 5±2 µM	48-h	Blood	None
3554	22100226	2012	VNWKKIILGKIIKVVK	LL-III/11	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 4±1 µM	48-h	Blood	None
3552	22100226	2012	VNWKKILGKIIKVVK	LL-III/9	15	Linear	L	None	Methoxylation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3553	22100226	2012	KNWKKILGKIIKVVK	LL-III/10	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 9 µM	48-h	Blood	None
3551	22100226	2012	VNWKKILGKIIKVVK	LL-III/8	15	Linear	L	None	Free	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 9 µM	48-h	Blood	None
3549	22100226	2012	VNWKKILGKIKKVVK	LL-III/4	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 18 µM	48-h	Blood	None
3550	22100226	2012	VNWKKILPKIIKVVK	LL-III/6	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 6±3 µM	48-h	Blood	None
3548	22100226	2012	VNWKKILKKIIKVVK	LL-III/3	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3547	22100226	2012	NVWKKILGKIIKVVK	LL-III/2	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 7±2 µM	48-h	Blood	None
3545	22100226	2012	VNWKKILGKIIKVVK	LL-III	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 5±3 µM	48-h	Blood	None
3546	22100226	2012	VNWKKILAKIIKVVK	LL-III/1	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Blood	None
3544	22100226	2012	VNWKKILGKIIKVVK	LL-III/37	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 13 µM	48-h	Colon	None
3542	22100226	2012	NKWKKILGKIIKVVK	LL-III/34	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 37 µM	48-h	Colon	None
3543	22100226	2012	VNWKKILAKIIKVVK	LL-III/36	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3541	22100226	2012	VNWKKVLGKVVKVVK	LL-III/27	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3539	22100226	2012	vnwkkllgkllkvvk	LL-III/25	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 20 µM	48-h	Colon	None
3540	22100226	2012	VYWKKILGKIIKVVK	LL-III/26	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 30 µM	48-h	Colon	None
3538	22100226	2012	VNWOOILGOIIOVVO	LL-III/24	15	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 20 µM	48-h	Colon	None
3537	22100226	2012	VNWKKLLGKLLKVVK	LL-III/23	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 15 µM	48-h	Colon	None
3535	22100226	2012	VNWKK-Aib-LGK-Aib-IK-Aib-VK	LL-III/19	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 28 µM	48-h	Colon	None
3536	22100226	2012	KNWKK-Aib-LKK-Aib-IK-Aib-VK	LL-III/22	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3534	22100226	2012	KNWKKILKKIIKVVK	LL-III/18	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3533	22100226	2012	VNWRRILGRIIRVVR	LL-III/17	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3532	22100226	2012	VN-Nal-KKLLGKLLKVVK	LL-III/16	15	Linear	L	Nal = 3-(1-naphthyl)alanine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3531	22100226	2012	VNFKKLLGKLLKVVK	LL-III/15	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 42 µM	48-h	Colon	None
3530	22100226	2012	vnwkkilgkiikvvk	LL-III/12	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 20 µM	48-h	Colon	None
3528	22100226	2012	KNWKKILGKIIKVVK	LL-III/10	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3529	22100226	2012	VNWKKIILGKIIKVVK	LL-III/11	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 48 µM	48-h	Colon	None
3527	22100226	2012	VNWKKILGKIIKVVK	LL-III/9	15	Linear	L	None	Methoxylation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 25± 5 µM	48-h	Colon	None
3525	22100226	2012	VNWKKILPKIIKVVK	LL-III/6	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3526	22100226	2012	VNWKKILGKIIKVVK	LL-III/8	15	Linear	L	None	Free	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3524	22100226	2012	VNWKKILGKIKKVVK	LL-III/4	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3522	22100226	2012	NVWKKILGKIIKVVK	LL-III/2	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 11 µM	48-h	Colon	None
3523	22100226	2012	VNWKKILKKIIKVVK	LL-III/3	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3521	22100226	2012	VNWKKILAKIIKVVK	LL-III/1	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 12± 3 µM	48-h	Colon	None
3519	22100226	2012	VNWKKILGKIIKVVK	LL-III/37	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 5±1 µM	48-h	Colon	None
3520	22100226	2012	VNWKKILGKIIKVVK	LL-III	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 18±4 µM	48-h	Colon	None
3518	22100226	2012	VNWKKILAKIIKVVK	LL-III/36	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8 µM	48-h	Cervix	None
3516	22100226	2012	VNWKKVLGKVVKVVK	LL-III/27	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 13±2 µM	48-h	Cervix	None
3517	22100226	2012	NKWKKILGKIIKVVK	LL-III/34	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 5±2 µM	48-h	Cervix	None
3515	22100226	2012	VYWKKILGKIIKVVK	LL-III/26	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 5±1 µM	48-h	Cervix	None
3513	22100226	2012	VNWOOILGOIIOVVO	LL-III/24	15	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Cervix	None
3514	22100226	2012	vnwkkllgkllkvvk	LL-III/25	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 4±2 µM	48-h	Cervix	None
3512	22100226	2012	VNWKKLLGKLLKVVK	LL-III/23	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 4 µM	48-h	Cervix	None
3511	22100226	2012	KNWKK-Aib-LKK-Aib-IK-Aib-VK	LL-III/22	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 11±7 µM	48-h	Cervix	None
3509	22100226	2012	KNWKKILKKIIKVVK	LL-III/18	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3 µM	48-h	Cervix	None
3510	22100226	2012	VNWKK-Aib-LGK-Aib-IK-Aib-VK	LL-III/19	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Cervix	None
3508	22100226	2012	VNWRRILGRIIRVVR	LL-III/17	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 9 µM	48-h	Cervix	None
3505	22100226	2012	vnwkkilgkiikvvk	LL-III/12	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 6±2 µM	48-h	Cervix	None
3506	22100226	2012	VNFKKLLGKLLKVVK	LL-III/15	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 7±1 µM	48-h	Cervix	None
3507	22100226	2012	VN-Nal-KKLLGKLLKVVK	LL-III/16	15	Linear	L	Nal = 3-(1-naphthyl)alanine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 6±1 µM	48-h	Cervix	None
3502	22100226	2012	VNWKKILGKIIKVVK	LL-III/9	15	Linear	L	None	Methoxylation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Cervix	None
3503	22100226	2012	KNWKKILGKIIKVVK	LL-III/10	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±4 µM	48-h	Cervix	None
3504	22100226	2012	VNWKKIILGKIIKVVK	LL-III/11	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±1 µM	48-h	Cervix	None
3499	22100226	2012	VNWKKILGKIKKVVK	LL-III/4	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 7±1 µM	48-h	Cervix	None
3500	22100226	2012	VNWKKILPKIIKVVK	LL-III/6	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Cervix	None
3501	22100226	2012	VNWKKILGKIIKVVK	LL-III/8	15	Linear	L	None	Free	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 12±1 µM	48-h	Cervix	None
3497	22100226	2012	NVWKKILGKIIKVVK	LL-III/2	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	Not tested	48-h	Cervix	None
3498	22100226	2012	VNWKKILKKIIKVVK	LL-III/3	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	Not tested	48-h	Cervix	None
3495	22100226	2012	VNWKKILGKIIKVVK	LL-III	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 4±1 µM	48-h	Cervix	None
3496	22100226	2012	VNWKKILAKIIKVVK	LL-III/1	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Cervix	None
3456	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3457	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	~15% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3454	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	48-h	Bladder	WO_2012042540_A2
3455	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<3% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3452	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	20% cytotoxicity at 1 µM	24-h	Bladder	WO2012042540A2
3453	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	~10% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3439	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	20% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3437	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	<10% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3438	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	72-h	Cervix	WO_2012042540_A2
3435	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~5% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3436	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~10% cytotoxicity at 1 µM	48-h	Cervix	WO2012042540A2
3434	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~15% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3421	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	20% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3420	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	72-h	Cervix	WO2012042540A2
3419	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	<10% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3418	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	10% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3417	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	5% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3416	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	~15% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3403	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	15% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3402	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3399	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	10% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3400	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	48-h	Colon	WO_2012042540_A2
3401	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<3% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3398	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	20% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3385	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	<45% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3384	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~45% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3383	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	<25% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3382	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~25% cytotoxicity at 1 µM	48-h	Bladder	WO_2012042540_A2
3381	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	<10% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3380	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	10% cytotoxicity at 1 µM	24-h	Bladder	WO2012042540A2
3367	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3366	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3365	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3362	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3363	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<20% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3364	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	~15% cytotoxicity at 1 µM	48-h	Colon	WO2012042540A2
3361	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Free	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	SNU-601	Gastric Cancer	MTT/MTS assay	0% survival rate at 100 µM	NA	Stomach	US_6800727_B2
3360	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Free	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	SNU-601	Gastric Cancer	MTT/MTS assay	~20% survival rate at 10 µM	NA	Stomach	US_6800727_B2
3359	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Free	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	Jurkat	Blood Cancer	MTT/MTS assay	0% survival rate at 100 µM	NA	Blood	US_6800727_B2
3358	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	Jurkat	Blood Cancer	MTT/MTS assay	~60% survival rate at 10 µM	NA	Blood	US_6800727_B2
3357	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	Calu-6	Lung Cancer	MTT/MTS assay	0% survival rate at 100 µM	NA	Lung	US_6800727_B2
3350	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	Calu-6	Lung Cancer	MTT/MTS assay	~90% survival rate at 10 µM	NA	Lung	US_6800727_B2
3351	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	Calu-6	Lung Cancer	MTT/MTS assay	<20% survival rate at 100 µM	NA	Lung	US_6800727_B2
3352	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	Jurkat	Blood Cancer	MTT/MTS assay	100% survival rate at 10 µM	NA	Blood	US_6800727_B2
3353	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	Jurkat	Blood Cancer	MTT/MTS assay	0% survival rate at 100 µM	NA	Blood	US_6800727_B2
3354	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	SNU-601	Gastric Cancer	MTT/MTS assay	~80% survival rate at 10 µM	NA	Stomach	US_6800727_B2
3355	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	SNU-601	Gastric Cancer	MTT/MTS assay	10% survival rate at 100 µM	NA	Stomach	US_6800727_B2
3356	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	Calu-6	Lung Cancer	MTT/MTS assay	35% survival rate at 10 µM	NA	Lung	US_6800727_B2
3341	23533710	2013	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Amidation	Free	Antihypertensive and Antimicrobial and Antiviral and Antioxidant	Bovine milk	AZ-97	Colon Cancer	MTT/MTS assay	Inhibition at 0.1g/l	NA	Colon	None
3333	23893605	2013	KISKRILTGKK	NK11	11	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >>100 µM	30-Min	Skin	None
3334	23893605	2013	KISKRILTGKK	NK11	11	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >>100 µM	2-h	Skin	None
3335	23893605	2013	KISKRILTGKK	NK11	11	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >>100 µM	4-h	Skin	None
3336	23893605	2013	KISKRILTGKK	NK11	11	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >>100 µM	24-h	Skin	None
3316	21453492, 23533710	2011	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Bovine lactoferrin (Lf-B)	Kelly	Brain Tumor	MTT/MTS assay	IC₅₀ =141 ± 3 µM	30-Min	Brain	None
3315	21453492, 23533710	2011	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Bovine lactoferrin (Lf-B)	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀ > 160 µM	30-Min	Breast	None
3314	21453492, 23533710	2011	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Bovine lactoferrin (Lf-B)	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀ > 160 µM	30-Min	Colon	None
3299	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Synthetic peptide	A-375	Skin Cancer	MTT/MTS assay	6.5 ± 1.07% cell viability at 80 µM	NA	Skin	None
3298	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Synthetic peptide	A-375	Skin Cancer	MTT/MTS assay	26.9 ± 0.5% cell viability at 60 µM	NA	Skin	None
3297	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Synthetic peptide	A-375	Skin Cancer	MTT/MTS assay	47.5 ± 1.66% cell viability at 40 µM	NA	Skin	None
3296	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Synthetic peptide	A-375	Skin Cancer	MTT/MTS assay	63.8 ± 0.8% cell viability at 20 µM	NA	Skin	None
3295	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Synthetic peptide	A-375	Skin Cancer	MTT/MTS assay	86 ± 0.57% cell viability at 10 µM	NA	Skin	None
3294	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Synthetic peptide	M14	Skin Cancer	MTT/MTS assay	13.8 ± 1.44% cell viability at 80 µM	NA	Skin	None
3293	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Synthetic peptide	M14	Skin Cancer	MTT/MTS assay	31.5 ± 1.49% cell viability at 60 µM	NA	Skin	None
3292	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Synthetic peptide	M14	Skin Cancer	MTT/MTS assay	50 ± 3.09% cell viability at 40 µM	NA	Skin	None
3291	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Synthetic peptide	M14	Skin Cancer	MTT/MTS assay	71.1 ± 2.84% cell viability at 20 µM	NA	Skin	None
3290	19957017	2010	KWKLFKKIPKFLHLAKKF	P18	18	Linear	L	None	Free	Free	Antibacterial	Bovine lactoferrin (Lf-B)	M14	Skin Cancer	MTT/MTS assay	92.2 ± 1.02% cell viability at 10 µM	NA	Skin	None
3287	19527490, 23533710	2009	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀ = 10 µM	NA	Blood	None
3286	19527490, 23533710	2009	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	Raji	Lymphoma Cancer	MTT/MTS assay	IC₅₀ = 13 µM	NA	Blood	None
3285	19527490, 23533710	2009	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	Sudhl-4	Skin Cancer	MTT/MTS assay	IC₅₀ = 16 µM	NA	Skin	None
3284	19527490, 23533710	2009	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	KMM-1	Skin Cancer	MTT/MTS assay	IC₅₀ = 57 µM	NA	Skin	None
3283	19527490, 23533710	2009	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	U-266	Lymphoma Cancer	MTT/MTS assay	IC₅₀ = 55 µM	NA	Blood	None
3282	19527490, 23533710	2009	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	KMS-5	Skin Cancer	MTT/MTS assay	IC₅₀ = 38 µM	NA	Skin	None
3281	19527490, 23533710	2009	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀ =148±8 µM	NA	Colon	None
3280	19527490, 23533710	2009	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	FEMX	Skin Cancer	MTT/MTS assay	IC₅₀ =40±7 µM	NA	Skin	None
3272	18815734	2008	KKKFPWWWPFKKK	PST13-RK	13	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of tritrpticin	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀ =80 µg/ml	NA	Breast	None
3271	18815734	2008	KKKFPWWWPFKKK	PST13-RK	13	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of tritrpticin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =90 µg/ml	NA	Lung	None
3269	18815734	2008	VRRFPWWWPFLRR	Tritrpticin	13	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of tritrpticin	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀ =142 µg/ml	NA	Breast	None
3268	18815734	2008	VRRFPWWWPFLRR	Tritrpticin	13	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of tritrpticin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ >200 µg/ml	NA	Lung	None
3267	22934601	2012	FLGALFKALSHLL	PTP-7b	13	Linear	L	None	Free	Free	Anticancer	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =32 µM	NA	Lung	None
3266	22934601	2012	FLGALFHALSKLL	PTP-7a	13	Linear	L	None	Free	Free	Anticancer	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =28 µM	NA	Lung	None
3253	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ =12.55 µM	72-h	Ovary	None
3252	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ =22.25 µM	72-h	Skin	None
3251	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ =29.10 µM	72-h	Prostate	None
3250	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ =22.51 µM	72-h	Stomach	None
3249	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀ =14.80 µM	72-h	Colon	None
3248	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =14.53 µM	72-h	Lung	None
3247	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ =21.48 µM	72-h	Renal	None
3246	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀	72-h	Ovary	None
3245	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ =27.39 µM	72-h	Skin	None
3244	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ =47.69 µM	72-h	Prostate	None
3242	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀ =27.00 µM	72-h	Colon	None
3243	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ =26.70 µM	72-h	Stomach	None
3240	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ =41.21 µM	72-h	Renal	None
3241	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =25.20 µM	72-h	Lung	None
3238	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ =13.16 µM	72-h	Skin	None
3239	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ =14.58 µM	72-h	Ovary	None
3235	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀ =14.80 µM	72-h	Colon	None
3236	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ =13.77 µM	72-h	Stomach	None
3237	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ =24.32 µM	72-h	Prostate	None
3233	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ =22.59 µM	72-h	Renal	None
3234	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =15.88 µM	72-h	Lung	None
3232	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ =22.06 µM	72-h	Ovary	None
3230	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ =46.51 µM	72-h	Prostate	None
3231	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ =13.97 µM	72-h	Skin	None
3229	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ =24.31 µM	72-h	Stomach	None
3228	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀ =24.63 µM	72-h	Colon	None
3227	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =20.36 µM	72-h	Lung	None
3226	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ =22.88 µM	72-h	Renal	None
3225	22413859	2012	KVKVKVKVPPTKVKVKVK	SVS-2	18	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	MDA-MB-436	Breast Cancer	MTT/MTS assay	IC₅₀ >100 µM	24-h	Breast	None
3224	22413859	2012	KVKVKVKVPPTKVKVKVK	SVS-2	18	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ >100 µM	24-h	Breast	None
3223	22413859	2012	KVKVKVKVPPTKVKVKVK	SVS-2	18	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	KB	Oral Cancer	MTT/MTS assay	IC₅₀ >100 µM	24-h	Oral mucosa	None
3222	22413859	2012	KVKVKVKVPPTKVKVKVK	SVS-2	18	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ >100 µM	24-h	Lung	None
3221	22413859	2012	kvkvkvkvPptkvkvkvk	D-SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	MDA-MB-436	Breast Cancer	MTT/MTS assay	IC₅₀ =3.2±0.4 µM	24-h	Breast	None
3220	22413859	2012	kvkvkvkvPptkvkvkvk	D-SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ =4.7±0.4 µM	24-h	Breast	None
3219	22413859	2012	kvkvkvkvPptkvkvkvk	D-SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	KB	Oral Cancer	MTT/MTS assay	IC₅₀ =4.5±0.5 µM	24-h	Oral mucosa	None
3218	22413859	2012	kvkvkvkvPptkvkvkvk	D-SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =3.2±0.6 µM	24-h	Lung	None
3217	22413859	2012	KVKVKVKVpPTKVKVKVK	SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	MDA-MB-436	Breast Cancer	MTT/MTS assay	IC₅₀ =5.6±0.5 µM	24-h	Breast	None
3216	22413859	2012	KVKVKVKVpPTKVKVKVK	SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC_{50_{=8.1±0.8 µM}}	24-h	Breast	None
3207	22413859	2012	KVKVKVKVpPTKVKVKVK	SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Bovine lactoferrin (Lf-B)	KB	Oral Cancer	MTT/MTS assay	NA	24-h	Oral mucosa	None
3206	22413859	2012	KVKVKVKVpPTKVKVKVK	SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	NA	24-h	Lung	None
3137	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ = 1.8 µM	24-h	Breast	None
3138	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 1.6 µM	24-h	Prostate	None
3139	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	U251-MG	Brain Tumor	MTT/MTS assay	IC₅₀ = 2.0 µM	24-h	Brain	None
3135	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	HI-57	Lung Cancer	MTT/MTS assay	IC₅₀ = 0.83 µM	24-h	Lung	None
3136	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	H-838	Lung Cancer	MTT/MTS assay	IC₅₀ = 1.6 µM	24-h	Lung	None
3132	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ = 1.8 µM	24-h	Breast	None
3133	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 2.1 µM	24-h	Prostate	None
3134	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	U251-MG	Brain Tumor	MTT/MTS assay	IC₅₀ = 2.9 µM	24-h	Brain	None
3129	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	U251-MG	Brain Tumor	MTT/MTS assay	IC₅₀ = 15.4 µM	24-h	Brain	None
3130	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	HI-57	Lung Cancer	MTT/MTS assay	IC₅₀ = 1.5 µM	24-h	Lung	None
3131	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	H-838	Lung Cancer	MTT/MTS assay	IC₅₀ = 1.6 µM	24-h	Lung	None
3126	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	H-838	Lung Cancer	MTT/MTS assay	IC₅₀ = 11.0 µM	24-h	Lung	None
3127	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ = 6.4 µM	24-h	Breast	None
3128	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 13.3 µM	24-h	Prostate	None
3123	23770440	2013	FLSLIPSLVGGSISAFK	TsAP-1	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	HI-57	Lung Cancer	MTT/MTS assay	IC₅₀ =55.9 µM	24-h	Lung	None
3124	23770440	2013	FLSLIPSLVGGSISAFK	TsAP-1	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	H-838	Lung Cancer	MTT/MTS assay	IC₅₀ =52.5 µM	24-h	Lung	None
3125	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	HI-57	Lung Cancer	MTT/MTS assay	IC₅₀ = 4.1 µM	24-h	Lung	None
3120	23993331	2013	KRLRRVWRRWR	MAP-04-04	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >80% at 75 µM	48-h	Breast	None
3121	23993331	2013	KRLRRVWRRWR	MAP-04-04	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >80% at 100 µM	48-h	Breast	None
3122	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=61.5 µM	48-h	Breast	None
3116	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability <40% at 75 µM	48-h	Breast	None
3117	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >20% at 100 µM	48-h	Breast	None
3118	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability ~100% at 25 µM	48-h	Breast	None
3119	23993331	2013	KRLRRVWRRWR	MAP-04-04	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >80% at 50 µM	48-h	Breast	None
3114	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >80% at 25 µM	48-h	Breast	None
3115	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability ~50% at 50 µM	48-h	Breast	None
2994	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	3 % Cytotoxicity at 6.25 mg/L	24-h	Fibrous connective tissue	None
2995	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	3 % Cytotoxicity at 3.125 mg/L	24-h	Fibrous connective tissue	None
2993	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	8 % Cytotoxicity at 12.5 mg/L	24-h	Fibrous connective tissue	None
2992	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	75 % Cytotoxicity at 25 mg/L	24-h	Fibrous connective tissue	None
2990	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	4 % Cytotoxicity at 3.125 mg/L	12-h	Fibrous connective tissue	None
2991	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Fibrous connective tissue	None
2989	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	4 % Cytotoxicity at 6.25 mg/L	12-h	Fibrous connective tissue	None
2988	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	12 % Cytotoxicity at 12.5 mg/L	12-h	Fibrous connective tissue	None
2986	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	76 % Cytotoxicity at 50 mg/L	12-h	Fibrous connective tissue	None
2987	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	12-h	Fibrous connective tissue	None
2985	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	6-h	Fibrous connective tissue	None
2983	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	5 %Cytotoxicity at 12.5 mg/L	6-h	Fibrous connective tissue	None
2984	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	7 % Cytotoxicity at 6.25 mg/L	6-h	Fibrous connective tissue	None
2982	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	6-h	Fibrous connective tissue	None
2980	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	5 % Cytotoxicity at 3.125 mg/L	3-h	Fibrous connective tissue	None
2981	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	75 % Cytotoxicity at 50 mg/L	6-h	Fibrous connective tissue	None
2979	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	10 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2978	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	8 % Cytotoxicity at 12.5 mg/L	3-h	Fibrous connective tissue	None
2976	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	60 % Cytotoxicity at 50 mg/L	3-h	Fibrous connective tissue	None
2977	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	50 % Cytotoxicity at 25 mg/L	3-h	Fibrous connective tissue	None
2973	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	8 % Cytotoxicity at 12.5 mg/L	24-h	Cervix	None
2974	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	3 % Cytotoxicity at 6.25 mg/L	24-h	Cervix	None
2975	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	3 % Cytotoxicity at 3.125 mg/L	24-h	Cervix	None
2972	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	75 % Cytotoxicity at 25 mg/L	24-h	Cervix	None
2970	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 3.125 mg/L	12-h	Cervix	None
2971	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Cervix	None
2969	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 6.25 mg/L	12-h	Cervix	None
2967	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	12-h	Cervix	None
2968	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	12 % Cytotoxicity at 12.5 mg/L	12-h	Cervix	None
2965	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	6-h	Cervix	None
2966	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	76 % Cytotoxicity at 50 mg/L	12-h	Cervix	None
2963	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 12.5 mg/L	6-h	Cervix	None
2964	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	7 % Cytotoxicity at 6.25 mg/L	6-h	Cervix	None
2962	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	6-h	Cervix	None
2961	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	75 % Cytotoxicity at 50 mg/L	6-h	Cervix	None
2959	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 6.25 mg/L	3-h	Cervix	None
2960	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 3.125 mg/L	3-h	Cervix	None
2958	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	8 % Cytotoxicity at 12.5 mg/L	3-h	Cervix	None
2957	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	50 % Cytotoxicity at 25 mg/L	3-h	Cervix	None
2956	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	60 % Cytotoxicity at 50 mg/L	3-h	Cervix	None
2911	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	LNCaP	Prostate Cancer	WST-1 assay	IC₅₀= 15.8 µM	72-h	Prostate	None
2912	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	COLO-587	Human epithelial Cancer	WST-1 assay	IC₅₀= 13.5 µM	72-h	Pancreatic	None
2910	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	HuCCT-1	Human epithelial Cancer	WST-1 assay	IC₅₀= 17.1 µM	72-h	Bileduct	None
2909	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	U-251	Brain Tumor	WST-1 assay	IC₅₀= 17.0 µM	72-h	Brain	None
2907	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	SF-295	Brain Tumor	WST-1 assay	IC₅₀= 19.1 µM	72-h	Brain	None
2908	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	SN-19	Brain Tumor	WST-1 assay	IC₅₀= 21.9 µM	72-h	Brain	None
2906	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	ZR75-1	Breast Cancer	WST-1 assay	IC₅₀= 19.4 µM	72-h	Breast	None
2905	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	BT-20	Breast Cancer	WST-1 assay	IC₅₀= 20.0 µM	72-h	Breast	None
2904	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	MDA-MB-231	Breast Cancer	WST-1 assay	IC₅₀= 27.0 µM	72-h	Breast	None
2903	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	SK-BR-3	Breast Cancer	WST-1 assay	IC₅₀= 25.7 µM	72-h	Breast	None
2902	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	T-47D	Breast Cancer	WST-1 assay	IC₅₀= 14.1 µM	72-h	Breast	None
2901	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	BT-474	Breast Cancer	WST-1 assay	IC₅₀= 34.5 µM	72-h	Breast	None
2881	20212453	2010	KWKLFKKIGAVLKVL	Camel	15	Linear	L	None	Free	Free	Antimicrobial	Ceropin-Melittin hybrid	WM1158	Skin Cancer	MTT/MTS assay	LC₅₀ = 4.1 µM	24-h	Skin	None
2880	20212453	2010	KWKLFKKIGAVLKVL	Camel	15	Linear	L	None	Free	Free	Antimicrobial	Ceropin-Melittin hybrid	4T1	Breast Cancer	MTT/MTS assay	LC₅₀ = 6.2 µM	24-h	Breast	None
2879	20212453	2010	KWKLFKKIGAVLKVL	Camel	15	Linear	L	None	Free	Free	Antimicrobial	Ceropin-Melittin hybrid	RENCA	Renal Cancer	MTT/MTS assay	LC₅₀ = 1.3 µM	24-h	Renal	None
2877	23583573	2013	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	Bcap-37	Breast Cancer	MTT/MTS assay	30 % Cell viability at 40 µM	1-h	Breast	None
2878	20212453	2010	KWKLFKKIGAVLKVL	Camel	15	Linear	L	None	Free	Free	Antimicrobial	Ceropin-Melittin hybrid	B16-F10	Skin Cancer	MTT/MTS assay	LC₅₀ = 1.75 µM	24-h	Skin	None
2876	23583573	2013	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	Bcap-37	Breast Cancer	MTT/MTS assay	45% Cell viability at 30 µM	1-h	Breast	None
2875	23583573	2013	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	Bcap-37	Breast Cancer	MTT/MTS assay	70% Cell viability at 20 µM	1-h	Breast	None
2871	16707464	2006	LKlLKKLlkKLLkLL	D-K6L9	15	Linear	Mix	None	Amidation	Free	Anticancer	Host Defense lytic Peptide	MB-231	Prostate Cancer	Enzyme Immunoassay (EIA)	LC₅₀=3 µMol/L	960-h	Prostate	None
2870	16707464	2006	LKlLKKLlkKLLkLL	D-K6L9	15	Linear	Mix	None	Amidation	Free	Anticancer	Host DefenseÐLike Lytic Peptide	CL-1	Lung Cancer	Enzyme Immunoassay (EIA)	LC₅₀=3 µMol/L	Not Available	Lung	None
2869	16707464	2006	LKlLKKLlkKLLkLL	D-K6L9	15	Linear	Mix	None	Amidation	Free	Anticancer	Host Defense lytic Peptide	22RV1	Prostate Cancer	Enzyme Immunoassay (EIA)	LC₅₀=6 µMol/L	Not Available	Prostate	None
2861	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	MDA-MB-231	Breast Cancer	WST-1 assay	IC₅₀=18.5 µMol/L	24-h	Breast	None
2860	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	H-322	Lung Cancer	WST-1 assay	IC₅₀=27.1 µMol/L	24-h	Lung	None
2859	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	A-172	Brain Tumor	WST-1 assay	IC₅₀=30.5 µMol/L	24-h	Brain	None
2858	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	T98G	Brain Tumor	WST-1 assay	IC₅₀=77.3 µMol/L	24-h	Brain	None
2857	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	KB	Oral Cancer	WST-1 assay	IC₅₀=37.4 µMol/L	24-h	Oral mucosa	None
2856	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	SU.86.86	Pancreatic Cancer	WST-1 assay	IC₅₀=28.0 µMol/L	24-h	Pancreatic	None
2855	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	BXPC-3	Pancreatic Cancer	WST-1 assay	IC₅₀=37.1 µMol/L	24-h	Pancreatic	None
2854	23577112, 21871946	2012	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	MCF-7	Breast Cancer	LDH leakage assay	32% Cytotoxicity at 40 µM	1-h	Breast	None
2853	23577112, 21871946	2012	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	MCF-7	Breast Cancer	MTT/MTS assay	61% Cell viability at 40 µM	1-h	Breast	None
2851	23577112, 21871946	2012	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	MDA-MB-231	Breast Cancer	MTT/MTS assay	22% Cell viability at 40 µM	1-h	Breast	None
2852	23577112, 21871946	2012	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	MDA-MB-231	Breast Cancer	LDH leakage assay	61% Cytotoxicity at 40 µM	1-h	Breast	None
2844	24246647	2014	GIIKKIIKKIIKKIIKKI	Short α-helical peptides	18	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HL-60	Leukemia Cancer	MTT/MTS assay	70% Cytotoxicity at 5 µM Approx	24-h	Blood	None
2843	24246647	2014	GIIKKIIKKIIKKI	Short α-helical peptides	14	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HL-60	Leukemia Cancer	MTT/MTS assay	90% Cytotoxicity at 5 µM Approx	24-h	Blood	None
2842	24246647	2014	GIIKKIIKKI	Short α-helical peptides	10	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HL-60	Leukemia Cancer	MTT/MTS assay	100% Cytotoxicity at 5 µM Approx	24-h	Blood	None
2840	24246647	2014	GIIKKIIKKIIKKI	Short α-helical peptides	14	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HeLa	Cervical Cancer	MTT/MTS assay	95% Cytotoxicity at 4 µM Approx	24-h	Cervix	None
2841	24246647	2014	GIIKKIIKKIIKKIIKKI	Short α-helical peptides	18	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HeLa	Cervical Cancer	MTT/MTS assay	80% Cytotoxicity at 4 µM Approx	24-h	Cervix	None
2839	24246647	2014	GIIKKIIKKI	Short α-helical peptides	10	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HeLa	Cervical Cancer	MTT/MTS assay	99% Cytotoxicity at 4 µM Approx	24-h	Cervix	None
2834	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	J774A.1	Tumor	MTT/MTS assay	IC₅₀=12 µM	96-h	Blood	None
2835	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	J774A.1	Tumor	MTT/MTS assay	IC₅₀=17 µM	96-h	Blood	None
2833	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	J774A.1	Tumor	MTT/MTS assay	IC₅₀=26 µM	24-h	Blood	None
2832	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	J774A.1	Tumor	MTT/MTS assay	IC₅₀=47 µM	24-h	Blood	None
2831	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=36 µM	96-h	Blood	None
2830	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=25 µM	96-h	Blood	None
2829	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=45 µM	72-h	Blood	None
2828	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=36 µM	72-h	Blood	None
2827	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=43 µM	48-h	Blood	None
2826	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=37 µM	48-h	Blood	None
2825	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=43 µM	24-h	Blood	None
2824	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=39 µM	24-h	Blood	None
2823	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=38 µM	2-h	Blood	None
2822	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=93 µM	2-h	Blood	None
2821	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=10 µM	48-h	Breast	None
2820	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=16 µM	48-h	Breast	None
2819	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=12 µM	24-h	Breast	None
2818	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=29 µM	24-h	Breast	None
2817	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=18 µM	2-h	Breast	None
2816	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=39 µM	2-h	Breast	None
2815	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=8 µM	48-h	Prostate	None
2814	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=28 µM	48-h	Prostate	None
2812	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=23 µM	24-h	Prostate	None
2813	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=9 µM	24-h	Prostate	None
2810	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=44 µM	2-h	Prostate	None
2811	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=26 µM	2-h	Prostate	None
2807	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2806	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2801	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2800	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2798	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2799	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =760 µg/ml	24-h	Cervix	US_06875744_B2
2796	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =380 µg/ml	24-h	Cervix	US_06875744_B2
2797	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2787	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2788	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =325 µg/ml	24-h	Cervix	US_06875744_B2
2790	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2791	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2792	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =820 µg/ml	24-h	Cervix	US_06875744_B2
2795	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2780	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2781	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2782	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2784	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =275 µg/ml	24-h	Cervix	US_06875744_B2
2785	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =550 µg/ml	24-h	Cervix	US_06875744_B2
2773	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2774	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2775	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2776	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Cervix	US_06875744_B2
2777	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2778	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2779	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Cervix	US_06875744_B2
2765	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2766	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =285 µg/ml	24-h	Cervix	US_06875744_B2
2768	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =55 µg/ml	24-h	Cervix	US_06875744_B2
2769	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2770	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =275 µg/ml	24-h	Cervix	US_06875744_B2
2772	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Cervix	US_06875744_B2
2762	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Cervix	US_06875744_B2
2763	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2764	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2759	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2758	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2751	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Cervix	US_06875744_B2
2752	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2753	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =610 µg/ml	24-h	Cervix	US_06875744_B2
2749	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =940 µg/ml	24-h	Cervix	US_06875744_B2
2750	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Cervix	US_06875744_B2
2747	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Cervix	US_06875744_B2
2748	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =780 µg/ml	24-h	Cervix	US_06875744_B2
2746	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =810 µg/ml	24-h	Cervix	US_06875744_B2
2745	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Cervix	US_06875744_B2
2743	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2744	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =87 µg/ml	24-h	Cervix	US_06875744_B2
2742	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2740	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Cervix	US_06875744_B2
2741	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Cervix	US_06875744_B2
2738	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =540 µg/ml	24-h	Cervix	US_06875744_B2
2739	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Cervix	US_06875744_B2
2737	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2734	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Cervix	US_06875744_B2
2735	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2732	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Cervix	US_06875744_B2
2731	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =70 µg/ml	24-h	Cervix	US_06875744_B2
2730	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =43 µg/ml	24-h	Cervix	US_06875744_B2
2729	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Cervix	US_06875744_B2
2726	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2725	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2724	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2723	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2722	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =670 µg/ml	24-h	Cervix	US_06875744_B2
2721	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =20 µg/ml	24-h	Cervix	US_06875744_B2
2718	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2717	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2716	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =380 µg/ml	24-h	Cervix	US_06875744_B2
2715	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Cervix	US_06875744_B2
2714	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =260 µg/ml	24-h	Cervix	US_06875744_B2
2711	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =570 µg/ml	24-h	Cervix	US_06875744_B2
2708	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =210 µg/ml	24-h	Cervix	US_06875744_B2
2709	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Cervix	US_06875744_B2
2707	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Cervix	US_06875744_B2
2706	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Cervix	US_06875744_B2
2705	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Cervix	US_06875744_B2
2702	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2703	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2700	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Cervix	US_06875744_B2
2701	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Cervix	US_06875744_B2
2699	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =15 µg/ml	24-h	Cervix	US_06875744_B2
2697	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Cervix	US_06875744_B2
2698	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Cervix	US_06875744_B2
2696	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =33 µg/ml	24-h	Cervix	US_06875744_B2
2695	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2693	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2694	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Cervix	US_06875744_B2
2692	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =280 µg/ml	24-h	Cervix	US_06875744_B2
2691	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Cervix	US_06875744_B2
2690	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =22 µg/ml	24-h	Cervix	US_06875744_B2
2689	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =15 µg/ml	24-h	Cervix	US_06875744_B2
2687	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Cervix	US_06875744_B2
2685	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =620 µg/ml	24-h	Cervix	US_06875744_B2
2686	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2684	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Cervix	US_06875744_B2
2682	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2681	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Cervix	US_06875744_B2
2680	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =62 µg/ml	24-h	Cervix	US_06875744_B2
2678	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =260 µg/ml	24-h	Cervix	US_06875744_B2
2676	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =25 µg/ml	24-h	Cervix	US_06875744_B2
2677	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Cervix	US_06875744_B2
2663	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2664	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Prostate	US_06875744_B2
2658	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2657	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2656	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2655	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2654	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2653	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =120 µg/ml	24-h	Prostate	US_06875744_B2
2652	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2649	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Prostate	US_06875744_B2
2648	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2647	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2645	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Prostate	US_06875744_B2
2644	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2642	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =450 µg/ml	24-h	Prostate	US_06875744_B2
2641	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =145 µg/ml	24-h	Prostate	US_06875744_B2
2639	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =260 µg/ml	24-h	Prostate	US_06875744_B2
2638	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Prostate	US_06875744_B2
2637	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Prostate	US_06875744_B2
2636	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =97 µg/ml	24-h	Prostate	US_06875744_B2
2635	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2634	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2633	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Prostate	US_06875744_B2
2631	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2632	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2630	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Prostate	US_06875744_B2
2629	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =440 µg/ml	24-h	Prostate	US_06875744_B2
2626	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2627	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =350 µg/ml	24-h	Prostate	US_06875744_B2
2625	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Prostate	US_06875744_B2
2623	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2622	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2620	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2621	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2619	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =900 µg/ml	24-h	Prostate	US_06875744_B2
2616	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2615	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2609	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2610	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2608	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =145 µg/ml	24-h	Prostate	US_06875744_B2
2607	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Prostate	US_06875744_B2
2605	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =800 µg/ml	24-h	Prostate	US_06875744_B2
2606	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2604	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2603	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2602	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Prostate	US_06875744_B2
2601	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Prostate	US_06875744_B2
2599	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2600	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2598	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Prostate	US_06875744_B2
2597	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Prostate	US_06875744_B2
2596	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Prostate	US_06875744_B2
2594	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2595	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2592	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2591	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2588	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Prostate	US_06875744_B2
2589	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =18 µg/ml	24-h	Prostate	US_06875744_B2
2587	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =66 µg/ml	24-h	Prostate	US_06875744_B2
2586	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =730 µg/ml	24-h	Prostate	US_06875744_B2
2583	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2582	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2581	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Prostate	US_06875744_B2
2579	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =83 µg/ml	24-h	Prostate	US_06875744_B2
2580	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =690 µg/ml	24-h	Prostate	US_06875744_B2
2578	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =31 µg/ml	24-h	Prostate	US_06875744_B2
2575	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2574	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2573	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =675 µg/ml	24-h	Prostate	US_06875744_B2
2572	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Prostate	US_06875744_B2
2571	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Prostate	US_06875744_B2
2568	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =270 µg/ml	24-h	Prostate	US_06875744_B2
2565	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =470 µg/ml	24-h	Prostate	US_06875744_B2
2566	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Prostate	US_06875744_B2
2564	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Prostate	US_06875744_B2
2563	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Prostate	US_06875744_B2
2562	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =66 µg/ml	24-h	Prostate	US_06875744_B2
2560	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =81 µg/ml	24-h	Prostate	US_06875744_B2
2558	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2559	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2556	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =47 µg/ml	24-h	Prostate	US_06875744_B2
2557	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =435 µg/ml	24-h	Prostate	US_06875744_B2
2555	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Prostate	US_06875744_B2
2554	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Prostate	US_06875744_B2
2553	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Prostate	US_06875744_B2
2552	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =77 µg/ml	24-h	Prostate	US_06875744_B2
2551	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =32 µg/ml	24-h	Prostate	US_06875744_B2
2550	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2549	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =280 µg/ml	24-h	Prostate	US_06875744_B2
2548	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Prostate	US_06875744_B2
2547	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Prostate	US_06875744_B2
2546	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Prostate	US_06875744_B2
2543	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =435 µg/ml	24-h	Prostate	US_06875744_B2
2544	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Prostate	US_06875744_B2
2542	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Prostate	US_06875744_B2
2541	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Prostate	US_06875744_B2
2539	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =19 µg/ml	24-h	Prostate	US_06875744_B2
2538	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =5 µg/ml	24-h	Prostate	US_06875744_B2
2537	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Prostate	US_06875744_B2
2535	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =280 µg/ml	24-h	Prostate	US_06875744_B2
2534	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Prostate	US_06875744_B2
2533	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =8 µg/ml	24-h	Prostate	US_06875744_B2
2521	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Lung	US_06875744_B2
2520	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =720 µg/ml	24-h	Lung	US_06875744_B2
2515	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2514	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2512	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2513	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2510	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Lung	US_06875744_B2
2511	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2509	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2506	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =540 µg/ml	24-h	Lung	US_06875744_B2
2504	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Lung	US_06875744_B2
2505	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2502	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Lung	US_06875744_B2
2501	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2498	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Lung	US_06875744_B2
2499	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =470 µg/ml	24-h	Lung	US_06875744_B2
2494	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Lung	US_06875744_B2
2495	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2496	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	Not Available	24-h	Lung	US_06875744_B2
2492	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =410 µg/ml	24-h	Lung	US_06875744_B2
2493	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =50 µg/ml	24-h	Lung	US_06875744_B2
2489	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2490	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Lung	US_06875744_B2
2491	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2488	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Lung	US_06875744_B2
2487	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Lung	US_06875744_B2
2486	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Lung	US_06875744_B2
2484	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =225 µg/ml	24-h	Lung	US_06875744_B2
2482	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Lung	US_06875744_B2
2483	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2480	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2479	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =850 µg/ml	24-h	Lung	US_06875744_B2
2478	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2477	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2476	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =450 µg/ml	24-h	Lung	US_06875744_B2
2473	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2472	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2467	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Lung	US_06875744_B2
2466	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2465	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =76 µg/ml	24-h	Lung	US_06875744_B2
2464	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Lung	US_06875744_B2
2463	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2462	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Lung	US_06875744_B2
2461	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =460 µg/ml	24-h	Lung	US_06875744_B2
2460	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =620 µg/ml	24-h	Lung	US_06875744_B2
2459	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =33 µg/ml	24-h	Lung	US_06875744_B2
2458	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Lung	US_06875744_B2
2457	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2456	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2455	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =50 µg/ml	24-h	Lung	US_06875744_B2
2454	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =470 µg/ml	24-h	Lung	US_06875744_B2
2453	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =8 µg/ml	24-h	Lung	US_06875744_B2
2452	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =95 µg/ml	24-h	Lung	US_06875744_B2
2451	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2449	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2448	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =920 µg/ml	24-h	Lung	US_06875744_B2
2446	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =52 µg/ml	24-h	Lung	US_06875744_B2
2445	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Lung	US_06875744_B2
2444	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Lung	US_06875744_B2
2443	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Lung	US_06875744_B2
2440	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2439	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2438	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	Not Available	24-h	Lung	US_06875744_B2
2437	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Lung	US_06875744_B2
2436	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =25 µg/ml	24-h	Lung	US_06875744_B2
2435	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Lung	US_06875744_B2
2432	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2431	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2430	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =860 µg/ml	24-h	Lung	US_06875744_B2
2429	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Lung	US_06875744_B2
2428	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =670 µg/ml	24-h	Lung	US_06875744_B2
2425	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Lung	US_06875744_B2
2423	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Lung	US_06875744_B2
2422	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =450 µg/ml	24-h	Lung	US_06875744_B2
2421	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Lung	US_06875744_B2
2420	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =270 µg/ml	24-h	Lung	US_06875744_B2
2419	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =127 µg/ml	24-h	Lung	US_06875744_B2
2417	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Lung	US_06875744_B2
2416	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2415	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2414	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =370 µg/ml	24-h	Lung	US_06875744_B2
2413	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Lung	US_06875744_B2
2412	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Lung	US_06875744_B2
2411	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =65 µg/ml	24-h	Lung	US_06875744_B2
2410	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Lung	US_06875744_B2
2409	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Lung	US_06875744_B2
2408	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =17 µg/ml	24-h	Lung	US_06875744_B2
2407	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2406	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Lung	US_06875744_B2
2405	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Lung	US_06875744_B2
2404	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Lung	US_06875744_B2
2403	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =6 µg/ml	24-h	Lung	US_06875744_B2
2401	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =245 µg/ml	24-h	Lung	US_06875744_B2
2400	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2399	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =420 µg/ml	24-h	Lung	US_06875744_B2
2398	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =33 µg/ml	24-h	Lung	US_06875744_B2
2396	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =57 µg/ml	24-h	Lung	US_06875744_B2
2395	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Lung	US_06875744_B2
2394	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =24 µg/ml	24-h	Lung	US_06875744_B2
2392	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 AM	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Lung	US_06875744_B2
2391	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Lung	US_06875744_B2
2390	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Lung	US_06875744_B2
2380	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2376	None	2005	VAKLLAKALKKLL	FLAK50D V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2375	None	2005	VAKKLAKLAKKLLAL	FLAK43 AM V	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2374	None	2005	VAKKLAKLAKKLAKLALAL	FLAK 25 AM V	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2372	None	2005	VAKFLAKFLKKAL	FLAK50 Q1V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2371	None	2005	VAKALAKALLKALKAL	FLAK 17 CV	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2368	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2367	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2362	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2361	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Skin	US_06875744_B2
2360	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Skin	US_06875744_B2
2359	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =920 µg/ml	24-h	Skin	US_06875744_B2
2358	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Skin	US_06875744_B2
2357	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Skin	US_06875744_B2
2356	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2353	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2352	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2351	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Skin	US_06875744_B2
2349	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Skin	US_06875744_B2
2348	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2346	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Skin	US_06875744_B2
2345	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2343	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =520 µg/ml	24-h	Skin	US_06875744_B2
2342	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2341	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2340	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =165 µg/ml	24-h	Skin	US_06875744_B2
2339	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2338	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2337	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Skin	US_06875744_B2
2335	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2336	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2334	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =110 µg/ml	24-h	Skin	US_06875744_B2
2333	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Skin	US_06875744_B2
2331	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Skin	US_06875744_B2
2319	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2320	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2323	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Skin	US_06875744_B2
2324	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2325	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2326	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =525 µg/ml	24-h	Skin	US_06875744_B2
2327	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2329	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Skin	US_06875744_B2
2330	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2304	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2305	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =135 µg/ml	24-h	Skin	US_06875744_B2
2306	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =36 µg/ml	24-h	Skin	US_06875744_B2
2307	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Skin	US_06875744_B2
2308	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =670 µg/ml	24-h	Skin	US_06875744_B2
2309	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2310	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =635 µg/ml	24-h	Skin	US_06875744_B2
2311	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Skin	US_06875744_B2
2312	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Skin	US_06875744_B2
2313	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2314	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =535 µg/ml	24-h	Skin	US_06875744_B2
2292	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =75 µg/ml	24-h	Skin	US_06875744_B2
2293	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Skin	US_06875744_B2
2295	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =690 µg/ml	24-h	Skin	US_06875744_B2
2296	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2298	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2299	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Skin	US_06875744_B2
2300	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =26 µg/ml	24-h	Skin	US_06875744_B2
2301	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =445 µg/ml	24-h	Skin	US_06875744_B2
2302	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Skin	US_06875744_B2
2303	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2291	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Skin	US_06875744_B2
2290	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Skin	US_06875744_B2
2286	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =820 µg/ml	24-h	Skin	US_06875744_B2
2287	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2285	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Skin	US_06875744_B2
2284	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Skin	US_06875744_B2
2283	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Skin	US_06875744_B2
2280	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Skin	US_06875744_B2
2279	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Skin	US_06875744_B2
2278	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =750 µg/ml	24-h	Skin	US_06875744_B2
2277	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =24 µg/ml	24-h	Skin	US_06875744_B2
2276	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =460 µg/ml	24-h	Skin	US_06875744_B2
2273	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =445 µg/ml	24-h	Skin	US_06875744_B2
2271	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =200 µg/ml	24-h	Skin	US_06875744_B2
2270	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Skin	US_06875744_B2
2269	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Skin	US_06875744_B2
2268	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =200 µg/ml	24-h	Skin	US_06875744_B2
2267	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2264	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2265	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =155 µg/ml	24-h	Skin	US_06875744_B2
2263	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Skin	US_06875744_B2
2262	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =205 µg/ml	24-h	Skin	US_06875744_B2
2261	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Skin	US_06875744_B2
2260	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Skin	US_06875744_B2
2259	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Skin	US_06875744_B2
2258	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Skin	US_06875744_B2
2256	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =43 µg/ml	24-h	Skin	US_06875744_B2
2257	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Skin	US_06875744_B2
2255	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2254	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Skin	US_06875744_B2
2253	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Skin	US_06875744_B2
2252	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =47 µg/ml	24-h	Skin	US_06875744_B2
2251	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Skin	US_06875744_B2
2249	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Skin	US_06875744_B2
2247	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =510 µg/ml	24-h	Skin	US_06875744_B2
2248	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2246	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =21 µg/ml	24-h	Skin	US_06875744_B2
2244	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =56 µg/ml	24-h	Skin	US_06875744_B2
2243	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Skin	US_06875744_B2
2242	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =53 µg/ml	24-h	Skin	US_06875744_B2
2238	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Skin	US_06875744_B2
2239	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Skin	US_06875744_B2
2240	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Skin	US_06875744_B2
2228	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2224	None	2005	VAKLLAKALKKLL	FLAK50D V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2223	None	2005	VAKKLAKLAKKLLAL	FLAK43 AM V	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2222	None	2005	VAKKLAKLAKKLAKLALAL	FLAK 25 AM V	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2220	None	2005	VAKFLAKFLKKAL	FLAK50 Q1V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2219	None	2005	VAKALKALLKALKAL	FLAK 17 CV	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2215	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2216	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2209	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Skin	US_06875744_B2
2210	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2207	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =920 µg/ml	24-h	Skin	US_06875744_B2
2208	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Skin	US_06875744_B2
2206	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Skin	US_06875744_B2
2205	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Skin	US_06875744_B2
2201	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2204	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2199	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Skin	US_06875744_B2
2200	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2197	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Skin	US_06875744_B2
2196	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2194	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Skin	US_06875744_B2
2193	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2191	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =520 µg/ml	24-h	Skin	US_06875744_B2
2190	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2189	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2188	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =165 µg/ml	24-h	Skin	US_06875744_B2
2187	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2186	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2185	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Skin	US_06875744_B2
2184	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2183	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2181	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Skin	US_06875744_B2
2182	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =110 µg/ml	24-h	Skin	US_06875744_B2
2179	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Skin	US_06875744_B2
2177	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Skin	US_06875744_B2
2178	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2174	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =525 µg/ml	24-h	Skin	US_06875744_B2
2175	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2173	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2172	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2171	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Skin	US_06875744_B2
2168	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2167	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2162	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =535 µg/ml	24-h	Skin	US_06875744_B2
2161	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2160	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Skin	US_06875744_B2
2158	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =635 µg/ml	24-h	Skin	US_06875744_B2
2159	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Skin	US_06875744_B2
2157	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2156	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =670 µg/ml	24-h	Skin	US_06875744_B2
2155	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Skin	US_06875744_B2
2154	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =36 µg/ml	24-h	Skin	US_06875744_B2
2153	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =135 µg/ml	24-h	Skin	US_06875744_B2
2152	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2151	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2150	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Skin	US_06875744_B2
2148	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =26 µg/ml	24-h	Skin	US_06875744_B2
2149	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =445 µg/ml	24-h	Skin	US_06875744_B2
2147	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Skin	US_06875744_B2
2146	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2143	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =690 µg/ml	24-h	Skin	US_06875744_B2
2144	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2139	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Skin	US_06875744_B2
2140	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =75 µg/ml	24-h	Skin	US_06875744_B2
2141	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Skin	US_06875744_B2
2138	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Skin	US_06875744_B2
2135	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2134	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =820 µg/ml	24-h	Skin	US_06875744_B2
2133	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Skin	US_06875744_B2
2132	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Skin	US_06875744_B2
2131	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Skin	US_06875744_B2
2128	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Skin	US_06875744_B2
2127	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Skin	US_06875744_B2
2126	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =750 µg/ml	24-h	Skin	US_06875744_B2
2125	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =24 µg/ml	24-h	Skin	US_06875744_B2
2124	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =460 µg/ml	24-h	Skin	US_06875744_B2
2121	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =445 µg/ml	24-h	Skin	US_06875744_B2
2119	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =200 µg/ml	24-h	Skin	US_06875744_B2
2118	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Skin	US_06875744_B2
2117	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Skin	US_06875744_B2
2116	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =200 µg/ml	24-h	Skin	US_06875744_B2
2115	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2113	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =155 µg/ml	24-h	Skin	US_06875744_B2
2112	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2111	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Skin	US_06875744_B2
2110	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =205 µg/ml	24-h	Skin	US_06875744_B2
2109	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Skin	US_06875744_B2
2108	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Skin	US_06875744_B2
2107	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Skin	US_06875744_B2
2106	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Skin	US_06875744_B2
2105	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Skin	US_06875744_B2
2104	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =43 µg/ml	24-h	Skin	US_06875744_B2
2103	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2102	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Skin	US_06875744_B2
2101	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Skin	US_06875744_B2
2100	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =47 µg/ml	24-h	Skin	US_06875744_B2
2099	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Skin	US_06875744_B2
2097	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Skin	US_06875744_B2
2096	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2095	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =510 µg/ml	24-h	Skin	US_06875744_B2
2094	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =21 µg/ml	24-h	Skin	US_06875744_B2
2092	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =56 µg/ml	24-h	Skin	US_06875744_B2
2091	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Skin	US_06875744_B2
2090	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =53 µg/ml	24-h	Skin	US_06875744_B2
2088	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 AM	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Skin	US_06875744_B2
2087	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Skin	US_06875744_B2
2086	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Skin	US_06875744_B2
2076	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2072	None	2005	VAKLLAKALKKLL	FLAK50D V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2071	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM V	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2070	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM V	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2068	None	2005	VAKFLAKFLKKAL	FLAK50 Q1V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2067	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 17 CV	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2063	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2064	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Colon	US_06875744_B2
2058	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2056	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Colon	US_06875744_B2
2057	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =870 µg/ml	24-h	Colon	US_06875744_B2
2055	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2053	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Colon	US_06875744_B2
2054	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2052	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2048	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2049	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Colon	US_06875744_B2
2047	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2045	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =360 µg/ml	24-h	Colon	US_06875744_B2
2044	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2042	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =370 µg/ml	24-h	Colon	US_06875744_B2
2041	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Colon	US_06875744_B2
2038	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2039	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Colon	US_06875744_B2
2037	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =750 µg/ml	24-h	Colon	US_06875744_B2
2036	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =61 µg/ml	24-h	Colon	US_06875744_B2
2034	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2035	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Colon	US_06875744_B2
2033	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =235 µg/ml	24-h	Colon	US_06875744_B2
2032	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2031	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2029	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =380 µg/ml	24-h	Colon	US_06875744_B2
2030	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Colon	US_06875744_B2
2027	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =285 µg/ml	24-h	Colon	US_06875744_B2
2026	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2025	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Colon	US_06875744_B2
2023	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2021	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2022	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2019	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Colon	US_06875744_B2
2020	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2016	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2015	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2010	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Colon	US_06875744_B2
2009	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2008	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Colon	US_06875744_B2
2006	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2007	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Colon	US_06875744_B2
2005	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =570 µg/ml	24-h	Colon	US_06875744_B2
2004	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =800 µg/ml	24-h	Colon	US_06875744_B2
2003	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =630 µg/ml	24-h	Colon	US_06875744_B2
2001	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Colon	US_06875744_B2
2002	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Colon	US_06875744_B2
1999	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2000	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1998	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Colon	US_06875744_B2
1996	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Colon	US_06875744_B2
1997	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =800 µg/ml	24-h	Colon	US_06875744_B2
1994	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1995	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =325 µg/ml	24-h	Colon	US_06875744_B2
1992	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1991	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =570 µg/ml	24-h	Colon	US_06875744_B2
1989	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Colon	US_06875744_B2
1987	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =57 µg/ml	24-h	Colon	US_06875744_B2
1988	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Colon	US_06875744_B2
1986	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Colon	US_06875744_B2
1983	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1982	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1980	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =51 µg/ml	24-h	Colon	US_06875744_B2
1981	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
1979	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Colon	US_06875744_B2
1976	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1975	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1974	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Colon	US_06875744_B2
1972	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Colon	US_06875744_B2
1973	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =17 µg/ml	24-h	Colon	US_06875744_B2
1969	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Colon	US_06875744_B2
1967	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =145 µg/ml	24-h	Colon	US_06875744_B2
1966	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Colon	US_06875744_B2
1964	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Colon	US_06875744_B2
1965	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ = µg/ml	24-h	Colon	US_06875744_B2
1963	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Colon	US_06875744_B2
1960	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1961	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =42 µg/ml	24-h	Colon	US_06875744_B2
1958	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =215 µg/ml	24-h	Colon	US_06875744_B2
1959	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Colon	US_06875744_B2
1957	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Colon	US_06875744_B2
1956	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
1955	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
1954	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Colon	US_06875744_B2
1953	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Colon	US_06875744_B2
1952	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =47 µg/ml	24-h	Colon	US_06875744_B2
1951	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1950	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Colon	US_06875744_B2
1949	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Colon	US_06875744_B2
1948	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =32 µg/ml	24-h	Colon	US_06875744_B2
1947	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Colon	US_06875744_B2
1944	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1945	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =120 µg/ml	24-h	Colon	US_06875744_B2
1943	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =435 µg/ml	24-h	Colon	US_06875744_B2
1942	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =13 µg/ml	24-h	Colon	US_06875744_B2
1940	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Colon	US_06875744_B2
1939	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Colon	US_06875744_B2
1938	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Colon	US_06875744_B2
1936	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =210 µg/ml	24-h	Colon	US_06875744_B2
1935	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =59 µg/ml	24-h	Colon	US_06875744_B2
1934	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =26 µg/ml	24-h	Colon	US_06875744_B2
1924	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	Not Available	24-h	Breast	US_06875744_B2
1920	None	2005	VAKLLAKALKKLL	FLAK50D V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Breast	US_06875744_B2
1918	None	2005	VAKKLAKLAKKLAKLALAL	FLAK 25 AM V	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Breast	US_06875744_B2
1919	None	2005	VAKKLAKLAKKLLAL	FLAK43 AM V	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =86 µg/ml	24-h	Breast	US_06875744_B2
1916	None	2005	VAKFLAKFLKKAL	FLAK50 Q1V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =92 µg/ml	24-h	Breast	US_06875744_B2
1915	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 17 CV	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Breast	US_06875744_B2
1912	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =315 µg/ml	24-h	Breast	US_06875744_B2
1911	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Breast	US_06875744_B2
1906	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1905	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =550 µg/ml	24-h	Breast	US_06875744_B2
1904	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =950 µg/ml	24-h	Breast	US_06875744_B2
1903	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =555 µg/ml	24-h	Breast	US_06875744_B2
1901	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Breast	US_06875744_B2
1902	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Breast	US_06875744_B2
1900	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1897	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =305 µg/ml	24-h	Breast	US_06875744_B2
1895	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =510 µg/ml	24-h	Breast	US_06875744_B2
1896	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =940 µg/ml	24-h	Breast	US_06875744_B2
1893	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =230 µg/ml	24-h	Breast	US_06875744_B2
1892	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1890	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Breast	US_06875744_B2
1889	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =61 µg/ml	24-h	Breast	US_06875744_B2
1886	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1887	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =135 µg/ml	24-h	Breast	US_06875744_B2
1885	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =315 µg/ml	24-h	Breast	US_06875744_B2
1884	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Breast	US_06875744_B2
1882	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1883	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =430 µg/ml	24-h	Breast	US_06875744_B2
1880	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1881	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Breast	US_06875744_B2
1879	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =315 µg/ml	24-h	Breast	US_06875744_B2
1878	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =106 µg/ml	24-h	Breast	US_06875744_B2
1877	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =110 µg/ml	24-h	Breast	US_06875744_B2
1875	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Breast	US_06875744_B2
1873	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Breast	US_06875744_B2
1874	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1871	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1869	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1870	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =625 µg/ml	24-h	Breast	US_06875744_B2
1868	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1867	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =500 µg/ml	24-h	Breast	US_06875744_B2
1864	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1863	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1858	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =440 µg/ml	24-h	Breast	US_06875744_B2
1856	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Breast	US_06875744_B2
1857	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1854	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =615 µg/ml	24-h	Breast	US_06875744_B2
1855	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =18 µg/ml	24-h	Breast	US_06875744_B2
1853	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =360 µg/ml	24-h	Breast	US_06875744_B2
1851	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =730 µg/ml	24-h	Breast	US_06875744_B2
1852	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Breast	US_06875744_B2
1850	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Breast	US_06875744_B2
1849	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =70 µg/ml	24-h	Breast	US_06875744_B2
1848	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1847	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =730 µg/ml	24-h	Breast	US_06875744_B2
1846	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Breast	US_06875744_B2
1845	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =500 µg/ml	24-h	Breast	US_06875744_B2
1844	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Breast	US_06875744_B2
1843	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Breast	US_06875744_B2
1842	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1840	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1839	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =620 µg/ml	24-h	Breast	US_06875744_B2
1837	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Breast	US_06875744_B2
1836	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Breast	US_06875744_B2
1835	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Breast	US_06875744_B2
1834	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Breast	US_06875744_B2
1830	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1831	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1829	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =65 µg/ml	24-h	Breast	US_06875744_B2
1828	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Breast	US_06875744_B2
1827	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Breast	US_06875744_B2
1824	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =540 µg/ml	24-h	Breast	US_06875744_B2
1823	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1821	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =42 µg/ml	24-h	Breast	US_06875744_B2
1822	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =970 µg/ml	24-h	Breast	US_06875744_B2
1820	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =465 µg/ml	24-h	Breast	US_06875744_B2
1817	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Breast	US_06875744_B2
1815	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Breast	US_06875744_B2
1814	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =475 µg/ml	24-h	Breast	US_06875744_B2
1813	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Breast	US_06875744_B2
1812	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Breast	US_06875744_B2
1811	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =105 µg/ml	24-h	Breast	US_06875744_B2
1809	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =31 µg/ml	24-h	Breast	US_06875744_B2
1808	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1807	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1806	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =500 µg/ml	24-h	Breast	US_06875744_B2
1805	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Breast	US_06875744_B2
1804	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Breast	US_06875744_B2
1803	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Breast	US_06875744_B2
1802	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =32 µg/ml	24-h	Breast	US_06875744_B2
1801	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Breast	US_06875744_B2
1800	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Breast	US_06875744_B2
1799	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =575 µg/ml	24-h	Breast	US_06875744_B2
1798	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Breast	US_06875744_B2
1797	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =260 µg/ml	24-h	Breast	US_06875744_B2
1796	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Breast	US_06875744_B2
1795	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Breast	US_06875744_B2
1793	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =98 µg/ml	24-h	Breast	US_06875744_B2
1792	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =760 µg/ml	24-h	Breast	US_06875744_B2
1791	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Breast	US_06875744_B2
1790	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =17 µg/ml	24-h	Breast	US_06875744_B2
1788	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Breast	US_06875744_B2
1787	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Breast	US_06875744_B2
1786	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =21 µg/ml	24-h	Breast	US_06875744_B2
1784	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Breast	US_06875744_B2
1783	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =65 µg/ml	24-h	Breast	US_06875744_B2
1782	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Breast	US_06875744_B2
1772	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 14.58 mM	24-h	Ovary	WO_2007133033_A1
1771	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 13.16 mM	24-h	Skin	WO_2007133033_A1
1770	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 24.32 mM	24-h	Prostate	WO_2007133033_A1
1769	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	IC₅₀ = 57 mM	24-h	Colon	WO_2007133033_A1
1768	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 13.77 mM	24-h	Stomach	WO_2007133033_A1
1767	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Colon	WO_2007133033_A1
1766	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 15.88 mM	24-h	Lung	WO_2007133033_A1
1765	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	Not Available	24-h	Renal	WO_2007133033_A1
1764	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 22.06 mM	24-h	Ovary	WO_2007133033_A1
1763	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 13.97 mM	24-h	Skin	WO_2007133033_A1
1762	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 46.51 mM	24-h	Prostate	WO_2007133033_A1
1761	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	IC₅₀ = 48 mM	24-h	Colon	WO_2007133033_A1
1760	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 22.31 mM	24-h	Stomach	WO_2007133033_A1
1759	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 24.63 mM	24-h	Colon	WO_2007133033_A1
1758	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 20.36 mM	24-h	Lung	WO_2007133033_A1
1757	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	Not Available	24-h	Renal	WO_2007133033_A1
1756	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 12.55 mM	24-h	Ovary	WO_2007133033_A1
1755	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 22.25 mM	24-h	Skin	WO_2007133033_A1
1754	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 29.1 mM	24-h	Prostate	WO_2007133033_A1
1753	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	WO_2007133033_A1
1752	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 22.51 mM	24-h	Stomach	WO_2007133033_A1
1751	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Colon	WO_2007133033_A1
1750	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 14.53 mM	24-h	Lung	WO_2007133033_A1
1749	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ = 21.48 mM	24-h	Renal	WO_2007133033_A1
1748	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 24.76 mM	24-h	Ovary	WO_2007133033_A1
1747	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 27.39 mM	24-h	Skin	WO_2007133033_A1
1746	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 47.69 mM	24-h	Prostate	WO_2007133033_A1
1745	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	WO_2007133033_A1
1744	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 26.7 mM	24-h	Stomach	WO_2007133033_A1
1743	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 25.2 mM	24-h	Lung	WO_2007133033_A1
1742	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ = 41.21 mM	24-h	Renal	WO_2007133033_A1
1741	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	IC₅₀ = 57 mM	24-h	Colon	US_008076284_B2
1740	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	IC₅₀ = 48 mM	24-h	Colon	US_008076284_B2
1739	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_008076284_B2
1738	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_008076284_B2
1737	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Colon	US_008076284_B2
1736	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 24.63 mM	24-h	Colon	US_008076284_B2
1735	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Colon	US_008076284_B2
1734	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 27 mM	24-h	Colon	US_008076284_B2
1733	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	Not Available	24-h	Renal	US_008076284_B2
1732	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 24.32 mM	24-h	Prostate	US_008076284_B2
1731	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 13.77 mM	24-h	Stomach	US_008076284_B2
1730	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 14.58 mM	24-h	Ovary	US_008076284_B2
1729	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Lung	US_008076284_B2
1728	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 13.16 mM	24-h	Skin	US_008076284_B2
1727	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	Not Available	24-h	Renal	US_008076284_B2
1726	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 46.51 mM	24-h	Prostate	US_008076284_B2
1725	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 24.31 mM	24-h	Stomach	US_008076284_B2
1724	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 22.06 mM	24-h	Ovary	US_008076284_B2
1723	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 20.36 mM	24-h	Lung	US_008076284_B2
1722	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 13.97 mM	24-h	Skin	US_008076284_B2
1721	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ = 21.48 mM	24-h	Renal	US_008076284_B2
1720	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 29.1 mM	24-h	Prostate	US_008076284_B2
1719	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 22.51 mM	24-h	Stomach	US_008076284_B2
1718	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 12.55 mM	24-h	Ovary	US_008076284_B2
1717	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 14.53 mM	24-h	Lung	US_008076284_B2
1716	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 22.25 mM	24-h	Skin	US_008076284_B2
1715	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ = 41.21 mM	24-h	Renal	US_008076284_B2
1714	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 47.69 mM	24-h	Prostate	US_008076284_B2
1713	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 26.7 mM	24-h	Stomach	US_008076284_B2
1712	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 24.76 mM	24-h	Ovary	US_008076284_B2
1710	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 27.39 mM	24-h	Skin	US_008076284_B2
1711	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 25.2 mM	24-h	Lung	US_008076284_B2
1709	11691780	2001	KLAKLAKKLAKLAK	DP1	14	Linear	L	None	Free	Free	Antimicrobial	Protein transduction domain	MCA205	Renal Cancer	MTT/MTS assay	LC₅₀ =< 50 µM	168-h	Renal	None
1705	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	MEC	Breast Cancer	MTT/MTS assay	29.33 Inhibition ratio at 50 µg/ml	24-h	Breast	None
1704	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	MEC	Breast Cancer	MTT/MTS assay	19.76 Inhibition ratio at 50 µg/ml	24-h	Breast	None
1703	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	MEC	Breast Cancer	MTT/MTS assay	27.99 Inhibition ratio at 50 µg/ml	24-h	Breast	None
1702	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	MEC	Breast Cancer	MTT/MTS assay	24.15Inhibition ratio at 50 µg/ml	24-h	Breast	None
1701	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HEK-293T	Renal Cancer	MTT/MTS assay	32.52 Inhibition ratio at 50 µg/ml	24-h	Renal	None
1700	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HEK-293T	Renal Cancer	MTT/MTS assay	27.86 Inhibition ratio at 50 µg/ml	24-h	Renal	None
1699	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HEK-293T	Renal Cancer	MTT/MTS assay	30.90 Inhibition ratio at 50 µg/ml	24-h	Renal	None
1698	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HEK-293T	Renal Cancer	MTT/MTS assay	30.82 Inhibition ratio at 50 µg/ml	24-h	Renal	None
1697	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HL7702	Liver Cancer	MTT/MTS assay	38.13 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1696	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HL7702	Liver Cancer	MTT/MTS assay	36.25 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1695	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HL7702	Liver Cancer	MTT/MTS assay	37.00 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1694	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HL7702	Liver Cancer	MTT/MTS assay	37.22 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1693	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	A-549	Lung Cancer	MTT/MTS assay	52.50 Inhibition ratio at 50 µg/ml	24-h	Lung	None
1692	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	A-549	Lung Cancer	MTT/MTS assay	47.26Inhibition ratio at 50 µg/ml	24-h	Lung	None
1691	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	A-549	Lung Cancer	MTT/MTS assay	50.64 Inhibition ratio at 50 µg/ml	24-h	Lung	None
1690	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	A-549	Lung Cancer	MTT/MTS assay	45.62 Inhibition ratio at 50 µg/ml	24-h	Lung	None
1689	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	BGC-823	Gastric Cancer	MTT/MTS assay	73.705 Inhibition ratio at 50 µg/ml	24-h	Stomach	None
1688	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	BGC-823	Gastric Cancer	MTT/MTS assay	62.49 Inhibition ratio at 50 µg/ml	24-h	Stomach	None
1687	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	BGC-823	Gastric Cancer	MTT/MTS assay	50.85 Inhibition ratio at 50 µg/ml	24-h	Stomach	None
1686	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	BGC-823	Gastric Cancer	MTT/MTS assay	48.19 Inhibition ratio at 50 µg/ml	24-h	Stomach	None
1685	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide aNot Available temporins	HepG-2	Liver Cancer	MTT/MTS assay	73.07 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1684	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide aNot Available temporins	HepG-2	Liver Cancer	MTT/MTS assay	60.22 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1683	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HepG-2	Liver Cancer	MTT/MTS assay	55.98 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1682	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HepG-2	Liver Cancer	MTT/MTS assay	50.90 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1681	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HeLa	Cervical Cancer	MTT/MTS assay	78.045 Inhibition ratio at 50 µg/ml	24-h	Cervix	None
1680	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HeLa	Cervical Cancer	MTT/MTS assay	73.09 Inhibition ratio at 50 µg/ml	24-h	Cervix	None
1679	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HeLa	Cervical Cancer	MTT/MTS assay	56.81 Inhibition ratio at 50 µg/ml	24-h	Cervix	None
1678	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HeLa	Cervical Cancer	MTT/MTS assay	52.32 Inhibition ratio at 50 µg/ml	24-h	Cervix	None
1677	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	SMMC-7721	Liver Cancer	MTT/MTS assay	86.175 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1676	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	SMMC-7721	Liver Cancer	MTT/MTS assay	70.39 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1675	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	SMMC-7721	Liver Cancer	MTT/MTS assay	59.37 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1674	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	SMMC-7721	Liver Cancer	MTT/MTS assay	52.77 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1673	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	SW-1116	Colorectal Cancer	MTT/MTS assay	81.465 Inhibition ratio at 50 µg/ml	24-h	Colon	None
1672	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	SW-1116	Colorectal Cancer	MTT/MTS assay	72.69 Inhibition ratio at 50 µg/ml	24-h	Colon	None
1671	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	SW-1116	Colorectal Cancer	MTT/MTS assay	62.73 Inhibition ratio at 50 µg/ml	24-h	Colon	None
1670	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	SW-1116	Colorectal Cancer	MTT/MTS assay	57.62 Inhibition ratio at 50 µg/ml	24-h	Colon	None
1648	12366526	2002	PAWRKARRWARRMKKLAA	L15	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=178 µM	4-h	Colon	None
1647	12366526	2002	PAWRKARRWAWRMKKLAA	L14	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=423 µM	4-h	Colon	None
1646	12366526	2002	PAWRKAFRKAWRMLKKAA	L13	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=29 µM	4-h	Colon	None
1645	12366526	2002	PAWRKAFRWAKRMLKKAA	L12	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=25 µM	4-h	Colon	None
1644	12366526	2002	PAARKAARWAWRMLKKGA	L11	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=248 µM	4-h	Colon	None
1643	12366526	2002	PAARKAFRWAWRMLKKAA	L10	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=35 µM	4-h	Colon	None
1642	12366526	2002	PAWRKAARWAWRMLKKAA	L9	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=52 µM	4-h	Colon	None
1641	12366526	2002	PAWAKAFRAAARMKLKAA	L8	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=180 µM	4-h	Colon	None
1640	12366526	2002	PAWRKAFRAAWRMLKKAA	L7	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=16 µM	4-h	Colon	None
1639	12366526	2002	PAWRKAFRWAARMLKKAA	L6	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=15 µM	4-h	Colon	None
1638	12366526	2002	PAWRKAFRWAWRMLKKAA	L5	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=14 µM	4-h	Colon	None
1637	12366526	2002	PAWFKARRWAWRMLKKAA	L4	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=57 µM	4-h	Colon	None
1636	12366526	2002	PAWRKAFRWAWRMKKLAA	L3	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=141 µM	4-h	Colon	None
1635	12366526	2002	PAWFKARRWAWRMKKLAA	L2	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=>440 µM	4-h	Colon	None
1634	12366526	2002	PEWFKCRRWQWRMKKLGA	L1	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=>404 µM	4-h	Colon	None
1632	12366526	2002	PAWRKARRWAWRMKKLAA	L14	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=141 µM	4-h	Breast	None
1633	12366526	2002	PAWRKARRWARRMKKLAA	L15	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=92 µM	4-h	Breast	None
1631	12366526	2002	PAWRKAFRKAWRMLKKAA	L13	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=12 µM	4-h	Breast	None
1630	12366526	2002	PAWRKAFRWAKRMLKKAA	L12	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=10 µM	4-h	Breast	None
1628	12366526	2002	PAARKAFRWAWRMLKKAA	L10	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=20 µM	4-h	Breast	None
1629	12366526	2002	PAARKAARWAWRMLKKGA	L11	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=75 µM	4-h	Breast	None
1627	12366526	2002	PAWRKAARWAWRMLKKAA	L9	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=32 µM	4-h	Breast	None
1625	12366526	2002	PAWRKAFRAAWRMLKKAA	L7	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=11 µM	4-h	Breast	None
1626	12366526	2002	PAWAKAFRAAARMKLKAA	L8	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=87 µM	4-h	Breast	None
1624	12366526	2002	PAWRKAFRWAARMLKKAA	L6	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=12 µM	4-h	Breast	None
1622	12366526	2002	PAWFKARRWAWRMLKKAA	L4	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=16 µM	4-h	Breast	None
1623	12366526	2002	PAWRKAFRWAWRMLKKAA	L5	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=8 µM	4-h	Breast	None
1621	12366526	2002	PAWRKAFRWAWRMKKLAA	L3	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=18 µM	4-h	Breast	None
1620	12366526	2002	PAWFKARRWAWRMKKLAA	L2	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=>254 µM	4-h	Breast	None
1619	12366526	2002	PEWFKCRRWQWRMKKLGA	L1	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=>404 µM	4-h	Breast	None
1617	12366526	2002	PAWRKARRWAWRMKKLAA	L14	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=125 µM	4-h	Skin	None
1618	12366526	2002	PAWRKARRWARRMKKLAA	L15	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=87 µM	4-h	Skin	None
1616	12366526	2002	PAWRKAFRKAWRMLKKAA	L13	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=14 µM	4-h	Skin	None
1615	12366526	2002	PAWRKAFRWAKRMLKKAA	L12	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=7.9 µM	4-h	Skin	None
1614	12366526	2002	PAARKAARWAWRMLKKGA	L11	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=116 µM	4-h	Skin	None
1613	12366526	2002	PAARKAFRWAWRMLKKAA	L10	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=24 µM	4-h	Skin	None
1611	12366526	2002	PAWAKAFRAAARMKLKAA	L8	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=110 µM	4-h	Skin	None
1612	12366526	2002	PAWRKAARWAWRMLKKAA	L9	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=35 µM	4-h	Skin	None
1610	12366526	2002	PAWRKAFRAAWRMLKKAA	L7	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=16 µM	4-h	Skin	None
1609	12366526	2002	PAWRKAFRWAARMLKKAA	L6	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=11 µM	4-h	Skin	None
1608	12366526	2002	PAWRKAFRWAWRMLKKAA	L5	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=6.6 µM	4-h	Skin	None
1607	12366526	2002	PAWFKARRWAWRMLKKAA	L4	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=31 µM	4-h	Skin	None
1606	12366526	2002	PAWRKAFRWAWRMKKLAA	L3	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=32 µM	4-h	Skin	None
1604	12366526	2002	PEWFKCRRWQWRMKKLGA	L1	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=>404 µM	4-h	Skin	None
1605	12366526	2002	PAWFKARRWAWRMKKLAA	L2	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=144 µM	4-h	Skin	None
1547	18656352	2008	KAQIRAMECNIL	A5	12	Linear	L	None	Free	Free	Anticancer	Cyclin B (285-296)	HCT-116	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	None
1542	16637646	2006	FKRIVQRIKDFLRNLV	dLL-37(17-32)c	16	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	HBMEC	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Not Available	None
1541	16637646	2006	LLGDFKRIVQRIKDF	LL-37(1-4,17-27)	15	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	HBMEC	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Not Available	None
1539	16637646	2006	FKRIVQRIKDFLRNLV	LL-37(17-32)b	16	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	HBMEC	Prostate Cancer	MTT/MTS assay	LC₅₀=25 µM	24-h	Not Available	None
1540	16637646	2006	FKRIVQRIKDFLR	LL-37(17-29)	13	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	HBMEC	Prostate Cancer	MTT/MTS assay	LC₅₀=55 µM	24-h	Not Available	None
1537	16637646	2006	LLGDFFRKSKEK	LL-37(1-12)	12	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	HBMEC	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Not Available	None
1536	16637646	2006	FKRIVQRIKDFLRNLV	dLL-37(17-32)c	16	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KB	Oral Cancer	MTT/MTS assay	Not Available	24-h	Not Available	None
1534	16637646	2006	FKRIVQRIKDFLR	LL-37(17-29)	13	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KB	Oral Cancer	MTT/MTS assay	LC₅₀=57 µM	24-h	Not Available	None
1535	16637646	2006	LLGDFKRIVQRIKDF	LL-37(1-4,17-27)	15	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KB	Oral Cancer	MTT/MTS assay	Not Available	24-h	Not Available	None
1533	16637646	2006	FKRIVQRIKDFLRNLV	LL-37(17-32)b	16	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KB	Oral Cancer	MTT/MTS assay	LC₅₀=30 µM	24-h	Not Available	None
1531	16637646	2006	LLGDFFRKSKEK	LL-37(1-12)	12	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KB	Oral Cancer	MTT/MTS assay	Not Available	24-h	Not Available	None
1530	16637646	2006	FKRiVQRiKDFlRNLV	dLL-37(17-32)c	16	Linear	Mix	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KBv	Tumor	MTT/MTS assay	Not Available	24-h	Not Available	None
1529	16637646	2006	LLGDFKRIVQRIKDF	LL-37(1-4,17-27)	15	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KBv	Tumor	MTT/MTS assay	Not Available	24-h	Not Available	None
1528	16637646	2006	FKRIVQRIKDFLR	LL-37(17-29)	13	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KBv	Tumor	MTT/MTS assay	LC₅₀=60 µM	24-h	Not Available	None
1527	16637646	2006	FKRIVQRIKDFLRNLV	LL-37(17-32)b	16	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KBv	Tumor	MTT/MTS assay	LC₅₀=30 µM	24-h	Not Available	None
1525	16637646	2006	LLGDFFRKSKEK	LL-37(1-12)	12	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KBv	Tumor	MTT/MTS assay	Not Available	24-h	Not Available	None
1444	12646578	2003	KLllKLKlKlLK	l3,4,8,10K5L7	12	Linear	Mix	None	Free	Free	Antibacterial	Diastereomeric peptide	D-122	Lung Cancer	XTT assay	LC₅₀ = >50 µM	24-h	Lung	None
1443	12646578	2003	KLlRLLkkLlRLlLK	l3,10,13K7,8K4R2L9	15	Linear	Mix	None	Free	Free	Antibacterial	Diastereomeric peptide	D-122	Lung Cancer	XTT assay	LC₅₀= 4.5 µM	24-h	Lung	None
1442	12646578	2003	KlllKLKlKlLK	l3,4,8,10K5L7	12	Linear	Mix	None	Free	Free	Antibacterial	Diastereomeric peptide	B16-F10	Skin Cancer	XTT assay	LC₅₀ = 100 µM	24-h	Skin	None
1441	12646578	2003	KLlRLLkkLlRLlLK	l3,10,13K7,8K4R2L9	15	Linear	Mix	None	Free	Free	Antibacterial	Diastereomeric peptide	B16-F10	Skin Cancer	XTT assay	LC₅₀ = 2.5 µM	24-h	Skin	None
1437	21955251	2011	GIIKKIIIKKIIIKKI	Cationic Amphiphilic	16	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HL-60	Pancreatic Cancer	WST-1 assay	IC₅₀ = 25 µM	Not Available	Pancreatic	None
1436	21955251	2011	GIIKKIIIKKI	Cationic Amphiphilic	11	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HL-60	Pancreatic Cancer	WST-1 assay	IC₅₀ = >500 µM	Not Available	Pancreatic	None
1433	21955251	2011	GIIKKIIIKKIIIKKI	Cationic Amphiphilic	16	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HeLa	Cervical Cancer	WST-1 assay	IC₅₀ = 15 µM	Not Available	Cervix	None
1432	21955251	2011	GIIKKIIIKKI	Cationic Amphiphilic	11	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HeLa	Cervical Cancer	WST-1 assay	IC₅₀ = 160 µM	Not Available	Cervix	None
1427	9022710	1996	FLPLIGRVLSGIL	Temporin A	13	Linear	L	None	Amidation	Free	Antimicrobial	Frog Rana temporaria	U-937	Lymphoma Cancer	MTT/MTS assay	15% Cytotoxicity at 0.5 µg/ml	6-h	Blood	None
1426	8335113, 21403917	1993	RGGRLCYCRRRFCVCVGR	Protegrin 1	18	Linear	L	None	Amidation	Free	Antimicrobial	Alpha helical peptide without cysteines	U-937	Lymphoma Cancer	MTT/MTS assay	61% Cytotoxicity at 0.5 µg/ml	6-h	Blood	None
1424	14508884, 21403917	2003	ILRWPWWPWRRK	OmigaNAn MBI-226	12	Linear	L	None	Amidation	Free	Antimicrobial	Helical peptide with a predominance of one or more amino acids tryptophane-rich	U-937	Lymphoma Cancer	MTT/MTS assay	27% Cytotoxicity at 0.5 µg/ml	6-h	Blood	None
1423	16512752, 21403917	2006	AKRHHGYKRKFH	Demegen P-113	12	Linear	L	None	Amidation	Free	Antimicrobial	Amphibian skin peptide	U-937	Lymphoma Cancer	MTT/MTS assay	15% Cytotoxicity at 0.5 µg/ml	6-h	Blood	None
1422	10504394, 21403917	2009	GLFDVIKKVASVIGGL	Citropin1.1	16	Linear	L	None	Amidation	Free	Antibacterial	Australian blue mountains tree frog, Litoria citropa	U-937	Lymphoma Cancer	MTT/MTS assay	60% Cytotoxicity at 0.5 µg/ml	6-h	Blood	None
1421	10455241, 21403917	2009	GLFDVIKKVASVIGGL	Citropin1.1	16	Linear	L	None	Amidation	Free	Antibacterial	Australian blue mountains tree frog, Litoria citropa	U-937	Lymphoma Cancer	MTT/MTS assay	60% Cytotoxicity at 0.5 µg/ml	6-h	Blood	None
1350	18931881	2008	ETFSDLWKLL	PNC-28	10	Linear	L	None	Free	Free	Anticancer	Antennapedia	MiaPaCa.2	Pancreatic Cancer	MTT/MTS assay	Cytotoxicity=80% µMo/ml	48-h	Pancreatic	None
1305	10951191	2000	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Prostate tumor cellline	Prostate Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Prostate	None
1304	10951191	2000	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Renal tumor cellline	Renal Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Renal	None
1303	10951191	2000	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Ovary tumor cellline	Ovarian Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Ovary	None
1301	10951191	2000	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Brain tumor cellline	Brain Tumor	Not Available	LC₅₀ = 10 µM	Not Available	Brain	None
1302	10951191	2000	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Skin tumor cellline	Skin Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Skin	None
1300	10951191	2000	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Colon tumor cellline	Colon Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Colon	None
1299	10951191	2000	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Lung tumor cellline	Lung Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Lung	None
1298	10951191	2000	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Leukemia tumor cellline	Leukemia Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Blood	None
1297	10951191	2000	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Breast tumor cellline	Breast Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Breast	None
1296	10951191	2000	GLFDIVKKIAGHIASSI	Aurein 3.2	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Prostate tumor cellline	Prostate Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Prostate	None
1295	10951191	2000	GLFDIVKKIAGHIASSI	Aurein 3.2	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Renal tumor cellline	Renal Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Renal	None
1294	10951191	2000	GLFDIVKKIAGHIASSI	Aurein 3.2	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Ovary tumor cellline	Ovarian Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Ovary	None
1293	10951191	2000	GLFDIVKKIAGHIASSI	Aurein 3.2	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Skin tumor cellline	Skin Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Skin	None
1292	10951191	2000	GLFDIVKKIAGHIASSI	Aurein 3.2	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Brain tumor cellline	Brain Tumor	Not Available	LC₅₀ = 10 µM	Not Available	Brain	None
1290	10951191	2000	GLFDIVKKIAGHIASSI	Aurein 3.2	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Lung tumor cellline	Lung Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Lung	None
1291	10951191	2000	GLFDIVKKIAGHIASSI	Aurein 3.2	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Colon tumor cellline	Colon Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Colon	None
1289	10951191	2000	GLFDIVKKIAGHIASSI	Aurein 3.2	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Leukemia tumor cellline	Leukemia Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Blood	None
1288	10951191	2000	GLFDIVKKIAGHIASSI	Aurein 3.2	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Breast tumor cellline	Breast Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Breast	None
1287	10951191	2000	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Prostate tumor cellline	Prostate Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Prostate	None
1286	10951191	2000	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Renal tumor cellline	Renal Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Renal	None
1285	10951191	2000	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Ovary tumor cellline	Ovarian Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Ovary	None
1284	10951191	2000	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Skin tumor cellline	Skin Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Skin	None
1283	10951191	2000	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Brain tumor cellline	Brain Tumor	Not Available	LC₅₀=10-100 µM	Not Available	Brain	None
1282	10951191	2000	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Colon tumor cellline	Colon Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Colon	None
1281	10951191	2000	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Lung tumor cellline	Lung Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Lung	None
1280	10951191	2000	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Leukemia tumor cellline	Leukemia Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Blood	None
1279	10951191	2000	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Breast tumor cellline	Breast Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Breast	None
1278	10951191	2000	GLFDIAKKVIGVIGSL	Aurein2.6	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Prostate tumor cellline	Prostate Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Prostate	None
1277	10951191	2000	GLFDIAKKVIGVIGSL	Aurein2.6	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Renal tumor cellline	Renal Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Renal	None
1276	10951191	2000	GLFDIAKKVIGVIGSL	Aurein2.6	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Ovary tumor cellline	Ovarian Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Ovary	None
1275	10951191	2000	GLFDIAKKVIGVIGSL	Aurein2.6	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Skin tumor cellline	Skin Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Skin	None
1274	10951191	2000	GLFDIAKKVIGVIGSL	Aurein2.6	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Brain tumor cellline	Brain Tumor	Not Available	LC₅₀ = 10 µM	Not Available	Brain	None
1273	10951191	2000	GLFDIAKKVIGVIGSL	Aurein2.6	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Colon tumor cellline	Colon Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Colon	None
1272	10951191	2000	GLFDIAKKVIGVIGSL	Aurein2.6	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Lung tumor cellline	Lung Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Lung	None
1271	10951191	2000	GLFDIAKKVIGVIGSL	Aurein2.6	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Leukemia tumor cellline	Leukemia Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Blood	None
1270	10951191	2000	GLFDIAKKVIGVIGSL	Aurein2.6	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Breast tumor cellline	Breast Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Breast	None
1269	10951191	2000	GLFDIVKKVVGAFGSL	Aurein2.5	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Prostate tumor cellline	Prostate Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Prostate	None
1268	10951191	2000	GLFDIVKKVVGAFGSL	Aurein2.5	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Renal tumor cellline	Renal Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Renal	None
1267	10951191	2000	GLFDIVKKVVGAFGSL	Aurein2.5	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Ovary tumor cellline	Ovarian Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Ovary	None
1266	10951191	2000	GLFDIVKKVVGAFGSL	Aurein2.5	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Skin tumor cellline	Skin Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Skin	None
1265	10951191	2000	GLFDIVKKVVGAFGSL	Aurein2.5	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Brain tumor cellline	Brain Tumor	Not Available	LC₅₀ = 10 µM	Not Available	Brain	None
1264	10951191	2000	GLFDIVKKVVGAFGSL	Aurein2.5	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Colon tumor cellline	Colon Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Colon	None
1263	10951191	2000	GLFDIVKKVVGAFGSL	Aurein2.5	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Lung tumor cellline	Lung Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Lung	None
1262	10951191	2000	GLFDIVKKVVGAFGSL	Aurein2.5	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Leukemia tumor cellline	Leukemia Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Blood	None
1261	10951191	2000	GLFDIVKKVVGAFGSL	Aurein2.5	16	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Breast tumor cellline	Breast Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Breast	None
1260	10951191	2000	GLFDIIKKIAESF	Aurein1.2	13	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Prostate tumor cellline	Prostate Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Prostate	None
1258	10951191	2000	GLFDIIKKIAESF	Aurein1.2	13	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Ovary tumor cellline	Ovarian Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Ovary	None
1259	10951191	2000	GLFDIIKKIAESF	Aurein1.2	13	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Renal tumor cellline	Renal Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Renal	None
1257	10951191	2000	GLFDIIKKIAESF	Aurein1.2	13	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Skin tumor cellline	Skin Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Skin	None
1256	10951191	2000	GLFDIIKKIAESF	Aurein1.2	13	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Brain tumor cellline	Brain Tumor	Not Available	LC₅₀ = 10 µM	Not Available	Brain	None
1255	10951191	2000	GLFDIIKKIAESF	Aurein1.2	13	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Colon tumor cellline	Colon Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Colon	None
1254	10951191	2000	GLFDIIKKIAESF	Aurein1.2	13	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Lung tumor cellline	Lung Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Lung	None
1253	10951191	2000	GLFDIIKKIAESF	Aurein1.2	13	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Leukemia tumor cellline	Leukemia Cancer	Not Available	LC₅₀=10-100 µM	Not Available	Blood	None
1252	10951191	2000	GLFDIIKKIAESF	Aurein1.2	13	Linear	L	None	Amidation	Free	Antimicrobial	Southern bell frog	Breast tumor cellline	Breast Cancer	Not Available	LC₅₀ = 10 µM	Not Available	Breast	None
1230	9352466	1997	KWKKFLKIGIGKFLHLAKKF	P8	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=1.8 µM	72-h	Lung	None
1229	9352466	1997	KWKLFAKIGIGKFLHLAKKF	P7	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=2.4 µM	72-h	Lung	None
1227	9352466	1997	KWKLFKKIGIGAFLHLAKKF	P5	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=3.2 µM	72-h	Lung	None
1228	9352466	1997	KWKLFKKIGIGKFKLAKKF	P6	19	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=3.1 µM	72-h	Lung	None
1226	9352466	1997	KWKLFKKIGIGKFLHLAKKF	P4	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=2.8 µM	72-h	Lung	None
1225	9352466	1997	KWKLFKKIGIGAFLHSAKKF	P3	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=10.9 µM	72-h	Lung	None
1224	9352466	1997	KWKLFKKIGIGKFLHSATTF	P2	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=47.7 µM	72-h	Lung	None
1223	9352466	1997	KWKLFKKIGIGAVLKVLKKG	P1	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=4.5 µM	72-h	Lung	None
1221	9352466	1997	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=15.8 µM	72-h	Lung	None
1222	9352466	1997	KWKLFKKIGIGAVLKVLTTG	CA-ME	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H146	Lung Cancer	MTT/MTS assay	IC₅₀=28.6 µM	72-h	Lung	None
1220	9352466	1997	KWKKFLKIGIGKFLHLAKKF	P8	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=2.3 µM	72-h	Lung	None
1219	9352466	1997	KWKLFAKIGIGKFLHLAKKF	P7	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=2.4 µM	72-h	Lung	None
1217	9352466	1997	KWKLFKKIGIGAFLHLAKKF	P5	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=2.9 µM	72-h	Lung	None
1218	9352466	1997	KWKLFKKIGIGKFKLAKKF	P6	19	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=2 µM	72-h	Lung	None
1216	9352466	1997	KWKLFKKIGIGKFLHLAKKF	P4	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=1.3 µM	72-h	Lung	None
1215	9352466	1997	KWKLFKKIGIGAFLHSAKKF	P3	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=9.3 µM	72-h	Lung	None
1214	9352466	1997	KWKLFKKIGIGKFLHSATTF	P2	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=37.9 µM	72-h	Lung	None
1213	9352466	1997	KWKLFKKIGIGAVLKVLKKG	P1	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=3.5 µM	72-h	Lung	None
1212	9352466	1997	KWKLFKKIGIGAVLKVLTTG	CA-ME	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=28.6 µM	72-h	Lung	None
1211	9352466	1997	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H128	Lung Cancer	MTT/MTS assay	IC₅₀=16.1 µM	72-h	Lung	None
1210	9352466	1997	KWKKFLKIGIGKFLHLAKKF	P8	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=2.6 µM	72-h	Lung	None
1209	9352466	1997	KWKLFAKIGIGKFLHLAKKF	P7	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=3.1 µM	72-h	Lung	None
1208	9352466	1997	KWKLFKKIGIGKFKLAKKF	P6	19	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=1.7 µM	72-h	Lung	None
1207	9352466	1997	KWKLFKKIGIGAFLHLAKKF	P5	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=2.9 µM	72-h	Lung	None
1206	9352466	1997	KWKLFKKIGIGKFLHLAKKF	P4	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=1.9 µM	72-h	Lung	None
1205	9352466	1997	KWKLFKKIGIGAFLHSAKKF	P3	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=9.3 µM	72-h	Lung	None
1204	9352466	1997	KWKLFKKIGIGKFLHSATTF	P2	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=36.2 µM	72-h	Lung	None
1197	10675500	2000	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=44 µM	72-h	Breast	None
1198	10675500	2000	KWKLFKKIKFLHSAKKF	CA-MA1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100 µM	72-h	Breast	None
1199	10675500	2000	KWKLFKKIPKFLHSAKKF	CA-MA2	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=28 µM	72-h	Breast	None
1200	10675500	2000	KWKLFKKIGPGKFLHSAKKF	CA-MA3	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=>100 µM	72-h	Breast	None
1201	9352466	1997	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=15.8 µM	72-h	Lung	None
1202	9352466	1997	KWKLFKKIGIGAVLKVLTTG	CA-ME	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=32.2 µM	72-h	Lung	None
1203	9352466	1997	KWKLFKKIGIGAVLKVLKKG	P1	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A-Magainin 2	NCI-H69	Lung Cancer	MTT/MTS assay	IC₅₀=3.4 µM	72-h	Lung	None
1190	10675500	2000	KWKLFKKIKFLHSAKKF	CA-MA1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=100 µM	72-h	Lung	None
1191	10675500	2000	KWKLFKKIPKFLHSAKKF	CA-MA2	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=25 µM	72-h	Lung	None
1192	10675500	2000	KWKLFKKIGPGKFLHSAKKF	CA-MA3	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=>100 µM	72-h	Lung	None
1193	10675500	2000	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=30 µM	72-h	Blood	None
1194	10675500	2000	KWKLFKKIKFLHSAKKF	CA-MA1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=65 µM	72-h	Blood	None
1195	10675500	2000	KWKLFKKIPKFLHSAKKF	CA-MA2	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=20 µM	72-h	Blood	None
1196	10675500	2000	KWKLFKKIGPGKFLHSAKKF	CA-MA3	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=75 µM	72-h	Blood	None
1189	10675500	2000	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=60 µM	72-h	Lung	None
1188	10675500	2000	KWKLFKKIGPGKFLHSAKKF	CA-MA3	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=>100 µM	72-h	Blood	None
1187	10675500	2000	KWKLFKKIPKFLHSAKKF	CA-MA2	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=35.1 µM	72-h	Blood	None
1185	10675500	2000	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=65 µM	72-h	Blood	None
1186	10675500	2000	KWKLFKKIKFLHSAKKF	CA-MA1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin-Magainin hybrid peptides	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=85.3 µM	72-h	Blood	None
1183	12005420	2001	KWKLFKKIPLKKF	C-9	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1184	12005420	2001	KWKLFKKIPKFLH	C-10	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1182	12005420	2001	KWKLFKKIPKFLHL	C-8	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=30 µM	48-h	Blood	None
1180	12005420	2001	KWKLFKKIPKFLHLA	C-6	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=27 µM	48-h	Blood	None
1181	12005420	2001	KWKLFKKIPLAKKF	C-7	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1179	12005420	2001	KWKLFKKIPHLAKKF	C-5	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=67 µM	48-h	Blood	None
1177	12005420	2001	KWKLFKKIPLHLAKKF	C-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=62 µM	48-h	Blood	None
1178	12005420	2001	KWKLFKKIPKFLHLAK	C-4	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=25 µM	48-h	Blood	None
1176	12005420	2001	KWKLFKKIPKFLHLAKK	C-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=23 µM	48-h	Blood	None
1175	12005420	2001	KWKLFKKIPFLHLAKKF	C-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=31 µM	48-h	Blood	None
1174	12005420	2001	WKKIPKFLHLLKKF	N-5L	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=10 µM	48-h	Blood	None
1173	12005420	2001	WFKKIPKFLHLLKKF	N-4L	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=3 µM	48-h	Blood	None
1172	12005420	2001	KWFKKIPKFLHLLKKF	N-3L	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=4.2 µM	48-h	Blood	None
1170	12005420	2001	WFKKIPKFLHLAKKF	N-4	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=24 µM	48-h	Blood	None
1171	12005420	2001	WKKIPKFLHLAKKF	N-5	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1168	12005420	2001	FKLFKKIPKFLHLAKKF	N-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=7 µM	48-h	Blood	None
1169	12005420	2001	KWFKKIPKFLHLAKKF	N-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=11 µM	48-h	Blood	None
1166	12005420	2001	KWKLFKKISKFLHLAKKF	[S9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=3 µM	48-h	Blood	None
1167	12005420	2001	WKLFKKIPKFLHLAKKF	N-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=6 µM	48-h	Blood	None
1165	12005420	2001	KWKLFKKILKFLHLAKKF	[L9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=3 µM	48-h	Blood	None
1164	12005420	2001	KWKFKKIPKFLHLAKKF	P18	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=3.5 µM	48-h	Blood	None
1163	12005420	2001	KWKLFKKIPKFLHSAKKF	CA-MA-P	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=25 µM	48-h	Blood	None
1162	12005420	2001	KWKLFKKIPKFLH	C-10	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1161	12005420	2001	KWKLFKKIPLKKF	C-9	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1160	12005420	2001	KWKLFKKIPKFLHL	C-8	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=54 µM	48-h	Blood	None
1159	12005420	2001	KWKLFKKIPLAKKF	C-7	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1158	12005420	2001	KWKLFKKIPKFLHLA	C-6	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=21 µM	48-h	Blood	None
1157	12005420	2001	KWKLFKKIPHLAKKF	C-5	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=81 µM	48-h	Blood	None
1156	12005420	2001	KWKLFKKIPKFLHLAK	C-4	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=31 µM	48-h	Blood	None
1155	12005420	2001	KWKLFKKIPLHLAKKF	C-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=74 µM	48-h	Blood	None
1154	12005420	2001	KWKLFKKIPKFLHLAKK	C-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=26 µM	48-h	Blood	None
1153	12005420	2001	KWKLFKKIPFLHLAKKF	C-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=32 µM	48-h	Blood	None
1152	12005420	2001	WKKIPKFLHLLKKF	N-5L	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=14 µM	48-h	Blood	None
1151	12005420	2001	WFKKIPKFLHLLKKF	N-4L	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=6 µM	48-h	Blood	None
1150	12005420	2001	KWFKKIPKFLHLLKKF	N-3L	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=4 µM	48-h	Blood	None
1149	12005420	2001	WKKIPKFLHLAKKF	N-5	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1148	12005420	2001	WFKKIPKFLHLAKKF	N-4	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=23 µM	48-h	Blood	None
1147	12005420	2001	KWFKKIPKFLHLAKKF	N-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=17 µM	48-h	Blood	None
1146	12005420	2001	FKLFKKIPKFLHLAKKF	N-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=11 µM	48-h	Blood	None
1145	12005420	2001	WKLFKKIPKFLHLAKKF	N-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=12 µM	48-h	Blood	None
1144	12005420	2001	KWKLFKKISKFLHLAKKF	[S9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=7 µM	48-h	Blood	None
1143	12005420	2001	KWKLFKKILKFLHLAKKF	[L9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=9 µM	48-h	Blood	None
1142	12005420	2001	KWKFKKIPKFLHLAKKF	P18	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=4 µM	48-h	Blood	None
1141	12005420	2001	KWKLFKKIPKFLHSAKKF	CA-MA-P	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=20 µM	48-h	Blood	None
1140	12005420	2001	KWKLFKKIPKFLH	C-10	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100. <µM	48-h	Breast	None
1139	12005420	2001	KWKLFKKIPLKKF	C-9	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100. <µM	48-h	Breast	None
1138	12005420	2001	KWKLFKKIPKFLHL	C-8	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=83 µM	48-h	Breast	None
1137	12005420	2001	KWKLFKKIPLAKKF	C-7	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100. <µM	48-h	Breast	None
1136	12005420	2001	KWKLFKKIPKFLHLA	C-6	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=47 µM	48-h	Breast	None
1135	12005420	2001	KWKLFKKIPHLAKKF	C-5	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100 µM	48-h	Breast	None
1134	12005420	2001	KWKLFKKIPKFLHLAK	C-4	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=54 µM	48-h	Breast	None
1133	12005420	2001	KWKLFKKIPLHLAKKF	C-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=79 µM	48-h	Breast	None
1132	12005420	2001	KWKLFKKIPKFLHLAKK	C-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=38 µM	48-h	Breast	None
1131	12005420	2001	KWKLFKKIPFLHLAKKF	C-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=26 µM	48-h	Breast	None
1130	12005420	2001	WKKIPKFLHLLKKF	N-5L	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=17 µM	48-h	Breast	None
1129	12005420	2001	WKKIPKFLHLLKKF	N-4L	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=5 µM	48-h	Breast	None
1128	12005420	2001	WFKKIPKFLHLLKKF	N-3L	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=5 µM	48-h	Breast	None
1127	12005420	2001	WKKIPKFLHLAKKF	N-5	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100. <µM	48-h	Breast	None
1126	12005420	2001	WFKKIPKFLHLAKKF	N-4	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=32 µM	48-h	Breast	None
1125	12005420	2001	KWFKKIPKFLHLAKKF	N-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=17 µM	48-h	Breast	None
1124	12005420	2001	FKLFKKIPKFLHLAKKF	N-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=11 µM	48-h	Breast	None
1123	12005420	2001	WKLFKKIPKFLHLAKKF	N-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=9.5 µM	48-h	Breast	None
1122	12005420	2001	KWKLFKKISKFLHLAKKF	[S9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=4 µM	48-h	Breast	None
1121	12005420	2001	KWKLFKKILKFLHLAKKF	[L9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=3 µM	48-h	Breast	None
1120	12005420	2001	KWKFKKIPKFLHLAKKF	P18	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=8 µM	48-h	Breast	None
1119	12005420	2001	KWKLFKKIPKFLHSAKKF	CA-MA-P	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=20 µM	48-h	Breast	None
1115	16572423	2008	FKCRRWQWRMKKLGA	Lactoferricin B	15	Linear	L	None	Amidation	Free	Antimicrobial	Temporins family	SH-SY-5Y2	Brain Tumor	MTT/MTS assay	IC₅₀=60 µM	48-h	Brain	None
1113	16572423	2008	FKCRRWQWRMKKLGA	Lactoferricin B	15	Linear	L	None	Amidation	Free	Antimicrobial	Temporins family	SK-N-DZ	Brain Tumor	MTT/MTS assay	IC₅₀=37 µM	48-h	Brain	None
1114	16572423	2008	FKCRRWQWRMKKLGA	Lactoferricin B	15	Linear	L	None	Amidation	Free	Antimicrobial	Temporins family	SHEP-12	Brain Tumor	MTT/MTS assay	IC₅₀=45 µM	48-h	Brain	None
1112	16572423	2008	FKCRRWQWRMKKLGA	Lactoferricin B	15	Linear	L	None	Amidation	Free	Antimicrobial	Temporins family	IMR-32	Brain Tumor	MTT/MTS assay	IC₅₀=29 µM	48-h	Brain	None
1111	16572423	2008	FKCRRWQWRMKKLGA	Lactoferricin B	15	Linear	L	None	Amidation	Free	Antibacterial	Temporins family	Kelly	Brain Tumor	MTT/MTS assay	IC₅₀=15.5 µM	48-h	Brain	None
1039	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5.25 µg/ml	96-h	Breast	None
1040	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=32.23 µg/ml	96-h	Breast	None
1037	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5.43 µg/ml	96-h	Breast	None
1038	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=17.56 µg/ml	96-h	Breast	None
1035	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Breast	None
1031	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=5.4 µg/ml	96-h	Liver	None
1032	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=30.79 µg/ml	96-h	Liver	None
1029	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	Not Available	96-h	Liver	None
1030	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=15.07 µg/ml	96-h	Liver	None
1027	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Liver	None
1023	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀=5.01 µg/ml	96-h	Prostate	None
1024	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀=28.9 µg/ml	96-h	Prostate	None
1021	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	96-h	Prostate	None
1022	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀=13.27 µg/ml	96-h	Prostate	None
1019	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Renal	None
1015	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=6.71 µg/ml	96-h	Renal	None
1016	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=26.8 µg/ml	96-h	Renal	None
1013	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=15.11 µg/ml	96-h	Renal	None
1014	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=14 µg/ml	96-h	Renal	None
1011	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Renal	None
1008	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=24.58 µg/ml	96-h	Lung	None
1006	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=13.94 µg/ml	96-h	Lung	None
1007	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=8.01 µg/ml	96-h	Lung	None
1005	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=9.09 µg/ml	96-h	Lung	None
1003	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Lung	None
7728	None	2019	AALVVILKKATEYVHS	IDP-NS10	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links L(3) and A(10)	Free	Free	Anticancer	Synthetic	RG1	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 7 μM	72-96 h	Brain	WO 2019/025432 A1;US011352395B2
7729	None	2019	AALVVILKKATEYVHS	IDP-NS10	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links L(3) and A(10)	Free	Free	Anticancer	Synthetic	GMB-27	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 7.5 μM	72-96 h	Brain	WO 2019/025432 Al;US20200157150A1
7730	None	2019	AALVVILKKATEYVHS	IDP-NS10	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links L(3) and A(10)	Free	Free	Anticancer	Synthetic	12015	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 10 μM	72-96 h	Brain	WO 2019/025432 Al
7731	None	2019	AALVVILKKATEYVHS	IDP-NS10	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links L(3) and A(10)	Free	Free	Anticancer	Synthetic	12089	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 4 μM	72-96 h	Brain	WO 2019/025432 Al
7732	None	2019	AALVVILKKATEYVHS	IDP-NS10	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links L(3) and A(10)	Free	Free	Anticancer	Synthetic	RG6	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 5 μM	72-96 h	Brain	WO 2019/025432 Al
7733	None	2019	AALVVILKKATEYVHS	IDP-NS10	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links L(3) and A(10)	Free	Free	Anticancer	Synthetic	RG4	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 5 μM	72-96 h	Brain	WO 2019/025432 Al
7734	None	2019	AALVVILKKATEYVHS	IDP-NS10	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links L(3) and A(10)	Free	Free	Anticancer	Synthetic	RG5	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 7 μM	72-96 h	Brain	WO 2019/025432 Al
7735	None	2019	AALVVILKKATEYVHS	IDP-NS10	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links L(3) and A(10)	Free	Free	Anticancer	Synthetic	12053	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 50 μM	72-96 h	Brain	WO 2019/025432 Al
7736	None	2019	RQRRNDLRSSFLTLRDH	IDP-NS02	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links D(5) and S(10)	Free	Free	Anticancer	Synthetic	NCI-H524	Lung Cancer	AlamarBlue assay	EC₅₀ ~ 5 μM	72-96 h	Lung	WO 2019/025432 Al
7737	None	2019	RQRRNDLRSSFLTLRDH	IDP-NS16	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(8) and R(15)	Free	Free	Anticancer	Synthetic	RG1	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 15 μM	72-96 h	Brain	WO 2019/025432 Al
7738	None	2019	RQRRNDLRSSFLTLRDH	IDP-NS16	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(8) and R(15)	Free	Free	Anticancer	Synthetic	12053	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 10 μM	72-96 h	Brain	WO 2019/025432 Al
7739	None	2019	RRNDLRSSFLTLRDHVP	IDP-Na05	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links S(8) and H(15)	Free	Free	Anticancer	Synthetic	RG1	Glioblastoma	AlamarBlue assay	EC₅₀ ~ 10 μM	72-96 h	Brain	WO 2019/025432 Al
7741	None	2020	RKRRNDLRSRFLALRDQ	IDP-wtL05	17	Linear	L	None	Free	Free	Anticancer	Synthetic	RPMI	Leukemia Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 10 μM	48-72 h	Blood	US20200239547A1
7742	None	2020	RKRRNDLRSRFLALRDQ	IDP-LS05	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(4) and F(11)	Free	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 5 μM	48-72 h	Blood	US20200239547A1
7743	None	2020	RKRRNDLRSRFLALRDQ	IDP-LS05	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(4) and F(11)	Free	Free	Anticancer	Synthetic	RPMI	Leukemia Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 6 μM	48-72 h	Blood	US20200239547A1
7744	None	2020	RKRRNDLRSRFLALRDQ	IDP-LS13	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(8) and R(15)	Free	Free	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 10 μM	48-72 h	Breast	US20200239547A1
7745	None	2020	RKRRNDLRSRFLALRDQ	IDP-LS13	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(8) and R(15)	Free	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 7 μM	48-72 h	Blood	US20200239547A1
7746	None	2020	RKRRNDLRSRFLALRDQ	IDP-LS13	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(8) and R(15)	Free	Free	Anticancer	Synthetic	RPMI	Leukemia Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 9 μM	48-72 h	Blood	US20200239547A1
7747	None	2020	RKRRNDLRSRFLALRDQ	IDP-LS13	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(8) and R(15)	Free	Free	Anticancer	Synthetic	U266	Lymphoma Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 10 μM	48-72 h	Blood	US20200239547A1
7748	None	2020	RKRRNDLRSRFLALRDQ	IDP-LS15	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(15) and Q(17)	Free	Free	Anticancer	Synthetic	RPMI	Leukemia Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 7 μM	48-72 h	Blood	US20200239547A1
7749	None	2020	RKRRNDLRSRFLALRDQ	IDP-LS15	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(15) and Q(17)	Free	Free	Anticancer	Synthetic	U266	Lymphoma Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 8 μM	48-72 h	Blood	US20200239547A1
7750	None	2020	APKVVILSKALEYLQA	IDP-LS16	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links I(6) and Y(13)	Free	Free	Anticancer	Synthetic	RPMI	Leukemia Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 15 μM	48-72 h	Blood	US20200239547A1
7751	None	2020	APKVVILSKALEYLQA	IDP-LS16	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links I(6) and Y(13)	Free	Free	Anticancer	Synthetic	U266	Lymphoma Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 10 μM	48-72 h	Blood	US20200239547A1
7752	None	2020	APKVVILSKALEYLQA	IDP-LS17	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links S(8) and Q(15)	Free	Free	Anticancer	Synthetic	RPMI	Leukemia Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 10 μM	48-72 h	Blood	US20200239547A1
7753	None	2020	APKVVILSKALEYLQA	IDP-LS17	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links S(8) and Q(15)	Free	Free	Anticancer	Synthetic	U266	Lymphoma Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 16 μM	48-72 h	Blood	US20200239547A1
7760	None	2020	SKAPKVVILSKALEYL	IDP-Lb01	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links S(1) and I(8)	Free	Free	Anticancer	Synthetic	NCl-H187	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 22.5 μM	48-72 h	Lung	US20200239547A1
7761	None	2020	SKAPKVVILSKALEYL	IDP-Lb01	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links S(1) and I(8)	Free	Free	Anticancer	Synthetic	NCl-H82	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 12.5 μM	48-72 h	Lung	US20200239547A1
7762	None	2020	SKAPKVVILSKALEYL	IDP-Lb01	16	Linear	L	-(CH₂)₂-CH=CH-(CH₂)₃; a biradical linker links S(1) and I(8)	Free	Free	Anticancer	Synthetic	NCl-H510A	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 22.5 μM	48-72 h	Lung	US20200239547A1
7763	None	2020	SKAPKVVILSKALEYL	IDP-Lb02	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links K(2) and L(9)	Free	Free	Anticancer	Synthetic	NCl-H187	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 22.5 μM	48-72 h	Lung	US20200239547A1
7764	None	2020	SKAPKVVILSKALEYL	IDP-Lb02	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₂; a biradical linker links K(2) and L(9)	Free	Free	Anticancer	Synthetic	NCl-H82	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 7.5 μM	48-72 h	Lung	US20200239547A1
7765	None	2020	SKAPKVVILSKALEYL	IDP-Lb02	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links K(2) and L(9)	Free	Free	Anticancer	Synthetic	NCl-H510A	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 15 μM	48-72 h	Lung	US20200239547A1
7766	None	2020	SKAPKVVILSKALEYL	IDP-Lb03	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links A(3) and S(10)	Free	Free	Anticancer	Synthetic	NCl-H187	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 22.5 μM	48-72 h	Lung	US20200239547A1
7767	None	2020	SKAPKVVILSKALEYL	IDP-Lb03	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links A(3) and S(10)	Free	Free	Anticancer	Synthetic	NCl-H82	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 5 μM	48-72 h	Lung	US20200239547A1
7768	None	2020	SKAPKVVILSKALEYL	IDP-Lb03	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links A(3) and S(10)	Free	Free	Anticancer	Synthetic	NCl-H510A	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 15 μM	48-72 h	Lung	US20200239547A1
7769	None	2020	SKAPKVVILSKALEYL	IDP-Lb04	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links P(4) and K(11)	Free	Free	Anticancer	Synthetic	NCl-H187	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ > 30 μM	48-72 h	Lung	US20200239547A1
7770	None	2020	SKAPKVVILSKALEYL	IDP-Lb04	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links P(4) and K(11)	Free	Free	Anticancer	Synthetic	NCl-H82	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 12.5 μM	48-72 h	Lung	US20200239547A1
7771	None	2020	SKAPKVVILSKALEYL	IDP-Lb04	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links P(4) and K(11)	Free	Free	Anticancer	Synthetic	NCl-H510A	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ > 30 μM	48-72 h	Lung	US20200239547A1
7772	None	2020	SKAPKVVILSKALEYL	IDP-Lb05	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links K(5) and A(12)	Free	Free	Anticancer	Synthetic	NCl-H187	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 10 μM	48-72 h	Lung	US20200239547A1
7773	None	2020	SKAPKVVILSKALEYL	IDP-Lb05	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links K(5) and A(12)	Free	Free	Anticancer	Synthetic	NCl-H82	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 7.5 μM	48-72 h	Lung	US20200239547A1
7774	None	2020	SKAPKVVILSKALEYL	IDP-Lb05	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links K(5) and A(12)	Free	Free	Anticancer	Synthetic	NCl-H510A	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 12.5 μM	48-72 h	Lung	US20200239547A1
7775	None	2020	SKAPKVVILSKALEYL	IDP-Lb06	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links V(6) and L(13)	Free	Free	Anticancer	Synthetic	NCl-H187	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 12.5 μM	48-72 h	Lung	US20200239547A1
7776	None	2020	SKAPKVVILSKALEYL	IDP-Lb06	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links V(6) and L(13)	Free	Free	Anticancer	Synthetic	NCl-H82	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 7.5 μM	48-72 h	Lung	US20200239547A1
7777	None	2020	SKAPKVVILSKALEYL	IDP-Lb06	16	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links V(6) and L(13)	Free	Free	Anticancer	Synthetic	NCl-H510A	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 12.5 μM	48-72 h	Lung	US20200239547A1
7778	None	2020	RRNDLRSRFLALRDQVP	IDP-La05	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(8) and Q(15)	Free	Free	Anticancer	Synthetic	NCl-H187	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 22.5 μM	48-72 h	Lung	US20200239547A1
7779	None	2020	RRNDLRSRFLALRDQVP	IDP-La05	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(8) and Q(15)	Free	Free	Anticancer	Synthetic	NCl-H82	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 15 μM	48-72 h	Lung	US20200239547A1
7780	None	2020	RRNDLRSRFLALRDQVP	IDP-La05	17	Linear	L	-(CH₂)₆-CH=CH-(CH₂)₃; a biradical linker links R(8) and Q(15)	Free	Free	Anticancer	Synthetic	NCl-H510A	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 10 μM	48-72 h	Lung	US20200239547A1
7781	None	2023	KRWHWWRRHWVVW	MAD1	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	OVCAR-3	Ovarian Cancer	MTT assay	IC₅₀ = 14.2 μM	48-h	Ovary	US11571454 B2
7782	None	2023	KRWHWWRRHWVVW	MAD1	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 36.2 μM	48-h	Lung	US11571454 B2
7783	None	2023	KRWHWWRRHWVVW	MAD1	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	NCI/ADR-RES	Ovarian Cancer	MTT assay	IC₅₀ = 85.6 μM	48-h	Ovary	US11571454 B2
7784	None	2023	LWKRWVGVWRKWL	DAP1	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 11.9 μM	48-h	Lung	US11571454 B2
7785	None	2023	LWKRWVGVWRKWL	DAP1	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	OVCAR-3	Ovarian Cancer	MTT assay	IC₅₀ = 8.6 μM	48-h	Ovary	US11571454 B2
7786	None	2023	LWKRWVGVWRKWL	DAP1	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	NCI/ADR-RES	Ovarian Cancer	MTT assay	IC₅₀ = 14.0 μM	48-h	Lung	US11571454 B2
7787	None	2023	LWKRWVGVWRKWL	DAP1	13	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	T-24	Bladder Cancer	MTT assay	IC₅₀ = 15.3 μM	48-h	Bladder	US11571454 B2
7790	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	U343	Glioblastoma	MTT assay	IC₅₀ = 0.781 μM	48-h	Brain	EP3279210 B1
7791	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	U373MG	Glioblastoma	MTT assay	IC₅₀ = 0.8717 μM	48-h	Brain	EP3279210 B1
7792	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	U251	Glioblastoma	MTT assay	IC₅₀ = 0.7607 μM	48-h	Brain	EP3279210 B1
7793	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	U87-MG	Glioblastoma	MTT assay	IC₅₀ = 0.9164 μM	48-h	Brain	EP3279210 B1
7794	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 3.064 μM	48-h	Liver	EP3279210 B1
7795	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	Hep3B	Liver Cancer	MTT assay	IC₅₀ = 0.7847 μM	48-h	Liver	EP3279210 B1
7796	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	293T	Renal Cancer	MTT assay	IC₅₀ = 1.107 μM	48-h	Renal	EP3279210 B1
7797	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 9.74 μM	48-h	Breast	EP3279210 B1
7798	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 0.8061 μM	48-h	Breast	EP3279210 B1
7799	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	HL-60	Blood Cancer	MTT assay	IC₅₀ = 1.111 μM	48-h	Blood	EP3279210 B1
7800	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	K-562	Blood Cancer	MTT assay	IC₅₀ = 1.103 μM	48-h	Blood	EP3279210 B1
7801	None	2016	NYPQRPCRGDKGPDC	5-2C	15	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	Hel	Blood Cancer	MTT assay	IC₅₀ = 1.055 μM	48-h	Blood	EP3279210 B1
7802	None	2018	GKCSTRGRKCCRRKK	hBD3-3	15	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	Cell Proliferation assay	Concentration dependent reduction in colony formation between 100 μM and 200 μM.	48-h	Breast	US009993519B2
7803	None	2018	GKCSTRGRKCMRRKK	hBD3-3 M1	15	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	Cell Proliferation assay	Concentration dependent reduction in colony formation between 100 μM and 200 μM.	48-h	Breast	US009993519B2
7804	None	2018	GKCSTRGRKMCRRKK	hBD3-3 M2	15	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	Cell Proliferation assay	Concentration dependent reduction in colony formation between 100 μM and 200 μM.	48-h	Breast	US009993519B2
7805	None	2018	GKCSTRGRKCCRRKK	hBD3-3	15	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	Annexin V/ PI staining assay	Inhibition in growth by apoptosis as cells positive for annexin V formed 50% of test group	8-h	Breast	US009993519B2
7806	None	2018	GKCSTRGRKCMRRKK	hBD3-3 M1	15	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	Annexin V/ PI staining assay	Inhibition in growth by apoptosis as cells positive for annexin V formed 50% of test group	8-h	Breast	US009993519B2
7807	None	2018	GKCSTRGRKMCRRKK	hBD3-3 M2	15	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	Annexin V/ PI staining assay	Inhibition in growth by apoptosis as cells positive for annexin V formed 50% of test group	8-h	Breast	US009993519B2
7811	None	2017	LGQQQPFPPQQPY	Alpha-gliadin peptide p31-43	13	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	9.4% growth inhibition at 70 μg/mL	72-h	Lung	US009669068B2
7812	None	2017	LGQQQPFPPQQPY	Alpha-gliadin peptide p31-43	13	Linear	L	None	Free	Free	Anticancer	Synthetic	NCI-H1975	Lung Cancer	MTT assay	36.3% growth inhibition at 70 μg/mL	72-h	Lung	US009669068B2
7813	None	2017	LGQQQPFPPQQPY	Alpha-gliadin peptide p31-43	13	Linear	L	None	Free	Free	Anticancer	Synthetic	PANC-1	Pancreatic Cancer	MTT assay	26.2% growth inhibition at 70 μg/mL	72-h	Pancreas	US009669068B2
7814	None	2017	LGQQQPFPPQQPY	Alpha-gliadin peptide p31-43	13	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	TUNEL assay	Mean apoptotic rate = 36% at 200 μg/mL	72-h	Lung	US009669068B2
7834	None	2023	KKRTLRKNDRKKR	Sample Peptide 5 from EP3604345B1	13	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HCC-827	Lung Cancer	CCK-8 / WST-8	Cell Viability = 106.5% at 25 μM	48-h	Lung	EP3604345B1
4676	None	2016	LTFAEYWAQLaAAAAAa	ALRN-6924	17	Linear	Mix	staple between Ala4 and d-Ala11	Free	Free	Antitumor	Synthetic	TP53-WT subcutaneous mouse xenograft models	Breast Cancer	Not Available	Tumor suppression at doses 2.5 mg/kg to 5mg/kg	28 days	Breast	WO2016049359A1
7848	None	2018	ACSAp(Dab)RYCYQKpPYH	Balixafortide	16	Cyclic ; Disulfide bridge: Cys2-Cys9	Mix	Dab = 2,4-diaminobutyric acid	Free	Free	Anticancer and Antitumor	Synthetic	Namalwa	Lymphoma	HUVEC sprouting	IC₅₀< 10 nM	Not available	Blood	None
7849	None	2018	ACSAp(Dab)RYCYQKpPYH	Balixafortide	16	Cyclic ; Disulfide bridge: Cys2-Cys9	Mix	Dab = 2,4-diaminobutyric acid	Free	Free	Anticancer and Antitumor	Synthetic	Jurkat	Blood Cancer	HUVEC sprouting	IC₅₀< 10 nM	Not available	Blood	None
7850	None	2018	ACSAp(Dab)RYCYQKpPYH	Balixafortide	16	Cyclic ; Disulfide bridge: Cys2-Cys9	Mix	Dab = 2,4-diaminobutyric acid	Free	Free	Anticancer and Antitumor	Synthetic	MDA-MB-231	Breast Cancer	HUVEC sprouting	IC₅₀< 20 nM	Not available	Breast	None
4682	15289344	2004	PGDSTRKCMDLKGNK	PCK3145	15	Linear	L	None	Free	Free	Anticancer and Antitumor	Derived from prostate secretory protein PSP-94	Mat Ly Lu	Prostate Cancer	TUNEL assay	Not available	15 days	Prostate	None
7847	30210643	2018	KEFLHPSKVDLPR	SOR-C13	13	Linear	L	None	Free	Free	Anticancer and Antitumor	Synthetic	SKOV-3	Ovarian Cancer	IP; daily; on days 1 to 12	Effectively inhibited the growth of tumor	12 days	Ovary	None